LTKBID,DILIRank_PubChem_CID,LabelCompoundName,ApprovalYear,DILIConcern,SeverityClass,LabelSection,AdjudicatedDILI,vDILIConcern,Greene_Annotation,Sakatis_Annotation,Xu_Annotation,Zhu_Annotation,SMILES,URL (accessed on 1/21/2016),"VER_DISP (1=LTKB-BD, 2=others)",DILIST_ID,CompoundName,DILIst Classification ,Routs of Administration ,PUBCHEM_CID_from_name,compound_id,_merge,pubchem_smiles
LT00003,667490,mercaptopurine,1953,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1=NC2=C(N1)C(=S)N=CN2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c3b5b8b0-bc5c-4ce9-bbdc-febba60c2658,1,1,mercaptopurine,1,Oral,667490,CID667490,both,C1=NC2=C(N1)C(=S)N=CN2
LT00004,1983,acetaminophen,1968,Most-DILI-Concern,5,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CC(=O)NC1=CC=C(C=C1)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42e4219a-a4ef-f090-f6a4-2fd2e213d397,2,2,acetaminophen,1,Oral,1983,CID1983,both,CC(=O)NC1=CC=C(C=C1)O
LT00006,2265,azathioprine,1968,Most-DILI-Concern,5,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aeab212e-2f56-498d-a286-400ba360a7d2,1,3,azathioprine,1,Oral,2265,CID2265,both,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-]
LT00009,2725,chlorpheniramine,1950,No-DILI-Concern,0,No match,,vNo-DILI-Concern,HH,,Positive,,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3065bc51-c210-483b-876d-14a4d060bdec,2,4,chlorpheniramine,0,Oral,2725,CID2725,both,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
LT00011,2796,clofibrate,1967,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,non-hepatotixic,Positive,,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,,1,5,clofibrate,1,Oral,2796,CID2796,both,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl
LT00013,2907,cyclophosphamide,1959,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1CNP(=O)(OC1)N(CCCl)CCCl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=369e6911-66bd-4544-9901-cf887fdf1dc2,1,6,cyclophosphamide,1,Oral,2907,CID2907,both,C1CNP(=O)(OC1)N(CCCl)CCCl
LT00015,681,dopamine,1974,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,C1=CC(=C(C=C1CCN)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=08f23f6e-150d-45ea-098e-f2edf64c21a1,2,7,dopamine,0,Intravenous,681,CID681,both,C1=CC(=C(C=C1CCN)O)O
LT00016,5757,estradiol,1954,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,WE,Hepatotoxic,Negative,,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ce4e37f-b55b-40cd-a194-ded0056ca594,1,8,estradiol,1,Oral,5757,CID5757,both,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3C=CC(=C4)O
LT00018,3386,fluoxetine,1987,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,WE,non-hepatotixic,Negative,Postive,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5f356c1b-96bd-4ef1-960c-91cf4905e6b1,1,9,fluoxetine,1,Oral,3386,CID3386,both,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F
LT00020,3463,gemfibrozil,1981,Most-DILI-Concern,4,Warnings and precautions,Yes,vMost-DILI-Concern,HH,,Positive,,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=75cac02c-56e3-4dfe-b1e2-4ce166b28833,1,10,gemfibrozil,1,Oral,3463,CID3463,both,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O
LT00022,3715,indomethacin,1965,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2f62bae-5fc0-4f8d-a8b4-446524bd53d1,1,11,indomethacin,1,Oral,3715,CID3715,both,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O
LT00023,3825,ketoprofen,1986,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,NE,,Negative,,CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c2c99853-1268-4998-a44b-2bf0c0b70fd2,2,12,ketoprofen,1,Oral,3825,CID3825,both,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
LT00024,453,mannitol,1964,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C(C(C(C(C(CO)O)O)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c395e13d-6ea1-4104-8b37-669cfb982f04,1,13,mannitol,0,Intravenous,6251,CID6251,both,C(C(C(C(C(CO)O)O)O)O)O
LT00026,126941,methotrexate,1953,Most-DILI-Concern,3,Box warning,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8df0780e-0fbd-4ab8-80b0-7a5eaa08ec0a,1,14,methotrexate,1,Oral,126941,CID126941,both,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
LT00030,4763,phenobarbital,,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,Hepatotoxic,,Postive,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=894c57ee-0f5f-41a1-9e0d-3f1f8fdfc9ab,1,15,phenobarbital,1,Oral,4763,CID4763,both,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
LT00032,1775,phenytoin,1953,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0c9321ae-cc4d-45f0-87d3-e2a5b4f60fde,1,16,phenytoin,1,Oral,1775,CID1775,both,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3
LT00034,5381226,rifampin,1971,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,WE,Hepatotoxic,Negative,Postive,C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=363d2275-fca2-4c6d-940c-137e89d9d78c,1,17,rifampin,1,Oral,135398735,CID135398735,both,C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C)/C
LT00036,5353990,tetracycline,1953,Less-DILI-Concern,2,Warnings and precautions,Yes,vLess-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CC1(C2CC3C(C(=O)/C(=C(\N)/O)/C(=O)C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eaa5b1bd-0927-46e4-b941-32fcc492d258,1,18,tetracycline,1,Oral,54675776,CID54675776,both,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O
LT00040,65140,abacavir,1998,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,,Positive,Postive,C1CC1NC2=NC(=NC3=C2N=CN3C4C[C@H](C=C4)CO)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5409c8ed-17c3-454f-bb88-d597ba8f84ec,1,19,abacavir,1,Oral,441300,CID441300,both,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4C[C@H](C=C4)CO
LT00041,2022,aciclovir,1982,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C1=NC2=C(N1COCCO)NC(=NC2=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f0d8278e-f521-451b-9093-16571eccd284,1,20,aciclovir,1,Oral,135398513,CID135398513,both,C1=NC2=C(N1COCCO)N=C(NC2=O)N
LT00043,2094,allopurinol,1966,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1=C2C(=NC=NC2=O)NN1,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=73cd79c1-6bab-4d7b-ae8b-0176efbaf5b9,1,21,allopurinol,1,Oral,135401907,CID135401907,both,C1=NNC2=C1C(=O)NC=N2
LT00045,34869,amineptine,,Most-DILI-Concern,8,Withdrawn,Yes,vMost-DILI-Concern,HH,,Positive,Postive,C1CC2=CC=CC=C2C(C3=CC=CC=C31)[NH2+]CCCCCCC(=O)O.[Cl-],,1,22,amineptine,1,Oral,34870,CID34870,both,C1CC2=CC=CC=C2C(C3=CC=CC=C31)[NH2+]CCCCCCC(=O)O.[Cl-]
LT00046,2157,amiodarone,1985,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=51be39a2-9134-402c-95ad-defe47406ff8,1,23,amiodarone,1,Oral,2157,CID2157,both,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I
LT00047,2160,amitriptyline,1961,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,WE,Hepatotoxic,Negative,Postive,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=091b3ffc-ccef-47f9-b13a-ef2812e02630,2,24,amitriptyline,1,Oral,2160,CID2160,both,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
LT00048,14956,amphotericin b,1964,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,WE,Hepatotoxic,Negative,,C[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f7be6506-4d20-401e-a0ff-02ad7c33158a,2,25,amphotericin b,1,Intravenous,5280965,CID5280965,both,C[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O
LT00049,6249,ampicillin,1971,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,Negative,Negative,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1422ac93-067c-489b-9b95-17cd00303f4c,2,26,ampicillin,1,Oral,6249,CID6249,both,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C
LT00052,3152,donepezil,1996,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,WE,non-hepatotixic,Negative,,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1e203cd-fd4c-4046-810b-5d7aea47525e,2,27,donepezil,1,Oral,3152,CID3152,both,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC
LT00053,2244,aspirin,1965,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,,non-hepatotixic,Negative,Postive,CC(=O)OC1=CC=CC=C1C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0d9502bd-7d0a-4f68-8c02-ed9296633823 ,2,28,aspirin,1,Oral,2244,CID2244,both,CC(=O)OC1=CC=CC=C1C(=O)O
LT00054,2148,aminohippurate,1944,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1=CC(=CC=C1C(=O)NCC(=O)O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a1975215-25f1-4c5a-878d-bcbf5326bb92,2,29,aminohippurate,0,Intravenous,2148,CID2148,both,C1=CC(=CC=C1C(=O)NCC(=O)O)N
LT00056,56069,bicalutamide,1995,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,,Positive,,C[C@](CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aeb2641f-4842-43ff-a4d8-d01b4ab3f47b,1,30,bicalutamide,1,Oral,2375,CID2375,both,C[C@](CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O
LT00058,444,bupropion,1985,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,WE,,Negative,Postive,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5cb7fd36-ae36-409b-af79-9c432e1cf5d9,1,31,bupropion,1,Oral,444,CID444,both,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C
LT00059,44093,captopril,1981,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,Postive,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9f7dae34-0112-4c11-b032-4f951e139705,1,32,captopril,1,Oral,44093,CID44093,both,C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O
LT00060,2554,carbamazepine,1968,Most-DILI-Concern,7,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f9ed987-5e34-4536-a22f-4898c9797e61,1,33,carbamazepine,1,Oral,2554,CID2554,both,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N
LT00061,498142,carboplatin,1989,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,,Positive,,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f330f5a2-2cad-402f-bcbb-26245a753276,1,34,carboplatin,1,Intravenous,426756,CID426756,both,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt]
LT00062,5481173,ceftazidime,1985,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,WE,Hepatotoxic,Negative,,CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=757c31dc-99ef-4960-b118-738b79631b1a,2,35,ceftazidime,1,Intravenous,5481173,CID5481173,both,CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]
LT00066,2710,chlorcyclizine,,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,,,,,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d50b5154-20a3-4c5b-ad7b-08c081340b12,2,36,chlorcyclizine,1,Oral,2710,CID2710,both,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
LT00067,2733,chlorzoxazone,1958,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,,Positive,Postive,C1=CC2=C(C=C1Cl)NC(=O)O2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=262297fa-891c-4696-923b-b961b57a06fd,1,37,chlorzoxazone,1,Oral,2733,CID2733,both,C1=CC2=C(C=C1Cl)NC(=O)O2
LT00068,2726,chlorpromazine,1957,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b9d57be1-17cb-42ac-8334-ef3494be7f17,1,38,chlorpromazine,1,Oral,2726,CID2726,both,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl
LT00071,441203,cisplatin,1978,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,,Positive,,N.N.Cl[Pt+2]Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de6302d5-85f0-4116-a709-57826c2c84fe,1,39,cisplatin,1,Intravenous,5702198,CID5702198,both,N.N.Cl[Pt+2]Cl
LT00074,3080,dimercaprol,1946,No-DILI-concern,0,No match,,vNo-DILI-Concern,HH,,Positive,,C(C(CS)S)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bee9a137-160f-47e8-a551-ca461ae4f51e,2,40,dimercaprol,0,Intramuscular,3080,CID3080,both,C(C(CS)S)O
LT00076,6167,colchicine,2009,Less-DILI-Concern,6,Adverse reactions,,Ambiguous DILI-concern,WE,non-hepatotixic,Negative,,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=56c130d1-7581-4152-99a2-0014ee9366c0,1,41,colchicine,0,Oral,6167,CID6167,both,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC
LT00077,16132357,corticotropin,1950,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC3=CN=CN3)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@@H]4CCCN4C(=O)[C@@H]5CCCN5C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae97eb2b-587a-4705-8c55-de0f97ee1f1f,2,42,corticotropin,0,Subcutaneous,16132265,CID16132265,both,CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC3=CN=CN3)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@@H]4CCCN4C(=O)[C@@H]5CCCN5C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)N
LT00079,2019,dactinomycin,1964,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f28e899c-6acb-4bd2-82ad-170720c62270,2,43,dactinomycin,1,Subcutaneous,457193,CID457193,both,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C
LT00080,2952,dantrolene,1974,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=57b4eec1-49e1-432c-95ae-0fe36e32d64b,1,44,dantrolene,1,Oral,6914273,CID6914273,both,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-]
LT00081,54680690,demeclocycline,1960,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,HH,,Positive,,CN(C)[C@H]1[C@@H]2C[C@@H]3[C@@H](C4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ec16fd0b-9185-4fed-a702-770b4fb1a1cd,2,45,demeclocycline,0,Oral,54680690,CID54680690,both,CN(C)[C@H]1[C@@H]2C[C@@H]3[C@@H](C4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O
LT00083,15330,propoxyphene,1957,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=49c4f24c-648b-2db2-5c00-2835d14b1275,2,46,propoxyphene,1,Oral,10100,CID10100,both,CCC(=O)OC(CC1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN(C)C
LT00084,3033,diclofenac,1988,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8e6e1aea-d1c9-f6bf-2a8c-0504437be95c,1,47,diclofenac,1,Oral,3033,CID3033,both,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl
LT00085,3059,diflunisal,1982,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,,Positive,,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7a78bb38-14d8-4a90-b883-482d4cebf716,2,48,diflunisal,1,Oral,3059,CID3059,both,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O
LT00087,3100,diphenhydramine,1946,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,non-hepatotixic,Negative,,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3e8446cc-5cd9-44e6-8bcd-125a61cd5a41,1,49,diphenhydramine,0,Oral,3100,CID3100,both,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
LT00091,41867,epirubicin,1999,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,NE,,Negative,,C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f91fc962-7c70-46a9-81fe-b98e93a2028a,2,50,epirubicin,0,Intravenous,41867,CID41867,both,C[C@H]1[C@@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O
LT00092,12560,erythromycin,1964,Most-DILI-Concern,5,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fda44eb6-7901-4b80-ba0b-216f6cacf3fd,1,51,erythromycin,1,Oral,12560,CID12560,both,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O
LT00094,36462,etoposide,1983,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,HH,Hepatotoxic,Positive,,C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=508a418e-985f-4208-9324-2230655bb5c2,2,52,etoposide,1,Oral,36462,CID36462,both,C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
LT00095,3325,famotidine,1986,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,WE,,Negative,,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a0bdf4d1-8458-4e4f-95aa-bcc38c0f32f8,1,53,famotidine,1,Oral,5702160,CID5702160,both,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N
LT00097,3331,felbamate,1993,Most-DILI-Concern,7,Box warning,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2e325d79-d0a4-4af7-b09b-96ee5a5b2a37,1,54,felbamate,1,Oral,3331,CID3331,both,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N
LT00098,3339,fenofibrate,1993,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2fe0bbd6-47a4-4836-beb1-0b635e3ab647,1,55,fenofibrate,1,Oral,3339,CID3339,both,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
LT00099,3342,fenoprofen,1976,Most-DILI-Concern,8,Warnings and precautions,Yes(literature),vMost-DILI-Concern,HH,,Positive,,CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dfc2ab1e-0d75-4eff-9489-2afb51b02702,1,56,fenoprofen,1,Oral,3342,CID3342,both,CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)O
LT00101,3397,flutamide,1989,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bae781d4-7101-4008-9af2-6e76b5e1c408,1,57,flutamide,1,Oral,3397,CID3397,both,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F
LT00106,3657,hydroxyurea,1967,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,,Positive,,C(=O)(N)NO,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a5c7030-5fac-4708-b309-f9d07103285a,1,58,hydroxyurea,1,Oral,3657,CID3657,both,C(=O)(N)NO
LT00107,5291,imatinib,2001,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,,,Postive,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=93ddb778-854f-4486-adca-4c5f9071a741,2,59,imatinib,1,Oral,5291,CID5291,both,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
LT00108,3696,imipramine,1959,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,HH,Hepatotoxic,Positive,,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=75bf3473-2d70-4d41-93cd-afa1015e45bb,1,60,imipramine,1,Oral,3696,CID3696,both,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31
LT00109,3748,iproniazid,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CC(C)NNC(=O)C1=CC=NC=C1,,1,61,iproniazid,1,Oral,3748,CID3748,both,CC(C)NNC(=O)C1=CC=NC=C1
LT00111,47576,ketoconazole,1981,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@@H]3CO[C@@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=91fffa92-709a-4e16-9335-e6f0338a5eb9,1,62,ketoconazole,1,Oral,456201,CID456201,both,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@@H]3CO[C@@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl
LT00112,3869,labetalol,1984,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e10796ac-7a39-4985-b5d7-732d939b140f,1,63,labetalol,1,Oral,3869,CID3869,both,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O
LT00113,3899,leflunomide,1998,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,HH,,Positive,Postive,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d3a4788f-6ff4-4804-9b41-7d6f0b27cd5c,1,64,leflunomide,1,Oral,3899,CID3899,both,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F
LT00116,4044,mefenamic acid,1967,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d77e13db-d1b1-4dbf-9de8-80827018cf43,2,65,mefenamic acid,1,Oral,4044,CID4044,both,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C
LT00117,54677470,meloxicam,2000,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,Negative,Postive,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06a401f0-4380-4081-86ed-a309a25abf6b,2,66,meloxicam,1,Oral,54677470,CID54677470,both,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O
LT00119,4091,metformin,1995,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,WE,,Negative,,CN(C)C(=N)N=C(N)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b8004451-7b26-425b-b5ea-cbb1b08e30e3,2,67,metformin,1,Oral,4091,CID4091,both,CN(C)C(=N)N=C(N)N
LT00121,38853,methyldopa,1962,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=227291e5-9baa-476a-93b8-b2142e61a4fe,1,68,methyldopa,1,Oral,38853,CID38853,both,C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N
LT00124,4449,nefazodone,1994,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=51ff7db5-aaf9-4c3c-86e6-958ebf16b60f,1,69,nefazodone,1,Oral,4449,CID4449,both,CCC1=NN(C(=O)N1CCOC2=CC=CC=C2)CCCN3CCN(CC3)C4=CC(=CC=C4)Cl
LT00125,5353830,nitrofurantoin,1953,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1C(=O)NC(=O)N1/N=C\C2=CC=C(O2)[N+](=O)[O-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6bdf87ae-daf1-4912-9d45-e06fa9eaaf1a,1,70,nitrofurantoin,1,Oral,6604200,CID6604200,both,C1C(=O)NC(=O)N1/N=C\C2=CC=C(O2)[N+](=O)[O-]
LT00126,6003770,olsalazine,1990,Less-DILI-Concern,8,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C1=CC(=C(C=C1N/N=C\2/C=CC(=O)C(=C2)C(=O)O)C(=O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f4858879-0b8b-484a-9742-112c92662e8a,2,71,olsalazine,1,Oral,22419,CID22419,both,C1=CC(=C(C=C1N=NC2=CC(=C(C=C2)O)C(=O)O)C(=O)O)O
LT00128,43815,paroxetine,1992,Less-DILI-Concern,8,Adverse reactions,Yes,vLess-DILI-Concern,WE,non-hepatotixic,Negative,Postive,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7b9e9d36-9b7d-4d47-8d8a-d37da85e7b24,1,72,paroxetine,1,Oral,43815,CID43815,both,C1CNC[C@H]([C@@H]1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4
LT00129,4735,pentamidine,1984,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cc2b635e-4840-4dc3-a177-5484371680e8,2,73,pentamidine,1,Intravenous,4735,CID4735,both,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N
LT00131,4746,perhexiline,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3,,1,74,perhexiline,1,Oral,4746,CID4746,both,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3
LT00133,5983,physostigmine,,No-DILI-concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,C[C@@]12CCN([C@@H]1N(C3=C2C=C(C=C3)OC(=O)NC)C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a7d04b2c-fe34-480d-8f7c-7cbcf447a70b,2,75,physostigmine,0,Intravenous,5983,CID5983,both,C[C@@]12CCN([C@@H]1N(C3=C2C=C(C=C3)OC(=O)NC)C)C
LT00134,4829,pioglitazone,1999,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,WE,non-hepatotixic,Negative,,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0478f0e7-87fb-4adb-ae9b-6624555ccbe4,1,76,pioglitazone,1,Oral,4829,CID4829,both,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
LT00136,657298,propylthiouracil,1947,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,,Hepatotoxic,,Postive,CCCC1=CC(=O)NC(=S)N1,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=120de758-f102-470a-892d-a61b18ff8f71,1,77,propylthiouracil,1,Oral,657298,CID657298,both,CCCC1=CC(=O)NC(=S)N1
LT00137,7028,pseudoephedrine,1975,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,C[C@@H]([C@H](C1=CC=CC=C1)O)NC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=40ac6155-eb0e-799c-9fb6-bb5ffdd40356,2,78,pseudoephedrine,0,Oral,7028,CID7028,both,C[C@@H]([C@H](C1=CC=CC=C1)O)NC
LT00138,3001055,ranitidine,1977,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,WE,Hepatotoxic,Negative,Postive,CN/C(=C\[N+](=O)[O-])/NCCSCC1=CC=C(O1)CN(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d0da9dd6-c691-4614-99c7-531b0bf34837,1,79,ranitidine,1,Oral,3001055,CID3001055,both,CN/C(=C\[N+](=O)[O-])/NCCSCC1=CC=C(O1)CN(C)C
LT00139,6323490,rifabutin,1992,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,,C[C@H]1/C=C/C=C(\C(=O)NC2=C3C(=NC4(N3)CCN(CC4)CC(C)C)C5=C6C(=C(C(=C5C2=O)O)C)O[C@@](C6=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)/C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3e1a6613-bdd3-4261-93b3-d7f5cc09064b,2,80,rifabutin,1,Oral,135398743,CID135398743,both,C[C@H]1/C=C/C=C(\C(=O)N=C2C(=C3C(=C4C2=NC5(N4)CCN(CC5)CC(C)C)C6=C(C(=C3O)C)O[C@@](C6=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)O)/C
LT00140,77999,rosiglitazone,1999,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,WE,non-hepatotixic,Negative,,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ec682aec-e98f-41a1-9d21-eb7580ea3a8a,2,81,rosiglitazone,1,Oral,77999,CID77999,both,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3
LT00141,19190,indocyanine green,1959,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC1(C(=[N+](C2=C1C3=CC=CC=C3C=C2)CCCCS(=O)(=O)[O-])C=CC=CC=CC=C4C(C5=C(N4CCCCS(=O)(=O)[O-])C=CC6=CC=CC=C65)(C)C)C.[Na+],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a24348da-94f8-4c1c-aa8a-a161c01b5cef,2,82,indocyanine green,0,Intravenous,11967809,CID11967809,both,CC1(C(=[N+](C2=C1C3=CC=CC=C3C=C2)CCCCS(=O)(=O)[O-])C=CC=CC=CC=C4C(C5=C(N4CCCCS(=O)(=O)[O-])C=CC6=CC=CC=C65)(C)C)C.[Na+]
LT00142,54454,simvastatin,1991,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,non-hepatotixic,Negative,Postive,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9999f4dc-60be-4c8f-8063-78144ed4431f,1,83,simvastatin,1,Oral,54454,CID54454,both,CCC(C)(C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C
LT00143,5833,spironolactone,1960,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=322f2b36-ca93-4a57-9413-ef4efbbb3c65,1,84,spironolactone,1,Oral,5833,CID5833,both,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]5([C@]4(CC3)C)CCC(=O)O5)C
LT00144,18283,stavudine,1994,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)CO,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7745cad8-720d-4755-87c7-9147c0915b0f,1,85,stavudine,1,Oral,18283,CID18283,both,CC1=CN(C(=O)NC1=O)[C@H]2C=C[C@H](O2)CO
LT00145,19649,streptomycin,1946,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=abd1f64e-4283-4370-aae8-3666316aa36e,1,86,streptomycin,0,Intramuscular,19649,CID19649,both,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(C=O)O
LT00146,5215,sulfadiazine,1941,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,Postive,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=10549cba-9c15-4d2e-a68c-5afbc178591d,2,87,sulfadiazine,1,Oral,5215,CID5215,both,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N
LT00147,5353980,sulfasalazine,1950,Most-DILI-Concern,5,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N/N=C/3\C=CC(=O)C(=C3)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=599be7ea-4036-4e43-a411-1c42369b1b8c,2,88,sulfasalazine,1,Oral,5339,CID5339,both,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O
LT00148,5352,sulindac,1978,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d150c3f3-c267-4d48-9502-4700670c954b,1,89,sulindac,1,Oral,1548887,CID1548887,both,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O
LT00152,2733526,tamoxifen,1977,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8e4710a7-8757-49be-8bec-a1dc39e6c695,1,90,tamoxifen,1,Oral,2733526,CID2733526,both,CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3
LT00153,5394,temozolomide,1999,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,,,Negative,,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=046a9011-3911-4d3f-a15f-fbb56d5aad56,2,91,temozolomide,1,Oral,5394,CID5394,both,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N
LT00154,2153,theophylline,1970,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,non-hepatotixic,Negative,,CN1C2=C(C(=O)N(C1=O)C)NC=N2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d4dee7ff-6f1a-45e0-9ade-cda3ff418ad1,2,92,theophylline,0,Oral,2153,CID2153,both,CN1C2=C(C(=O)N(C1=O)C)NC=N2
LT00155,5487,tizanidine,1996,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,,,Postive,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=234b4e5e-8305-4d2d-840e-e69f0219c6fb,2,93,tizanidine,1,Oral,5487,CID5487,both,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl
LT00156,4659569,tolcapone,1998,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,HH,,Positive,Postive,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a0e47a9d-78e7-4523-983a-aa259f221736,1,94,tolcapone,1,Oral,4659569,CID4659569,both,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-]
LT00160,3121,valproic acid,1978,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CCCC(CCC)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=740a1ae9-19f0-4a0f-a431-e4b9ffb9381a,1,95,valproic acid,1,Oral,3121,CID3121,both,CCCC(CCC)C(=O)O
LT00161,441141,vancomycin,1964,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,HH,,Positive,,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H](C(C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9[C@@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8d63431-46d0-407b-b350-bb8e57e34f65,1,96,vancomycin,1,Oral,14969,CID14969,both,C[C@H]1[C@H]([C@@](C[C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)[C@H](C(C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)[C@@H](NC(=O)[C@H]([C@@H](C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)CO)O)O)(C)N)O
LT00162,445354,vitamin a,1949,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,Positive,,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1c00853-695a-4859-6c8b-22374a98f46d,2,97,vitamin a,1,Intramuscular,445354,CID445354,both,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/CO)/C)/C
LT00163,35370,zidovudine,1987,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9907acb2-e4a0-46f9-93c0-a8d7b7ce98cf,1,98,zidovudine,1,Oral,35370,CID35370,both,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N=[N+]=[N-]
LT00164,5732,zolpidem,1992,Less-DILI-Concern,7,Adverse reactions,,Ambiguous DILI-concern,WE,non-hepatotixic,Negative,,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de7a700d-2757-40c2-8e50-9a6b106ab011,2,99,zolpidem,0,Oral,5732,CID5732,both,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C
LT00165,5734,zonisamide,2000,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2b59734e-e070-4847-ae43-350eba867c33,2,100,zonisamide,1,Oral,5734,CID5734,both,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N
LT00166,1046,pyrazinamide,1971,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1=CN=C(C=N1)C(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ecee3128-a47f-4ced-a1db-4f58c5f3e9c6,1,101,pyrazinamide,1,Oral,1046,CID1046,both,C1=CN=C(C=N1)C(=O)N
LT00167,57363,finasteride,1992,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,,non-hepatotixic,,,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=63ed2cec-c677-45bd-a802-64a9ec54046f,2,102,finasteride,1,Oral,57363,CID57363,both,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C
LT00168,5591,troglitazone,1997,Most-DILI-Concern,8,Withdrawn,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CC1=C(C(=C2CCC(OC2=C1C)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C)O,,1,103,troglitazone,1,Oral,5591,CID5591,both,CC1=C(C2=C(CCC(O2)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C(=C1O)C)C
LT00172,1548972,fluvastatin,1993,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,Negative,Postive,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aad8b373-0aec-4efb-8e61-3d8114b31127,2,104,fluvastatin,1,Oral,446155,CID446155,both,CC(C)N1C2=CC=CC=C2C(=C1/C=C/[C@@H](C[C@@H](CC(=O)O)O)O)C3=CC=C(C=C3)F
LT00173,3476,glimepiride,1995,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,WE,,Negative,,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=60e9397e-83b9-489e-9683-6f87e458bbaa,1,105,glimepiride,1,Oral,3476,CID3476,both,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C
LT00174,5656,venlafaxine,1993,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,,non-hepatotixic,,Postive,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e5a31f69-c237-49b7-83a2-d04eebbc30ce,1,106,venlafaxine,1,Oral,5656,CID5656,both,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O
LT00175,2162,amlodipine,1992,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,,non-hepatotixic,,Postive,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bef1a169-9186-43e9-b673-64fdb658984f,2,107,amlodipine,1,Oral,2162,CID2162,both,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN
LT00177,13342,vinblastine,1965,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f073b58e-56d6-4c8d-a2ce-b37719402d77,2,108,vinblastine,0,Intravenous,241903,CID241903,both,CC[C@@]1(C[C@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
LT00178,2764,ciprofloxacin,1987,Most-DILI-Concern,7,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d8d72fe-e89c-4e08-9ca1-ec64c4890205,1,109,ciprofloxacin,1,Oral,2764,CID2764,both,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
LT00179,3365,fluconazole,1990,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa7572ca-0ea0-4259-bc79-acb88c9f492d,1,110,fluconazole,1,Oral,3365,CID3365,both,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O
LT00180,5865,prednisone,1955,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,WE,non-hepatotixic,Negative,,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9b682e76-7b10-43a9-9527-81a633b7d0c0,2,111,prednisone,1,Oral,5865,CID5865,both,C[C@]12CC(=O)[C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C
LT00181,3958,lorazepam,1977,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a936b58-5039-458c-b0b4-a5a0269386a2,2,112,lorazepam,0,Oral,3958,CID3958,both,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl
LT00182,55283,itraconazole,1992,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,,,Postive,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5CO[C@](O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae50721d-ee15-4ee7-9fe7-afd98c56461b,2,113,itraconazole,1,Oral,3793,CID3793,both,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OC[C@H]5CO[C@](O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl
LT00183,5035,raloxifene,1997,No-DILI-Concern,0,No match,,vNo-DILI-Concern,WE,non-hepatotixic,Negative,,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbee500a-34e2-4819-987b-da107eacbb27,2,114,raloxifene,0,Oral,5035,CID5035,both,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O
LT00184,55245,mifepristone,2000,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=542f3fae-8bc8-4f00-9228-e4b66c9ad6a9,2,115,mifepristone,0,Oral,55245,CID55245,both,CC#C[C@@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)O
LT00185,2801,clomipramine,1989,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,,Positive,,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3823106e-6be3-4154-a607-caa3a69dc75c,2,116,clomipramine,1,Oral,2801,CID2801,both,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl
LT00186,54687,pravastatin,1991,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,non-hepatotixic,,Postive,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=99e0e848-f8f3-4b42-b880-8fbc42633948,1,117,pravastatin,1,Oral,54687,CID54687,both,CC[C@H](C)C(=O)O[C@H]1C[C@@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@H](C[C@H](CC(=O)O)O)O)O
LT00187,84029,clarithromycin,1991,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,non-hepatotixic,Positive,Postive,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4b9d7052-a54f-3ee1-ab0e-633b087f4802,2,118,clarithromycin,1,Oral,84029,CID84029,both,CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
LT00188,5754,hydrocortisone,1951,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,Negative,,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb8f1024-e2d4-4394-ac45-d807a4caf4af,2,119,hydrocortisone,0,Oral,5754,CID5754,both,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O
LT00192,5994,progesterone,1976,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,HH,non-hepatotixic,Positive,,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b0a40ca9-c1d8-4611-9cfa-edcae58b6ebe,2,120,progesterone,1,Oral,5994,CID5994,both,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C
LT00194,5280793,ergocalciferol,1941,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17fbd9e8-0a1c-4e6d-89c6-710bec23a341,1,121,ergocalciferol,0,Oral,5280793,CID5280793,both,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](CCC3=C)O)C
LT00199,3672,ibuprofen,1974,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,WE,Hepatotoxic,Negative,Postive,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=751887d9-71da-4226-8ae1-d7ca59259cbe,1,122,ibuprofen,1,Oral,3672,CID3672,both,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
LT00200,3779,isoproterenol,1956,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c4288d64-4f76-44f8-d097-4bd3955f5676,1,123,isoproterenol,0,Intravenous,3779,CID3779,both,CC(C)NCC(C1=CC(=C(C=C1)O)O)O
LT00204,3826,ketorolac,1989,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,,Positive,,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=688f5dec-a6db-43c6-a1f8-5df99d08d395,1,124,ketorolac,1,Oral,3826,CID3826,both,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O
LT00205,4927,promethazine,1951,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,NE,,Negative,,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=983f46b1-3710-416d-b8d1-56587296f26a,2,125,promethazine,1,Oral,4927,CID4927,both,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C
LT00206,4594,omeprazole,1989,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,,non-hepatotixic,,Postive,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=276c3f70-890e-4afa-af48-8630f9689785,2,126,omeprazole,1,Oral,4594,CID4594,both,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC
LT00207,2585,carvedilol,1995,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2ba6d893-ae2a-4535-b904-667d206f93af,2,127,carvedilol,1,Oral,2585,CID2585,both,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O
LT00209,6253,cytarabine,1969,Most-DILI-Concern,3,Box warning,Yes,vMost-DILI-Concern,,Hepatotoxic,,,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c4fdc56e-efd7-4825-a518-ef430b2b3df0,1,128,cytarabine,1,Intravenous,6253,CID6253,both,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O
LT00216,47811,pergolide,1988,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CCCN1C[C@@H](C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34)CSC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a26390e8-eb86-4623-8cdd-45b24b14df74,2,129,pergolide,0,Oral,47811,CID47811,both,CCCN1C[C@@H](C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34)CSC
LT00217,4499,nisoldipine,1995,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,NE,non-hepatotixic,Negative,,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e3780ba1-46ef-410c-b2fc-f1ffbfb598f3,2,130,nisoldipine,0,Oral,4499,CID4499,both,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
LT00219,2771,citalopram,1998,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,WE,,Negative,,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bfccb051-7d05-4457-9823-9b460ee12232,2,131,citalopram,1,Oral,2771,CID2771,both,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
LT00222,6010,methyltestosterone,1973,Less-DILI-Concern,2,Warnings and precautions,Yes,vLess-DILI-Concern,,,,Postive,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=77bb4ef4-c10e-4acc-8225-651d003f4561,2,132,methyltestosterone,1,Oral,6010,CID6010,both,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C
LT00223,6013,testosterone,1953,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,non-hepatotixic,,Postive,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9af8ef50-f650-44ca-a272-135bfce9daca,2,133,testosterone,1,Oral,6013,CID6013,both,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C
LT00225,4891,praziquantel,1982,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,NE,,Negative,,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=34ce1cdd-648e-4f1e-8512-bf3d4cc22eb9,2,134,praziquantel,0,Oral,4891,CID4891,both,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2
LT00227,5472,ticlopidine,1991,Most-DILI-Concern,4,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1ebcf65-f6c3-4267-99aa-1c6b203dffc7,1,135,ticlopidine,1,Oral,5472,CID5472,both,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl
LT00230,3016,diazepam,1963,Less-DILI-Concern,4,Adverse reactions,,Ambiguous DILI-concern,,,,,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa7c7ec3-1c32-4902-8625-5e09f09f44dc,2,136,diazepam,0,Oral,3016,CID3016,both,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
LT00233,1548955,clomiphene,1967,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,,Positive,,CCN(CC)CCOC1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\Cl)/C3=CC=CC=C3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=df518802-0efd-4da4-816d-65a7e92cecd2,2,137,clomiphene,1,Oral,2800,CID2800,both,CCN(CC)CCOC1=CC=C(C=C1)/C(=C(/C2=CC=CC=C2)\Cl)/C3=CC=CC=C3
LT00234,5282379,isotretinoin,1982,Most-DILI-Concern,5,Warnings and precautions,Yes,vMost-DILI-Concern,HH,,Positive,,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)O)/C)/C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a31fd109-d0fd-4ab9-ba98-a3d64333c18d,1,138,isotretinoin,1,Oral,5282379,CID5282379,both,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\C(=O)O)/C)/C
LT00235,9902,oxymetholone,1972,Most-DILI-Concern,7,Box warning,Yes,vMost-DILI-Concern,,,,Postive,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(CC(=CO)C(=O)C4)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4b9c6c34-9cb2-4d70-b70e-c7ce2fda4212,1,139,oxymetholone,1,Oral,5281034,CID5281034,both,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(CC(=CO)C(=O)C4)C
LT00240,3308,etodolac,1991,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,,,Postive,CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=86719bea-90f8-4696-ad0c-10a31967c850,1,140,etodolac,1,Oral,3308,CID3308,both,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O
LT00243,3478,glipizide,1984,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06505b04-656c-47ef-83ba-ab977bdcaaf4,2,141,glipizide,1,Oral,3478,CID3478,both,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
LT00246,4723,pemoline,1975,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,HH,,Positive,Postive,C1=CC=C(C=C1)C2C(=O)N=C(O2)N,,1,142,pemoline,1,Oral,4723,CID4723,both,C1=CC=C(C=C1)C2C(=O)N=C(O2)N
LT00248,2812,clotrimazole,1975,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,WE,non-hepatotixic,Negative,,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0bc4b876-ddee-4f03-b44f-544348739a26,1,143,clotrimazole,1,Oral,2812,CID2812,both,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4
LT00252,2662,celecoxib,1998,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,Positive,Postive,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d52185d-421f-4e34-8db7-f7676db2a226,2,144,celecoxib,1,Oral,2662,CID2662,both,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F
LT00256,2170,amoxapine,1980,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,WE,,Negative,,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a16297df-3158-48db-85e5-5cd506885556,2,145,amoxapine,0,Oral,2170,CID2170,both,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
LT00257,3737,iothalamate sodium,1963,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)C(=O)NC)I,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2c07ce91-cc83-45e3-bd2b-f923a9c8286c,2,146,iothalamate sodium,0,Intravenous,23667529,CID23667529,both,CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)C(=O)NC)I
LT00258,60823,atorvastatin,1996,Most-DILI-Concern,5,Warnings and precautions,Yes,vMost-DILI-Concern,,Hepatotoxic,,Postive,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=263f60b2-355e-4389-b47f-146854184da8,2,147,atorvastatin,1,Oral,60823,CID60823,both,CC(C)C1=C(C(=C(N1CC[C@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4
LT00259,4585,olanzapine,1996,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,non-hepatotixic,,,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8c2fb7b-210d-4e44-9c86-bb999deec2fe,2,148,olanzapine,1,Oral,135398745,CID135398745,both,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C
LT00260,4463,nevirapine,1996,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,,Hepatotoxic,,Postive,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=82598cb3-a0eb-4ff2-8b8d-d8da96c25388,1,149,nevirapine,1,Oral,4463,CID4463,both,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
LT00261,4909,primidone,1954,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=418a70aa-8480-4748-a1a8-af39f4962bf0,1,150,primidone,0,Oral,4909,CID4909,both,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2
LT00262,60780,vinorelbine,1994,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CCC1=CC2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=145fb50b-7bde-408c-b81d-91fe9f128bf6,2,151,vinorelbine,0,Intravenous,5311497,CID5311497,both,CCC1=CC2C[C@@](C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC
LT00263,2187,anastrozole,1995,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=03586c40-eb32-45c5-beb7-6762a6b78790,2,152,anastrozole,1,Oral,2187,CID2187,both,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N
LT00264,5029,rabeprazole,1999,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=52459f70-e1f5-41bb-a9f4-e68ef5f5dcf5,2,153,rabeprazole,1,Oral,5029,CID5029,both,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC
LT00265,55185,azithromycin,1991,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,WE,Hepatotoxic,Negative,Postive,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H](C([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7bb07118-4b39-4b0b-914a-a4675f732c11,2,154,azithromycin,1,Oral,447043,CID447043,both,CC[C@@H]1[C@@]([C@@H]([C@H](N(C[C@@H](C[C@@]([C@@H](C([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O
LT00266,5503,tolazamide,1966,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8e26b95-96f4-4b0d-929d-31dd240cfe44,2,155,tolazamide,1,Oral,5503,CID5503,both,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CCCCCC2
LT00267,5002,quetiapine,1997,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,Postive,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c499823e-d939-4950-bdeb-e7023f663fa2,2,156,quetiapine,1,Oral,5002,CID5002,both,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42
LT00270,3324,famciclovir,1994,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=50194d47-2761-4bfd-a35b-9c6a186694a5,2,157,famciclovir,0,Oral,3324,CID3324,both,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C
LT00277,2249,atenolol,1981,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,NE,,Negative,Postive,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3a8c88aa-ca0d-4c23-8ffb-e6d913ef619c,2,158,atenolol,1,Oral,2249,CID2249,both,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O
LT00278,2333,benzbromarone,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br,,1,159,benzbromarone,1,Oral,2333,CID2333,both,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br
LT00279,31101,bromocriptine,1978,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=deeea4f0-389e-4b2f-b0a7-60a87feac62a,2,160,bromocriptine,1,Oral,31101,CID31101,both,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O
LT00280,2478,busulfan,1954,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,,CS(=O)(=O)OCCCCOS(=O)(=O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bf456fc7-3a79-47f7-8acc-600b5e2f0dc2,1,161,busulfan,1,Oral,2478,CID2478,both,CS(=O)(=O)OCCCCOS(=O)(=O)C
LT00286,2708,chlorambucil,1957,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=967ed3ff-d99b-41e8-b768-dfb586d3d9a6,2,162,chlorambucil,1,Oral,2708,CID2708,both,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl
LT00287,2818,clozapine,1989,Most-DILI-Concern,5,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8672ee49-ee2e-4239-98ce-7e23e1ab7b10,1,163,clozapine,1,Oral,135398737,CID135398737,both,CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42
LT00288,5351166,dacarbazine,1975,Most-DILI-Concern,6,Box warning,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,,CN(C)N/N=C\1/C(=NC=N1)C(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b6b97e41-5f15-498c-abfb-d8443ea4d216,1,164,dacarbazine,1,Intravenous,135398738,CID135398738,both,CN(C)/N=N/C1=C(NC=N1)C(=O)N
LT00289,2955,dapsone,1979,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0792169d-c6f9-4af0-93ae-b75d710c47a9,2,165,dapsone,1,Oral,2955,CID2955,both,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N
LT00292,30322,digoxin,1975,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,non-hepatotixic,Negative,,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=62795623-a2bc-4dd2-8989-3b9782bfd80e,1,166,digoxin,0,Oral,2724385,CID2724385,both,C[C@@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@H](O[C@H](C[C@@H]2O)O[C@@H]3[C@H](O[C@H](C[C@@H]3O)O[C@H]4CC[C@]5([C@@H](C4)CC[C@@H]6[C@@H]5C[C@H]([C@]7([C@@]6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O
LT00295,3117,disulfiram,1951,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,Hepatotoxic,,Postive,CCN(CC)C(=S)SSC(=S)N(CC)CC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06b00003-a94f-4fe8-808c-e6e101b06ebe,1,167,disulfiram,1,Oral,3117,CID3117,both,CCN(CC)C(=S)SSC(=S)N(CC)CC
LT00296,5362032,enalapril,1985,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,,,,Postive,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e31289f1-4b59-418a-a893-c748ce073f6c,1,168,enalapril,1,Oral,5388962,CID5388962,both,CCOC(=O)[C@@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O
LT00299,3440,furosemide,1966,Less-DILI-Concern,2,Adverse reactions,,Ambiguous DILI-concern,HH,Hepatotoxic,Positive,,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=230cb29d-697e-4257-aa33-683c8f26243f,1,169,furosemide,0,Oral,3440,CID3440,both,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl
LT00300,3446,gabapentin,1993,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,NE,,Negative,Postive,C1CCC(CC1)(CC(=O)O)CN,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cff7de45-148b-4e96-88fd-6052bf75b5f7,2,170,gabapentin,1,Oral,3446,CID3446,both,C1CCC(CC1)(CC(=O)O)CN
LT00302,3488,glibenclamide,1984,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d8fbab4-d7a7-4f4f-bbcc-56e603f72f73,2,171,glibenclamide,1,Oral,3488,CID3488,both,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
LT00306,3767,isoniazid,1952,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1=CN=CC=C1C(=O)NN,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9499f1cf-2f46-4047-8b71-90aee7dee854,1,172,isoniazid,1,Oral,3767,CID3767,both,C1=CN=CC=C1C(=O)NN
LT00307,3883,lansoprazole,1995,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,Postive,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb034790-ccc0-4df4-ac12-b7715cc0d42b,2,173,lansoprazole,1,Oral,3883,CID3883,both,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
LT00308,4030,mebendazole,1974,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,,Positive,,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c338415f-41e0-071d-8c51-a80a02ebf2cd,1,174,mebendazole,1,Oral,4030,CID4030,both,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3
LT00309,4171,metoprolol,,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,,,,Postive,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb05420c-fd24-4672-9f62-fdd313819287,1,175,metoprolol,1,Oral,4171,CID4171,both,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
LT00311,5360515,naltrexone,1984,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,HH,,Positive,,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4a63f1e0-b2a3-4355-af61-852ea3521707,1,176,naltrexone,0,Oral,5360515,CID5360515,both,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O
LT00312,938,niacin,1957,Most-DILI-Concern,7,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1=CC(=CN=C1)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=414b3d30-cc7f-4f91-b21e-5090b7f5b529,1,177,niacin,1,Oral,938,CID938,both,C1=CC(=CN=C1)C(=O)O
LT00313,4485,nifedipine,1981,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,Hepatotoxic,Positive,,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d8d582f9-12d0-4aab-9a64-c8bd072a7741,1,178,nifedipine,1,Oral,4485,CID4485,both,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC
LT00314,4495,nimesulide,,Most-DILI-Concern,8,Withdrawn,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2,,1,179,nimesulide,1,Oral,4495,CID4495,both,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2
LT00315,3033637,nizatidine,1988,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CN/C(=C\[N+](=O)[O-])/NCCSCC1=CSC(=N1)CN(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbfb5d8a-a136-4d78-befa-d2cea6661030,1,180,nizatidine,1,Oral,3033637,CID3033637,both,CN/C(=C\[N+](=O)[O-])/NCCSCC1=CSC(=N1)CN(C)C
LT00327,5793,dextrose,1971,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C([C@@H]1[C@H]([C@@H]([C@H](C(O1)O)O)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=085614c7-ada4-4e2c-87c0-c9bc2f18365a,2,181,dextrose,0,Intravenous,66370,CID66370,both,C([C@@H]1[C@H]([C@@H]([C@H](C(O1)O)O)O)O)O
LT00328,3086319,cholestyramine,1973,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CC(C)(C(=O)NCCS(=O)(=O)[O-])OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dd434ef8-8af3-434c-a0a0-9a0b18459ba0,2,182,cholestyramine,0,Oral,70695641,CID70695641,both,CC(C)(C(=O)NCCS(=O)(=O)[O-])OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl
LT00330,23701736,sodium lactate,1971,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,[13CH3]C(C(=O)[O-])O.[Na+],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=324a8674-c4a6-4afb-b504-aa2f67f5793e,2,183,sodium lactate,0,Intravenous,23666456,CID23666456,both,[13CH3]C(C(=O)[O-])O.[Na+]
LT00332,2520,verapamil,1981,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,WE,,Negative,Postive,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a0343397-897b-46d6-943f-a87e07e1de10,1,184,verapamil,1,Oral,2520,CID2520,both,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC
LT00335,31703,doxorubicin,1974,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,Hepatotoxic,Positive,Postive,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=21d9c619-7e94-49e2-ac41-31e9ea96554a,2,185,doxorubicin,1,Intravenous,31703,CID31703,both,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O
LT00341,2809,clorazepate,1972,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,Negative,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a82b479-64bd-474f-93e2-c97ce5cce9df,2,186,clorazepate,0,Oral,2809,CID2809,both,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)O
LT00349,638678,protirelin,1976,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1C[C@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@@H]3CCC(=O)N3)C(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=af5da799-76bf-415a-9dc7-99c7ddc62bc4,2,187,protirelin,0,Intravenous,638678,CID638678,both,C1C[C@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@@H]3CCC(=O)N3)C(=O)N
LT00350,9833444,sincalide,1976,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CSCC[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N)NC(=O)[C@H](CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)[C@H](CC(=O)O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c56a824b-a8ba-42db-b05c-49c731130879,2,188,sincalide,0,Intravenous,9833444,CID9833444,both,CSCC[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N)NC(=O)[C@H](CC4=CC=C(C=C4)OS(=O)(=O)O)NC(=O)[C@H](CC(=O)O)N
LT00355,16129665,secretin,2002,No-DILI-concern,0,No match,,vNo-DILI-Concern,,,,,CC(C)CC(C(=O)NC(C(C)C)C(=O)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC2=NC=CN2)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b4dfe70f-0a86-4488-9ba1-dcd8f86cbfcd ,2,189,secretin,0,Intravenous,16129665,CID16129665,both,CC(C)CC(C(=O)NC(C(C)C)C(=O)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC2=NC=CN2)N
LT00358,6398588,sucralfate,1981,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-].O.O.O.[Al],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2687d670-8af6-42a2-9081-fee112e80fc0,2,190,sucralfate,0,Oral,121494085,CID121494085,both,C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@]2([C@H]([C@@H]([C@H](O2)OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])COS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-])OS(=O)(=O)[O-].O.O.O.[Al]
LT00361,24014,cupric chloride,1986,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,Cl[Cu]Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a84d61a4-8e7f-4be1-aba6-f633b334aafc,2,191,cupric chloride,0,Intravenous,24014,CID24014,both,Cl[Cu]Cl
LT00375,71433,trientine hydrochloride,1985,No-DILI-Concern,1,No match,,vNo-DILI-Concern,HH,,Positive,,C(CNCCNCCN)N.Cl.Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0ed52ecf-cda9-4a06-bacc-2c2827cc8967,2,192,trientine hydrochloride,0,Oral,71433,CID71433,both,C(CNCCNCCN)N.Cl.Cl
LT00379,2727,chlorpropamide,1958,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,HH,Hepatotoxic,Positive,,CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=baa54287-8065-da1a-f19e-ce8daf61bd01,1,193,chlorpropamide,1,Oral,2727,CID2727,both,CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl
LT00380,6435893,cyclosporine,1983,Most-DILI-Concern,7,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=29891f95-9079-4880-7abc-194e49767dd5,1,194,cyclosporine,1,Oral,5284373,CID5284373,both,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)[C@@H]([C@H](C)C/C=C/C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C
LT00385,451668,decitabine,2006,Less-DILI-Concern,4,Adverse reactions,,Ambiguous DILI-concern,,,,,C1[C@@H]([C@H](O[C@H]1N2C=NC(=NC2=O)N)CO)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acaf6e50-7cd3-4431-98ef-d1c07e3ed8c2,2,195,decitabine,0,Intravenous,451668,CID451668,both,C1[C@@H]([C@H](O[C@H]1N2C=NC(=NC2=O)N)CO)O
LT00386,2973,deferoxamine,1968,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,HH,,Positive,,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab55b0f1-d6f3-4e7e-aabd-b98c083d3b60,1,196,deferoxamine,1,Intravenous,2973,CID2973,both,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O
LT00393,5281011,doxycycline,1967,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,Postive,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)/C(=C(\N)/O)/C(=O)[C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4ae0ff63-c577-478e-9fa0-b7c22a8e7de4,1,197,doxycycline,1,Oral,54671203,CID54671203,both,C[C@@H]1[C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O
LT00394,60198,exemestane,1999,Most-DILI-Concern,4,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf066b7a-032a-416c-8d40-15ba581423e3,2,198,exemestane,1,Oral,60198,CID60198,both,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC(=C)C4=CC(=O)C=C[C@]34C
LT00397,3333,felodipine,1991,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,Postive,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dd39c559-5c5d-4d3b-9228-c44085e1699f,2,199,felodipine,1,Oral,3333,CID3333,both,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
LT00399,31378,fludrocortisone,1955,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5cffa20-9a22-43c5-9e89-3225852c2dfa,2,200,fludrocortisone,0,Oral,31378,CID31378,both,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O)F
LT00400,3372,fluphenazine,1959,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6cd6ba35-3481-48c1-87db-dc74ce9d7d75,2,201,fluphenazine,0,Oral,3372,CID3372,both,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO
LT00402,123631,gefitinib,2003,Most-DILI-Concern,4,Warnings and precautions,Yes,vMost-DILI-Concern,,,Positive,,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=827d60e8-7e07-41b7-c28b-49ef1c4a5a41,2,202,gefitinib,1,Oral,123631,CID123631,both,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4
LT00405,3559,haloperidol,1967,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=913fdc2f-36eb-47e1-aaee-7bfb542d3ed3,1,203,haloperidol,1,Oral,3559,CID3559,both,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
LT00414,4075,mesalazine,1950,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C1=CC(=C(C=C1N)C(=O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=70adfac7-f8b7-405c-86aa-b1f30343d38b,2,204,mesalazine,1,Oral,4075,CID4075,both,C1=CC(=C(C=C1N)C(=O)O)O
LT00416,5281021,minocycline,1971,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=O)/C(=C(/N)\O)/C1=O)O)O)O)N(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e7b88a48-12b3-461d-b356-0d7ae4e8fd44,1,205,minocycline,1,Oral,54675783,CID54675783,both,CN(C)[C@H]1[C@@H]2C[C@@H]3CC4=C(C=CC(=C4C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C
LT00419,3741,ioversol,1988,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=549d38db-d4ed-4708-8f76-7cdaa157063f,2,206,ioversol,0,Intravenous,3741,CID3741,both,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO
LT00429,4614,oxaprozin,1992,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,,Positive,Postive,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=765a0b09-d93b-eb04-7eed-1eb260500dc0,2,207,oxaprozin,1,Oral,4614,CID4614,both,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
LT00430,36314,paclitaxel,1992,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ea28753a-8631-460a-bfdc-b101eb8ac84a,2,208,paclitaxel,1,Intravenous,36314,CID36314,both,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C
LT00433,5775,phentolamine,1952,No-DILI-Concern,0,No match,,vNo-DILI-Concern,HH,,Positive,,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=658672ce-5251-4d17-9a5f-58d3abf62ed1,1,209,phentolamine,0,Intravenous,5775,CID5775,both,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O
LT00435,4893,prazosin,1976,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7293cef3-ef9e-40dc-9995-875ef047f693,2,210,prazosin,0,Oral,4893,CID4893,both,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC
LT00437,4917,prochlorperazine,1956,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,HH,Hepatotoxic,Positive,,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6b0e958b-fde0-74ea-b196-1e62f90b5bbe,2,211,prochlorperazine,1,Oral,4917,CID4917,both,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl
LT00438,16132344,corticorelin ovine triflutate,1996,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC3=CN=CN3)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N)NC(=O)[C@@H]4CCCN4C(=O)[C@@H]5CCCN5C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3c39dcea-d8f7-8594-01e6-24e8d6fa4d2f,2,212,corticorelin ovine triflutate,0,Intravenous,16132344,CID16132344,both,CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC3=CN=CN3)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N)NC(=O)[C@@H]4CCCN4C(=O)[C@@H]5CCCN5C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)N
LT00439,24477,sodium thiosulfate,1992,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,[O-]S(=O)(=S)[O-].[Na+].[Na+],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=82f55408-2de9-463d-85e8-b39c3b259f0b,2,213,sodium thiosulfate,0,Intravenous,24477,CID24477,both,[O-]S(=O)(=S)[O-].[Na+].[Na+]
LT00443,6436030,sirolimus,1999,Less-DILI-Concern,8,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3275b824-3f82-4151-2ab2-0036a9ba0acc,2,214,sirolimus,1,Oral,5284616,CID5284616,both,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)CC4CC[C@H]([C@@H](C4)OC)O)C)/C)O)OC)C)C)/C)OC
LT00448,439492,tacrolimus,1994,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](C=C(C1)C)CC=C)O)C)C(=C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)O)C)OC)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=93d03943-0655-44f6-b494-57bd1e336a34,1,215,tacrolimus,1,Oral,445643,CID445643,both,C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](C=C(C1)C)CC=C)O)C)C(=C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)O)C)OC)OC
LT00450,5426,thalidomide,1998,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2eda833b-1357-4ed4-a093-194524fcb061,2,216,thalidomide,1,Oral,5426,CID5426,both,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O
LT00451,5452,thioridazine,1962,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b8d8c29a-414d-4622-bffd-b742725b20f0,2,217,thioridazine,1,Oral,5452,CID5452,both,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC
LT00452,2723601,thioguanine,1966,Less-DILI-Concern,2,Warnings and precautions,Yes,vLess-DILI-Concern,HH,,Positive,,C1=NC2=C(N1)C(=S)N=C(N2)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dfda4177-3c9d-44ab-3ca6-e4db8e9fc603,1,218,thioguanine,1,Oral,2723601,CID2723601,both,C1=NC2=C(N1)C(=S)N=C(N2)N
LT00453,5505,tolbutamide,1961,Less-DILI-Concern,2,Adverse reactions,,Ambiguous DILI-concern,HH,,Positive,,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3995eed8-39ec-ce5e-8cc2-062f93445c8d,1,219,tolbutamide,0,Oral,5505,CID5505,both,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C
LT00455,5284627,topiramate,1996,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,Negative,Postive,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a48b6716-cf81-e694-c0c7-92c87e9d37ce,2,220,topiramate,1,Oral,5284627,CID5284627,both,CC1(O[C@@H]2CO[C@@]3([C@H]([C@@H]2O1)OC(O3)(C)C)COS(=O)(=O)N)C
LT00457,5566,trifluoperazine,1959,Less-DILI-Concern,2,Warnings and precautions,,Ambiguous DILI-concern,HH,,Positive,,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b902b380-cb41-48a4-bd42-5c357125397f,1,221,trifluoperazine,0,Oral,5566,CID5566,both,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F
LT00460,25077179,triptorelin pamoate,2000,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a2f71c34-4493-4d58-9c23-f8543babe95f,2,222,triptorelin pamoate,1,Intramuscular,25074469,CID25074469,both,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8
LT00461,3086677,alatrofloxacin mesylate,1997,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,Postive,C[C@@H](C(=O)N[C@@H](C)C(=O)NC1[C@H]2[C@@H]1CN(C2)C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F)N,,1,223,alatrofloxacin mesylate,1,Oral,5282517,CID5282517,both,C[C@@H](C(=O)N[C@@H](C)C(=O)NC1[C@H]2[C@@H]1CN(C2)C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F)N
LT00462,5311,vorinostat,2006,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,Negative,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cd86ee78-2781-468b-930c-3c4677bcc092,2,224,vorinostat,0,Oral,5311,CID5311,both,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO
LT00465,25081014,nesiritide,2001,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCCN)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CO)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC4C=NC=N4)C(=O)O)CC(C)C)CO)CO)CO)CO,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=44c45bfe-461f-4398-8f20-ea771b2403ee,2,225,nesiritide,0,Intravenous,71308561,CID71308561,both,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCCN)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]3CCCN3C(=O)[C@H](CO)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC4C=NC=N4)C(=O)O)CC(C)C)CO)CO)CO)CO
LT00475,16130957,ganirelix acetate,1999,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCNC(=NCCCC[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C)NCC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=96118395-557e-4998-842d-424a59d574b6,2,226,ganirelix acetate,0,Subcutaneous,23724914,CID23724914,both,CCNC(=NCCCC[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C)NCC
LT00478,6741,methylprednisolone,1957,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e5369cef-689e-45bc-b530-405a05838fe5,2,228,methylprednisolone,1,Oral,6741,CID6741,both,C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O
LT00480,23663870,gamma hydroxybutyric acid,2002,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C(CC(=O)[O-])CO.[Na+],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=926eb076-a4a8-45e4-91ef-411f0aa4f3ca,2,229,gamma hydroxybutyric acid,0,Oral,10413,CID10413,both,C(CC(=O)[O-])CO.[Na+]
LT00485,5487301,tegaserod,2002,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,Negative,CCCCCN=C(N)NN/C=C/1\C=NC2=C1C=C(C=C2)CO,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a274e3ea-bf67-4f81-aaa0-10475b20cd69,2,230,tegaserod,0,Oral,135409453,CID135409453,both,CCCCCN=C(N)N/N=C/C1=CNC2=C1C=C(C=C2)OC
LT00488,5852,penicillamine,1970,Less-DILI-Concern,2,Warnings and precautions,Yes,vLess-DILI-Concern,,,,,CC(C)([C@H](C(=O)O)N)S,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=80e736d3-2017-4d68-94b4-38255c3c59c6,1,231,penicillamine,1,Oral,5852,CID5852,both,CC(C)([C@H](C(=O)O)N)S
LT00492,16132446,pramlintide,2005,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N)NC(=O)[C@@H]4CCCN4C(=O)CNC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CN=CN6)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2262f20-bedb-43d9-b274-6ce275b0a69e,2,232,pramlintide,0,Subcutaneous,70691388,CID70691388,both,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N)NC(=O)[C@@H]4CCCN4C(=O)CNC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC6=CN=CN6)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)N
LT00493,176168,lanthanum carbonate,2004,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C(=O)([O-])[O-].C(=O)([O-])[O-].C(=O)([O-])[O-].O.[La+3].[La+3],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f10776b2-2c25-4343-aabe-68f302e5cb54,2,233,lanthanum carbonate,0,Oral,168924,CID168924,both,C(=O)([O-])[O-].C(=O)([O-])[O-].C(=O)([O-])[O-].O.[La+3].[La+3]
LT00498,1986,acetazolamide,1953,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,,Positive,,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a0dc2da1-f42f-483a-83de-56ad81b728df,2,234,acetazolamide,1,Oral,1986,CID1986,both,CC(=O)NC1=NN=C(S1)S(=O)(=O)N
LT00499,2082,albendazole,1996,Most-DILI-Concern,7,Warnings and precautions,Yes,vMost-DILI-Concern,HH,,Positive,Postive,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3b7e8429-0b57-477f-ba44-51789a5d0da1,2,235,albendazole,1,Oral,2082,CID2082,both,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC
LT00501,2118,alprazolam,1981,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f0bfdd42-caa1-402d-b040-1ac6082ea10a,2,236,alprazolam,1,Oral,2118,CID2118,both,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4
LT00502,2123,altretamine,1990,Less-DILI-Concern,2,Adverse reactions,,Ambiguous DILI-concern,,,,,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8456a8db-a7f6-4bc0-86be-e9c8c374140b,1,237,altretamine,0,Oral,2123,CID2123,both,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C
LT00503,2130,amantadine,1968,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,NE,,Negative,,C1C2CC3CC1CC(C2)(C3)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce3e1ae0-17f4-4fa3-9d9c-4239c54ae6ea,1,238,amantadine,0,Oral,2130,CID2130,both,C1C2CC3CC1CC(C2)(C3)N
LT00505,4649,4-aminosalicylic acid,1994,Most-DILI-Concern,5,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,,C1=CC(=C(C=C1N)O)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f2753dc-5f0c-4f49-9335-e519afb69ba6,1,239,4-aminosalicylic acid,1,Oral,4649,CID4649,both,C1=CC(=C(C=C1N)O)C(=O)O
LT00507,33613,amoxicillin,1974,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,WE,non-hepatotixic,Negative,Postive,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=20c86622-85b7-4827-a317-57aee79dfe57,1,240,amoxicillin,1,Oral,33613,CID33613,both,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)C(=O)O)C
LT00511,174174,atropine,1973,No-DILI-Concern,0,No match,,vNo-DILI-Concern,HH,non-hepatotixic,Positive,,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7cd7aae9-c8fc-4724-a0fe-1cc7ccf931a2,1,241,atropine,0,Intravenous,174174,CID174174,both,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3
LT00513,39941,benoxaprofen,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,HH,,Positive,Postive,CC(C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)Cl)C(=O)O,,1,242,benoxaprofen,1,Oral,39941,CID39941,both,CC(C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)Cl)C(=O)O
LT00515,60877,emtricitabine,2003,Less-DILI-Concern,2,Warnings and precautions,,Ambiguous DILI-concern,,,,,C1[C@H](O[C@H](S1)CO)N2C=C(C(=NC2=O)N)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d6599395-3944-44f9-97f2-e0424c6b6a1f,2,243,emtricitabine,0,Oral,60877,CID60877,both,C1[C@H](O[C@H](S1)CO)N2C=C(C(=NC2=O)N)F
LT00516,3034812,trospium,2004,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1CC[N+]2(C1)[C@H]3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cd0d2e18-9e16-ac18-c35c-a150bb5cb67b,2,244,trospium,0,Oral,5284632,CID5284632,both,C1CC[N+]2(C1)[C@H]3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-]
LT00519,60726,bromfenac,2005,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1=CC(=C(C(=C1)CC(=O)O)N)C(=O)C2=CC=C(C=C2)Br,,1,245,bromfenac,1,Oral,60726,CID60726,both,C1=CC(=C(C(=C1)C(=O)C2=CC=C(C=C2)Br)N)CC(=O)O
LT00528,158440,gadofosveset trisodium,2008,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1CC(CCC1OP(=O)([O-])OC[C@@H](CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-])(C2=CC=CC=C2)C3=CC=CC=C3.O.[Na+].[Na+].[Na+].[Gd+3],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8175d0e7-b627-6c68-73e6-d1fc7660775d,2,246,gadofosveset trisodium,0,Intravenous,73049652,CID73049652,both,C1CC(CCC1OP(=O)([O-])OC[C@@H](CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-])(C2=CC=CC=C2)C3=CC=CC=C3.O.[Na+].[Na+].[Na+].[Gd+3]
LT00532,2802,clonazepam,1975,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,Negative,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1617e8e2-54a8-4119-b865-d20d2350df3e,2,247,clonazepam,1,Oral,2802,CID2802,both,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl
LT00537,16157882,exenatide,2005,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCC[C@H]3C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N4CCC[C@H]4C(=O)N5CCC[C@H]5C(=O)N6CCC[C@H]6C(=O)N[C@@H](CO)C(=O)N)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC8=CC=CC=C8)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC9=CN=CN9)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c621d002-b7bf-4f3a-af68-4f70fd298d05,2,248,exenatide,0,Subcutaneous,45588096,CID45588096,both,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCC[C@H]3C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N4CCC[C@H]4C(=O)N5CCC[C@H]5C(=O)N6CCC[C@H]6C(=O)N[C@@H](CO)C(=O)N)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC8=CC=CC=C8)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CC9=CN=CN9)N
LT00538,153941,entecavir,2005,Most-DILI-Concern,7,Warnings and precautions,,Ambiguous DILI-concern,,,,,C=C1[C@H](C[C@@H]([C@H]1CO)O)N2C=NC3=C2NC(=NC3=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=046e61c9-9298-4b2e-b76e-b26b81fecd20,2,249,entecavir,0,Oral,135398508,CID135398508,both,C=C1[C@H](C[C@@H]([C@H]1CO)O)N2C=NC3=C2N=C(NC3=O)N
LT00539,28417,danazol,1976,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=db372b81-28e6-44c7-a6c8-1c15362bec0d,1,250,danazol,1,Oral,28417,CID28417,both,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC5=C(C[C@]34C)C=NO5
LT00540,30323,daunorubicin,1979,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=64c62283-a6e8-48c7-8918-d6955bea5eb0,2,251,daunorubicin,0,Intravenous,30323,CID30323,both,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O
LT00545,441281,dimenhydrinate,1972,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CN1C(=C2C(=NC(=N2)Cl)N(C1=O)C)[O-].C[NH+](C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bc71539e-1a33-4709-8a24-c2894e8dbc1c,2,252,dimenhydrinate,0,Intravenous,10660,CID10660,both,CN1C(=C2C(=NC(=N2)Cl)N(C1=O)C)[O-].C[NH+](C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
LT00547,3156,doxapram,1965,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b8eb330a-a75b-46cb-b694-5be9327ed2eb,2,253,doxapram,0,Intravenous,3156,CID3156,both,CCN1CC(C(C1=O)(C2=CC=CC=C2)C3=CC=CC=C3)CCN4CCOCC4
LT00554,134018,febuxostat,2009,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=54de10ef-fe5f-4930-b91d-6bbb04c664bd,2,254,febuxostat,1,Oral,134018,CID134018,both,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O
LT00557,3510,granisetron,1993,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d0e05816-ccf8-4008-b5de-4d3fbc3de3c1,2,255,granisetron,0,Oral,5284566,CID5284566,both,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C
LT00558,441140,griseofulvin,1962,Most-DILI-Concern,8,Warnings and precautions,Yes(literature),vMost-DILI-Concern,HH,,Positive,,C[C@@H]1CC(=O)C=C([C@]12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=39ac6363-93bc-4e12-a7a7-667eafac42a5,1,256,griseofulvin,1,Oral,441140,CID441140,both,C[C@@H]1CC(=O)C=C([C@]12C(=O)C3=C(O2)C(=C(C=C3OC)OC)Cl)OC
LT00559,3637,hydralazine,1953,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,Hepatotoxic,,Postive,C1=CC=C2C(=C1)C=NN=C2NN,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ddbbdb09-3202-42d7-bbb0-08331dde2f54,2,257,hydralazine,1,Oral,3637,CID3637,both,C1=CC=C2C(=C1)C=NN=C2NN
LT00560,15250,ibufenac,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,HH,,Positive,,CC(C)CC1=CC=C(C=C1)CC(=O)O,,1,258,ibufenac,1,Oral,15250,CID15250,both,CC(C)CC1=CC=C(C=C1)CC(=O)O
LT00562,3690,ifosfamide,1988,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,,C1CN(P(=O)(OC1)NCCCl)CCCl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=14f535d7-4593-4cee-94fb-54ee239d95d2,1,259,ifosfamide,1,Intravenous,3690,CID3690,both,C1CN(P(=O)(OC1)NCCCl)CCCl
LT00563,5493381,deferasirox,2005,Most-DILI-Concern,7,Box warning,Yes,vMost-DILI-Concern,,,,,C1=C/C(=C/2\N/C(=C\3/C=CC=CC3=O)/N(N2)C4=CC=C(C=C4)C(=O)O)/C(=O)C=C1,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3495a70c-870c-4968-940e-8baea152cf85,1,260,deferasirox,1,Oral,214348,CID214348,both,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O
LT00565,5329102,sunitinib,2006,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,,,,,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=43a4d7f8-48ae-4a63-9108-2fa8e3ea9d9c,1,261,sunitinib,1,Oral,5329102,CID5329102,both,CCN(CC)CCNC(=O)C1=C(NC(=C1C)/C=C\2/C3=C(C=CC(=C3)F)NC2=O)C
LT00568,6474909,ivermectin,1996,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CCC(C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C.C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)O[C@@H]1C(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=681888c9-af79-4b7d-ae80-c3f4f6f1effd,2,262,ivermectin,1,Oral,6321424,CID6321424,both,CCC(C)[C@@H]1[C@H](CC[C@@]2(O1)C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)C.C[C@H]1CC[C@]2(C[C@@H]3C[C@H](O2)C/C=C(/[C@H]([C@H](/C=C/C=C/4\CO[C@H]5[C@@]4([C@@H](C=C([C@H]5O)C)C(=O)O3)O)C)O[C@H]6C[C@@H]([C@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@H]([C@@H](O7)C)O)OC)OC)\C)O[C@@H]1C(C)C
LT00569,60825,lamivudine,1995,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,WE,,Negative,Postive,C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d5e70d8-9bf9-212c-63a4-44785f3fd015,1,263,lamivudine,1,Oral,60825,CID60825,both,C1[C@H](O[C@H](S1)CO)N2C=CC(=NC2=O)N
LT00570,5361917,methylnaltrexone bromide,2008,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C[N+]1(CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O)CC6CC6.[Br-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c488fb7c-0a5b-487c-b452-996809d1cb99,2,264,methylnaltrexone bromide,0,Subcutaneous,5361917,CID5361917,both,C[N+]1(CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O)CC6CC6.[Br-]
LT00572,3902,letrozole,1997,Less-DILI-Concern,2,Warnings and precautions,Yes,vLess-DILI-Concern,,,,,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ebda73d-82a3-4b17-8a81-a1f258003d32,2,265,letrozole,1,Oral,3902,CID3902,both,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3
LT00573,125017,desvenlafaxine,2008,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0f43610c-f290-46ea-d186-4f998ed99fce,2,266,desvenlafaxine,1,Oral,125017,CID125017,both,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O
LT00574,3948,lomefloxacin,1992,Less-DILI-Concern,4,Adverse reactions,,Ambiguous DILI-concern,HH,,Positive,,CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=173018f5-fd76-4480-90f8-4b7efe328444,2,267,lomefloxacin,0,Oral,3948,CID3948,both,CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O
LT00575,3950,lomustine,1976,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,,C1CCC(CC1)NC(=O)N(CCCl)N=O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17893de9-7d54-448c-9fca-d10642046d14,2,268,lomustine,1,Oral,3950,CID3950,both,C1CCC(CC1)NC(=O)N(CCCl)N=O
LT00576,53232,lovastatin,1987,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,non-hepatotixic,Negative,Postive,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=058b94d0-9811-4dd2-a28d-377a26e5e6f8,1,269,lovastatin,1,Oral,53232,CID53232,both,CC[C@H](C)C(=O)O[C@H]1C[C@H](C=C2[C@H]1[C@H]([C@H](C=C2)C)CC[C@@H]3C[C@H](CC(=O)O3)O)C
LT00577,159269,telbivudine,2006,Less-DILI-Concern,2,Warnings and precautions,,Ambiguous DILI-concern,,,,,CC1=CN(C(=O)NC1=O)[C@@H]2C[C@H]([C@@H](O2)CO)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0664309d-1342-4a63-ba5f-4b899cdf3bec,2,270,telbivudine,0,Oral,159269,CID159269,both,CC1=CN(C(=O)NC1=O)[C@@H]2C[C@H]([C@@H](O2)CO)O
LT00580,1349907,methimazole,1950,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,,Positive,,CN1C=CNC1=S,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9e6b80b8-6780-da50-f18f-30e6fe7b01b9,1,271,methimazole,1,Oral,1349907,CID1349907,both,CN1C=CNC1=S
LT00581,4107,methocarbamol,1957,Less-DILI-Concern,5,Adverse reactions,,Ambiguous DILI-concern,,non-hepatotixic,,,COC1=CC=CC=C1OCC(COC(=O)N)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=32863f21-30ff-4a8b-a2e6-8ab14a37af0d,2,272,methocarbamol,0,Oral,4107,CID4107,both,COC1=CC=CC=C1OCC(COC(=O)N)O
LT00584,4173,metronidazole,1963,No-DILI-Concern,3,No match,Yes,vLess-DILI-Concern,HH,,Positive,Postive,CC1=NC=C(N1CCO)[N+](=O)[O-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b019ffd-1f70-43f6-bc33-dd16e1481531,1,273,metronidazole,1,Oral,4173,CID4173,both,CC1=NC=C(N1CCO)[N+](=O)[O-]
LT00587,4201,minoxidil,1979,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f3800f0-b6da-4dfe-8c32-39bb5eb0262a,1,274,minoxidil,0,Oral,4201,CID4201,both,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O
LT00588,5746,mitomycin,1981,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,,Hepatotoxic,,Negative,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ff676355-313d-4575-8f2f-e4a1e9527477,1,275,mitomycin,1,Intravenous,5746,CID5746,both,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N
LT00589,4236,modafinil,1998,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,non-hepatotixic,,Postive,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f3b3097f-80b8-4410-af21-dcdea144e3c3,2,276,modafinil,1,Oral,4236,CID4236,both,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
LT00590,9849808,fesoterodine,2008,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(C)C(=O)OC1=C(C=C(C=C1)CO)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2.C(=C/C(=O)O)\C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5be745f0-8ae7-4c3c-9962-37d6263326f1,2,277,fesoterodine,0,Oral,6918558,CID6918558,both,CC(C)C(=O)OC1=C(C=C(C=C1)CO)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2.C(=C/C(=O)O)\C(=O)O
LT00592,5284596,naloxone,1971,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b598c237-032d-4bb5-0e92-50eabd863dac,2,278,naloxone,0,Intravenous,5284596,CID5284596,both,C=CCN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O
LT00593,1302,naproxen,1976,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,WE,Hepatotoxic,Negative,Postive,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cb8a73cd-960c-4569-b2d6-abbcd2096689,1,279,naproxen,1,Oral,156391,CID156391,both,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O
LT00594,60026,nateglinide,2000,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,non-hepatotixic,,,CC(C)C1CCC(CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=78679aac-28ba-4828-8189-4a2fc8de2b71,2,280,nateglinide,0,Oral,5311309,CID5311309,both,CC(C)C1CCC(CC1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O
LT00595,4454,neomycin,1964,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=777dbfab-f83e-4738-ae1e-78619a9f82a7,1,281,neomycin,0,Oral,8378,CID8378,both,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N
LT00600,1549000,levocetirizine dihydrochloride,2007,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C1CN(CCN1CCOCC(=O)O)[C@H](C2=CC=CC=C2)C3=CC=C(C=C3)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4f43d057-cba8-4366-86ba-4be361e4c71f,2,282,levocetirizine dihydrochloride,1,Oral,9955977,CID9955977,both,C1CN(CCN1CCOCC(=O)O)[C@H](C2=CC=CC=C2)C3=CC=C(C=C3)Cl
LT00602,11953884,nystatin,1964,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C[C@@H]1[C@H]([C@@H]([C@@H](C(O1)OC\2CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C(C(/C=C/C=C/CC/C=C/C=C/C=C/C=C2)C)O)C)C)O)O)O)O)O)O)C(=O)O)O)O)N)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e87b8480-987d-4f82-87bf-cf831d6984a1,1,283,nystatin,0,Oral,6433272,CID6433272,both,C[C@@H]1[C@H]([C@@H]([C@@H](C(O1)OC\2CC(C(C(CC(=O)CC(C(CCC(CC(CC(CC(=O)OC(C(C(C(/C=C/C=C/CC/C=C/C=C/C=C/C=C2)C)O)C)C)O)O)O)O)O)O)C(=O)O)O)O)N)O
LT00605,5280972,oxytetracycline,1964,Less-DILI-Concern,2,Warnings and precautions,,Ambiguous DILI-concern,,,,,C[C@@]1([C@H]2[C@@H]([C@H]3[C@@H](C(=O)/C(=C(\N)/O)/C(=O)[C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)N(C)C)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6b4de8c9-8a32-4a07-9183-419d6177ea08,1,284,oxytetracycline,0,Oral,54675779,CID54675779,both,C[C@@]1([C@H]2[C@@H]([C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O
LT00606,4679,pantoprazole,2000,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=742ca9f4-9fba-44d4-29a8-1fe3a04f1af6,2,285,pantoprazole,1,Oral,4679,CID4679,both,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC
LT00612,5755,prednisolone,1955,Less-DILI-Concern,3,Adverse reactions,Yes(literature),vLess-DILI-Concern,,,,,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f7d51cb7-9015-4062-b306-509d23104195,1,286,prednisolone,1,Oral,5755,CID5755,both,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O
LT00613,4908,primaquine,1952,No-DILI-Concern,0,No match,,vNo-DILI-Concern,WE,,Negative,,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1bfbf4ae-81b8-4160-a00d-6322aadd4b59,1,287,primaquine,0,Oral,4908,CID4908,both,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2
LT00614,4915,procarbazine,1969,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,,Positive,,CC(C)NC(=O)C1=CC=C(C=C1)CNNC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de1c8271-64d8-4ea5-85e8-871faa4d7632,2,288,procarbazine,1,Oral,4915,CID4915,both,CC(C)NC(=O)C1=CC=C(C=C1)CNNC
LT00618,197712,ambrisentan,2007,Less-DILI-Concern,7,Adverse reactions,,Ambiguous DILI-concern,,,,,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=725d4e73-6c83-477a-adc6-0ae4a133a844,1,289,ambrisentan,0,Oral,6918493,CID6918493,both,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C
LT00624,31143,secobarbital,1950,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,CCC[C@@H](C)C1(C(=O)NC(=O)NC1=O)CC=C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=19647025-6c7b-4079-8040-51e26347b014,2,290,secobarbital,0,Oral,5193,CID5193,both,CCC[C@@H](C)C1(C(=O)NC(=O)NC1=O)CC=C
LT00625,68617,sertraline,1991,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,WE,non-hepatotixic,Negative,Postive,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fe9e8b7d-61ea-409d-84aa-3ebd79a046b5,1,291,sertraline,1,Oral,68617,CID68617,both,CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
LT00627,5253,sotalol,1992,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,non-hepatotixic,,,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6616d1a2-09a6-429c-8d19-0ac6354980bb,2,292,sotalol,0,Oral,5253,CID5253,both,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O
LT00632,5340,sulfathiazole,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CS2,,1,293,sulfathiazole,1,Oral,5340,CID5340,both,C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CS2
LT00634,5402,terbinafine,1992,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,,,Postive,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0dd09005-149a-2817-1d72-e1fde0f99987,1,294,terbinafine,1,Oral,1549008,CID1549008,both,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21
LT00635,5430,thiabendazole,1967,Most-DILI-Concern,7,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,"http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/16096slr033,16097slr026_mintezol_lbl.pdf",2,295,thiabendazole,1,Oral,5430,CID5430,both,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3
LT00636,38409,ticrynafen,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1=CSC(=C1)C(=O)C2=C(C(=C(C=C2)OCC(=O)O)Cl)Cl,,1,296,ticrynafen,1,Oral,38409,CID38409,both,C1=CSC(=C1)C(=O)C2=C(C(=C(C=C2)OCC(=O)O)Cl)Cl
LT00637,5479,tinidazole,2004,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f55bcc41-2e8d-4ee5-9993-05c7d86f2d2c,2,297,tinidazole,1,Oral,5479,CID5479,both,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C
LT00640,3002977,maraviroc,2007,Most-DILI-Concern,3,Box warning,,vMost-DILI-Concern,,,,,CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=46f30ac5-c96b-429e-976d-8c5ee1c0761b,1,298,maraviroc,1,Oral,3002977,CID3002977,both,CC1=NN=C(N1C2C[C@H]3CC[C@@H](C2)N3CC[C@@H](C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C
LT00642,11598201,raltegravir,2007,Most-DILI-Concern,7,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,CC1=NN=C(O1)C(=O)NC(C)(C)C2=N/C(=C(/NCC3=CC=C(C=C3)F)\O)/C(=O)C(=O)N2C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89a5ec53-d956-4329-8004-0f40f51c88a3,2,299,raltegravir,1,Oral,54671008,CID54671008,both,CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F
LT00644,153994,clevidipine,2008,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=095081a0-1398-11dc-82e1-0002a5d5c51b,2,300,clevidipine,0,Intravenous,153994,CID153994,both,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
LT00645,62959,trovafloxacin,1997,Most-DILI-Concern,8,Withdrawn,Yes,vMost-DILI-Concern,HH,,Positive,Postive,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=da9b26bb-d2d7-4113-a0f9-c6c2280f4875,1,301,trovafloxacin,1,Oral,62959,CID62959,both,C1[C@@H]2[C@@H](C2N)CN1C3=C(C=C4C(=O)C(=CN(C4=N3)C5=C(C=C(C=C5)F)F)C(=O)O)F
LT00646,219024,regadenoson,2008,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CNC(=O)C1=CN(N=C1)C2=NC3=C(C(=N2)N)N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=057289f4-2e18-4c1e-bed4-6c1858e2ef16,2,302,regadenoson,0,Intravenous,219024,CID219024,both,CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N
LT00647,6691,warfarin,1954,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,WE,non-hepatotixic,Negative,,CC(=O)CC(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3fb2aa58-3a40-4255-a261-e2db5b9a5dde,1,303,warfarin,1,Oral,54678486,CID54678486,both,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O
LT00648,5719,zaleplon,1999,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b8032b14-5068-19d5-e063-839ed25d7200,2,304,zaleplon,0,Oral,5719,CID5719,both,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C
LT00649,60490,zileuton,1996,Most-DILI-Concern,5,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aee65202-fddb-497f-9f11-17cc727cb157,1,305,zileuton,1,Oral,60490,CID60490,both,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O
LT00650,14789,ferumoxytol,2009,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,O[Fe]=O.O[Fe]=O.[Fe],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=32b0e320-a739-11dc-a704-0002a5d5c51b,2,306,ferumoxytol,0,Intravenous,14789,CID14789,both,O[Fe]=O.O[Fe]=O.[Fe]
LT00653,193962,etravirine,2008,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6a9cbc29-9f15-4b24-8d86-206b82887f3d,2,307,etravirine,1,Oral,193962,CID193962,both,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N
LT00656,5312125,silodosin,2008,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C[C@H](CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a21163d6-e1b9-4490-bce3-751e0823797c,2,308,silodosin,0,Oral,5312125,CID5312125,both,C[C@H](CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F
LT00658,3038497,fospropofol,2008,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,,,,,CC(C)C1=C(C(=CC=C1)C(C)C)OCOP(=O)([O-])[O-].[Na+].[Na+],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8cc837aa-14f0-4809-9ca1-6cc7ff84646b,2,309,fospropofol,1,Intravenous,3038498,CID3038498,both,CC(C)C1=C(C(=CC=C1)C(C)C)OCOP(=O)([O-])[O-].[Na+].[Na+]
LT00659,65628,bendamustine,2008,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=39d53698-57fa-7c99-fc5b-f52a55684826,2,310,bendamustine,0,Intravenous,65628,CID65628,both,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O
LT00661,216237,tolvaptan,2009,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5526617c-c7b9-4556-886d-729bbabbc566,2,311,tolvaptan,1,Oral,216237,CID216237,both,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C
LT00663,9915926,eltrombopag olamine,2008,Most-DILI-Concern,4,Box warning,,vMost-DILI-Concern,,,,,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N/N=C/3\C=CC=C(C3=O)C4=CC(=CC=C4)C(=O)O)C.C(CO)N.C(CO)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=616224ff-a925-4b38-9ca2-00fbf669380f,1,312,eltrombopag olamine,1,Oral,135449331,CID135449331,both,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C.C(CO)N.C(CO)N
LT00664,6433091,tapentadol,2008,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCC(C1=CC(=CC=C1)O)C(C)CN(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=07c33315-90c9-4a73-bf1d-bca70c7e0ff5,2,313,tapentadol,0,Oral,9838022,CID9838022,both,CCC(C1=CC(=CC=C1)O)C(C)CN(C)C
LT00665,6918456,prasugrel hydrochloride,2009,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,,,,,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5fe9c118-c44b-48d7-a142-9668ae3df0c6,2,314,prasugrel hydrochloride,1,Oral,10158453,CID10158453,both,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4
LT00667,49800073,saxagliptin,2009,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H](C34CC5CC(C3)CC(C5)(C4)O)N.Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d45fc842-2563-4421-86af-a55b3191e19b,2,315,saxagliptin,0,Oral,11243969,CID11243969,both,C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H](C34CC5CC(C3)CC(C5)(C4)O)N.Cl
LT00669,5352062,romidepsin,2009,No-DILI-concern,0,No match,,vNo-DILI-Concern,,,,,C/C=C\1/C(=O)N[C@H](C(=O)O[C@H]\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=03b39d40-90fe-11df-9de6-0002a5d5c51b ,2,316,romidepsin,0,Intravenous,5352062,CID5352062,both,C/C=C\1/C(=O)N[C@H](C(=O)O[C@H]\2CC(=O)N[C@@H](C(=O)N[C@H](CSSCC/C=C2)C(=O)N1)C(C)C)C(C)C
LT00671,208898,dronedarone,2009,Most-DILI-Concern,7,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7fa41601-7fb5-4155-8e50-2ae903f0d2d6,2,317,dronedarone,1,Oral,208898,CID208898,both,CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC
LT00672,10113978,pazopanib,2009,Most-DILI-Concern,8,Box warning,Yes(literature),vMost-DILI-Concern,,,,,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5b7b3a4-c3a4-4722-8ca5-8f6a5c622553,1,318,pazopanib,1,Oral,10113978,CID10113978,both,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N
LT00674,154228,pancrelipase,,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C[Si]12OCCN(CC(O1)COCC=C)CC(O2)COCC=C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1431edd-0fc5-4ebc-8c10-53deb0db0d23,2,319,pancrelipase,0,Oral,154228,CID154228,both,C[Si]12OCCN(CC(O1)COCC=C)CC(O2)COCC=C
LT00682,33036,dexchlorpheniramine,1981,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CN(C)CC[C@@H](C1=CC=C(C=C1)Cl)C2=CC=CC=N2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1950f4d6-7fc2-44cd-9f7d-1359315353fc,2,320,dexchlorpheniramine,0,Oral,33036,CID33036,both,CN(C)CC[C@@H](C1=CC=C(C=C1)Cl)C2=CC=CC=N2
LT00683,44152182,ecallantide,2009,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N4CCC[C@H]4C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N5CCC[C@H]5C(=O)N3)CC(=O)O)CC(=O)O)C)CCCCN)CC6=CC=CC=C6)C)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CO)NC(=O)[C@H](CC8=CN=CN8)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)N)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)CCSC)CCCCN)CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC2=O)CCC(=O)O)CC(=O)N)CCC(=O)N)CC(=O)N)CCCNC(=N)N)CC9=CC=CC=C9)CCC(=O)O)CO)CC(C)C)CCC(=O)O)CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC1=CC=CC=C1)CCC(=O)O)CCC(=O)O)CCC(=O)N)CCCNC(=N)N)[C@H](C)O)CC1=CC=CC=C1)[C@@H](C)CC)CC(=O)N)CC1=CC=CC=C1)CC1=CC=CC=C1)CC1=CNC2=CC=CC=C21)CCCNC(=N)N)CC1=CN=CN1)C)C)CCCNC(=N)N)CC1=CC=C(C=C1)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f56aec67-c662-477c-b866-bfc23e8809cf,2,321,ecallantide,0,Subcutaneous,44152182,CID44152182,both,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N4CCC[C@H]4C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N5CCC[C@H]5C(=O)N3)CC(=O)O)CC(=O)O)C)CCCCN)CC6=CC=CC=C6)C)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CO)NC(=O)[C@H](CC8=CN=CN8)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)N)C(=O)N[C@@H]([C@H](C)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)CCSC)CCCCN)CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@@H](NC2=O)CCC(=O)O)CC(=O)N)CCC(=O)N)CC(=O)N)CCCNC(=N)N)CC9=CC=CC=C9)CCC(=O)O)CO)CC(C)C)CCC(=O)O)CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CC1=CC=CC=C1)CCC(=O)O)CCC(=O)O)CCC(=O)N)CCCNC(=N)N)[C@H](C)O)CC1=CC=CC=C1)[C@@H](C)CC)CC(=O)N)CC1=CC=CC=C1)CC1=CC=CC=C1)CC1=CNC2=CC=CC=C21)CCCNC(=N)N)CC1=CN=CN1)C)C)CCCNC(=N)N)CC1=CC=C(C=C1)O
LT00684,23663956,divalproex sodium,1983,Most-DILI-Concern,8,Box warning,,vMost-DILI-Concern,,,,,CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=18f7f458-9276-4e9d-94b2-99ca8dd4cebf,2,322,divalproex sodium,1,Oral,23663956,CID23663956,both,CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+]
LT00686,151166,lumiracoxib,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,Positive,Postive,CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O,,1,323,lumiracoxib,1,Oral,151166,CID151166,both,CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O
LT00687,60919,tasosartan,,Most-DILI-Concern,8,Discontinued,,vMost-DILI-Concern,HH,,Positive,,CC1=C2CCC(=O)N(C2=NC(=N1)C)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,,1,324,tasosartan,1,Oral,60919,CID60919,both,CC1=C2CCC(=O)N(C2=NC(=N1)C)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
LT00690,8269,oxyphenisatin,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,CC(=O)OC1=CC=C(C=C1)C2(C3=CC=CC=C3NC2=O)C4=CC=C(C=C4)OC(=O)C,,1,325,oxyphenisatin,1,Oral,31315,CID31315,both,CC(=O)OC1=CC=C(C=C1)C2(C3=CC=CC=C3NC2=O)C4=CC=C(C=C4)OC(=O)C
LT00691,65592,tilbroquinol,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,CC1=CC(=C(C2=C1C=CC=N2)O)Br,,1,326,tilbroquinol,1,Oral,65592,CID65592,both,CC1=CC(=C(C2=C1C=CC=N2)O)Br
LT00692,30951,alclofenac,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,C=CCOC1=C(C=C(C=C1)CC(=O)O)Cl,,1,327,alclofenac,1,Oral,30951,CID30951,both,C=CCOC1=C(C=C(C=C1)CC(=O)O)Cl
LT00693,3001322,aplaviroc ,,Most-DILI-Concern,8,Discontinued,,vMost-DILI-Concern,,,,,CCCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)[C@@H](C5CCCCC5)O,,1,328,aplaviroc,1,Oral,3001322,CID3001322,both,CCCCN1C(=O)[C@H](NC(=O)C12CCN(CC2)CC3=CC=C(C=C3)OC4=CC=C(C=C4)C(=O)O)[C@@H](C5CCCCC5)O
LT00694,21382,clomacran,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,CN(C)CCCC1C2=CC=CC=C2NC3=C1C=C(C=C3)Cl,,1,329,clomacran,1,Oral,21382,CID21382,both,CN(C)CCCC1C2=CC=CC=C2NC3=C1C=C(C=C3)Cl
LT00695,32756,dermatan,,Most-DILI-Concern,8,Discontinued,,vMost-DILI-Concern,,,,,CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1O)CO)OS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O)O)O,,1,330,dermatan,1,Intravenous,32756,CID32756,both,CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1O)CO)OS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O)O)O
LT00696,71169,isaxonine,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,CC(C)NC1=NC=CC=N1,,1,331,isaxonine,1,Oral,71169,CID71169,both,CC(C)NC1=NC=CC=N1
LT00697,6761,pipamazine,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,C1CN(CCC1C(=O)N)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,,1,332,pipamazine,1,Oral,6761,CID6761,both,C1CN(CCC1C(=O)N)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl
LT00698,153270,pralnacasan ,,Most-DILI-Concern,8,Discontinued,,vMost-DILI-Concern,,,,,CCO[C@H]1[C@H](CC(=O)O1)NC(=O)[C@@H]2CCCN3N2C(=O)[C@H](CCC3=O)NC(=O)C4=NC=CC5=CC=CC=C54,,1,333,pralnacasan,1,Oral,153270,CID153270,both,CCO[C@H]1[C@H](CC(=O)O1)NC(=O)[C@@H]2CCCN3N2C(=O)[C@H](CCC3=O)NC(=O)C4=NC=CC5=CC=CC=C54
LT00699,11033,sulfacarbamide,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,C1=CC(=CC=C1N)S(=O)(=O)NC(=O)N,,1,334,sulfacarbamide,1,Oral,11033,CID11033,both,C1=CC(=CC=C1N)S(=O)(=O)NC(=O)N
LT00700,29321,triacetyldiphenolisatin,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,CC(=O)N1C2=CC=CC=C2C(C1=O)(C3=CC=C(C=C3)OC(=O)C)C4=CC=C(C=C4)OC(=O)C,,1,335,triacetyldiphenolisatin,1,Oral,29321,CID29321,both,CC(=O)N1C2=CC=CC=C2C(C1=O)(C3=CC=C(C=C3)OC(=O)C)C4=CC=C(C=C4)OC(=O)C
LT00701,172307,fiduxosin ,,Most-DILI-Concern,8,Discontinued,,vMost-DILI-Concern,,,,,COC1=CC=CC2=C1[C@@H]3CN(C[C@@H]3CO2)CCCCN4C(=O)C5=C(C6=NC(=CN=C6S5)C7=CC=CC=C7)NC4=O,,1,336,fiduxosin,1,Oral,172307,CID172307,both,COC1=CC=CC2=C1[C@@H]3CN(C[C@@H]3CO2)CCCCN4C(=O)C5=C(C6=NC(=CN=C6S5)C7=CC=CC=C7)NC4=O
LT00702,5480200,pafuramidine ,,Most-DILI-Concern,8,Discontinued,,vMost-DILI-Concern,,,,,CO/N=C(\N)/C1=CC=C(C=C1)C2=CC=C(O2)C3=CC=C(C=C3)/C(=N/OC)/N,,1,337,pafuramidine,1,Oral,5480200,CID5480200,both,CO/N=C(\N)/C1=CC=C(C=C1)C2=CC=C(O2)C3=CC=C(C=C3)/C(=N/OC)/N
LT00703,71467,phenoxypropazine,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,CC(COC1=CC=CC=C1)NN,,1,338,phenoxypropazine,1,Oral,71467,CID71467,both,CC(COC1=CC=CC=C1)NN
LT00706,65513,histamine diphosphate,1939,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1=C(NC=N1)CCN.OP(=O)(O)O.OP(=O)(O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1159c24c-d9ce-49a2-b0bd-dc27c710f146,2,339,histamine diphosphate,0,Subcutaneous,65513,CID65513,both,C1=C(NC=N1)CCN.OP(=O)(O)O.OP(=O)(O)O
LT00711,9433,aminophylline,1940,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a7c01224-b32b-40ef-935b-164893a93b22,2,340,aminophylline,0,Oral,9433,CID9433,both,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N
LT00713,4058,meperidine,1942,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f9e0a64-cae4-4a56-8a3e-3dec2e705759,2,341,meperidine,0,Oral,4058,CID4058,both,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2
LT00716,10836,methamphetamine,1943,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,,C[C@@H](CC1=CC=CC=C1)NC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=15e150c7-1347-40fb-9f58-c390521bc6f9,2,342,methamphetamine,0,Oral,10836,CID10836,both,C[C@@H](CC1=CC=CC=C1)NC
LT00723,4095,methadone,1947,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b72a120-ca4e-4b90-7d89-52967a39adb3,2,343,methadone,0,Oral,4095,CID4095,both,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
LT00727,3162,doxylamine,1948,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bf64865f-4cf8-444a-9106-62abf2f22879,2,345,doxylamine,0,Oral,3162,CID3162,both,CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C
LT00730,2370,bethanechol,1948,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(C[N+](C)(C)C)OC(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9445fc1-8a27-4a93-8fe7-90ae5f2aaab7,1,347,bethanechol,0,Oral,2370,CID2370,both,CC(C[N+](C)(C)C)OC(=O)N
LT00734,5745,cortisone acetate,1950,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=105133d9-2991-4dd2-8d99-beb81aed8aad,2,348,cortisone acetate,0,Oral,5745,CID5745,both,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O
LT00737,3042,dicyclomine,1950,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a553bda-1e3d-4b80-913f-73dd54655033,2,349,dicyclomine,0,Oral,3042,CID3042,both,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2
LT00738,439260,norepinephrine,1950,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1=CC(=C(C=C1[C@H](CN)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31dcd090-2f1b-405a-9c2e-04fc535ccf4d,1,350,norepinephrine,0,Intravenous,439260,CID439260,both,C1=CC(=C(C=C1[C@H](CN)O)O)O
LT00740,3182,dyphylline,1951,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d7ed7c0-9646-11de-a404-0002a5d5c51b,2,351,dyphylline,0,Oral,3182,CID3182,both,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O
LT00742,5816,epinephrine,1951,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CNC[C@@H](C1=CC(=C(C=C1)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8da22eb1-0965-4d4e-b15d-91db7193548e,1,352,epinephrine,0,Subcutaneous,5816,CID5816,both,CNC[C@@H](C1=CC(=C(C=C1)O)O)O
LT00749,5314,succinylcholine,1952,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=579ff759-3099-45f5-befe-c4b79106c87e,1,353,succinylcholine,0,Intravenous,5314,CID5314,both,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C
LT00752,5359272,levorphanol,1953,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CN1CC[C@]23CCCC[C@H]2[C@H]1CC4=C3C=C(C=C4)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b2ab70e4-ca0c-4a73-9c98-974bf94e890c,2,355,levorphanol,0,Oral,5359272,CID5359272,both,CN1CC[C@]23CCCC[C@H]2[C@H]1CC4=C3C=C(C=C4)O
LT00753,4934,propantheline,1953,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13)C(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84a920c8-b637-4741-b9b2-fc607e245ce0,2,356,propantheline,0,Oral,4934,CID4934,both,CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13)C(C)C
LT00759,2564,carbinoxamine,1974,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CN(C)CCOC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1edca669-8879-408a-b09c-259e363dd95c,1,357,carbinoxamine,0,Oral,2564,CID2564,both,CN(C)CCOC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2
LT00774,2140,diatrizoate,1954,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7496d736-9f7d-4136-ad5d-b24c7803c21b,2,358,diatrizoate,0,Intravenous,2140,CID2140,both,CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I
LT00780,4812,phytonadione,1955,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,Negative,CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1e4cf5e1-37fd-4bf9-a078-0c185f77fa5c,2,359,phytonadione,0,Oral,5284607,CID5284607,both,CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
LT00781,4032,mecamylamine,1956,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,,CC1(C2CCC(C2)C1(C)NC)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1fc95fe-7816-47b6-b73d-b2f644f79872,2,360,mecamylamine,0,Oral,4032,CID4032,both,CC1(C2CCC(C2)C1(C)NC)C
LT00783,5920,liothyronine,1956,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,non-hepatotixic,Negative,,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=38ef3766-bb9a-402e-9e4a-ad8bb5b26e4c,1,361,liothyronine,0,Oral,5920,CID5920,both,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)C[C@@H](C(=O)O)N)I)I)O
LT00787,6476,methsuximide,1957,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC1(CC(=O)N(C1=O)C)C2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=64a6ee88-c6b1-4e13-8208-b6772ef65a74,2,362,methsuximide,0,Oral,6476,CID6476,both,CC1(CC(=O)N(C1=O)C)C2=CC=CC=C2
LT00790,4057,mepenzolate,1956,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C[N+]1(CCCC(C1)OC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=71b7afe6-4625-4467-adb7-510769da2b17,2,363,mepenzolate,0,Oral,4057,CID4057,both,C[N+]1(CCCC(C1)OC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C
LT00792,4034,meclizine,1957,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4b10e789-3f47-4008-a989-40a419379a23,1,364,meclizine,0,Oral,4034,CID4034,both,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl
LT00798,5282443,triprolidine,1984,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC1=CC=C(C=C1)/C(=C\CN2CCCC2)/C3=CC=CC=N3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cc466d33-cf3e-4f1c-a794-6d3d79903adf,2,365,triprolidine,0,Oral,5282443,CID5282443,both,CC1=CC=C(C=C1)/C(=C\CN2CCCC2)/C3=CC=CC=N3
LT00800,7699,benzonatate,1958,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,,,,,CCCCNC1=CC=C(C=C1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=199a42ae-4d19-4e68-934d-dabd27084988,1,366,benzonatate,1,Oral,7699,CID7699,both,CCCCNC1=CC=C(C=C1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC
LT00801,169893,Sodium polystyrene sulfonate,1958,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C=CC1=CC=CC=C1S(=O)(=O)[O-].[Ca+2],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2017bfbe-cda8-46f1-b4f1-9c086c3249a9,2,367,Sodium polystyrene sulfonate,0,Oral,75905,CID75905,both,C=CC1=CC=CC=C1S(=O)(=O)[O-].[Ca+2]
LT00802,3038,dichlorphenamide,1958,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,Negative,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17f2f05d-7375-4d7d-8083-174ed27e736f,2,368,dichlorphenamide,0,Oral,3038,CID3038,both,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N
LT00805,4771,phentermine,1959,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,,non-hepatotixic,,Negative,CC(C)(CC1=CC=CC=C1)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7ca86c66-409b-4852-8631-c3ada6e60738,1,369,phentermine,1,Oral,4771,CID4771,both,CC(C)(CC1=CC=CC=C1)N
LT00806,7029,diethylpropion,1959,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCN(CC)C(C)C(=O)C1=CC=CC=C1,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=330965ca-154f-42d2-bb7c-9494bf036c92,2,370,diethylpropion,0,Oral,7029,CID7029,both,CCN(CC)C(C)C(=O)C1=CC=CC=C1
LT00808,5284604,oxymorphone,1959,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c9c381b4-94d1-4294-aa37-1a5a5423812d,2,371,oxymorphone,0,Oral,5284604,CID5284604,both,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)O)O4)O
LT00810,16960,dexbrompheniramine,,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,,,CN(C)CC[C@@H](C1=CC=C(C=C1)Br)C2=CC=CC=N2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0d203b5c-8b10-428b-8703-17be6b4ce6eb,2,372,dexbrompheniramine,0,Oral,16960,CID16960,both,CN(C)CC[C@@H](C1=CC=C(C=C1)Br)C2=CC=CC=N2
LT00817,2381,biperiden,1959,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O,,1,373,biperiden,0,Oral,2381,CID2381,both,C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O
LT00818,6883,isosorbide dinitrate,1968,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)O[N+](=O)[O-])O[N+](=O)[O-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f6b4e8b5-1a45-4ba0-8416-4261b95c2f51,2,374,isosorbide dinitrate,0,Oral,6883,CID6883,both,C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)O[N+](=O)[O-])O[N+](=O)[O-]
LT00822,4062,mepivacaine,1960,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,Negative,CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5ad26708-14fe-4d31-91df-fa6813bdde7c,2,375,mepivacaine,0,Subcutaneous,4062,CID4062,both,CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C
LT00825,2315,bendroflumethiazide,1959,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3f11df27-710b-4903-a985-74ee4674a844,2,376,bendroflumethiazide,1,Oral,2315,CID2315,both,C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2
LT00826,12460,phendimetrazine,1976,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,,CC1C(OCCN1C)C2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d11411e2-ccfa-49b0-8470-5682053cfb1b,1,377,phendimetrazine,0,Oral,30487,CID30487,both,CC1C(OCCN1C)C2=CC=CC=C2
LT00827,439302,oxytocin,1980,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d7d1280-f286-4f39-89f3-2b96571810e6,2,378,oxytocin,0,Intravenous,439302,CID439302,both,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N
LT00829,3518,guanethidine,1960,No-DILI-Concern,0,No match,,vNo-DILI-Concern,HH,,Positive,,C1CCCN(CCC1)CCN=C(N)N,,1,379,guanethidine,0,Oral,3518,CID3518,both,C1CCCN(CCC1)CCN=C(N)N
LT00831,3291,ethosuximide,1960,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,HH,,Positive,,CCC1(CC(=O)NC1=O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9d2075a7-8b88-42d5-8df5-05e4ca72f4b2,2,380,ethosuximide,0,Oral,3291,CID3291,both,CCC1(CC(=O)NC1=O)C
LT00832,2341,benzphetamine,1960,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3fd6b3a8-b17b-4b98-ad03-a8af7b6f3368,1,381,benzphetamine,0,Oral,5311017,CID5311017,both,CC(CC1=CC=CC=C1)N(C)CC2=CC=CC=C2
LT00836,3494,glycopyrrolate,1961,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d200bd44-9856-4104-a29e-a4cca3db6737,2,382,glycopyrrolate,0,Oral,11693,CID11693,both,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C
LT00838,4174,metyrapone,1961,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(C)(C1=CN=CC=C1)C(=O)C2=CN=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24880533-7236-434a-ab1b-07773fef8a8c,1,383,metyrapone,0,Oral,4174,CID4174,both,CC(C)(C1=CN=CC=C1)C(=O)C2=CN=CC=C2
LT00841,15459,metaxalone,1962,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,,,,Negative,CC1=CC(=CC(=C1)OCC2CNC(=O)O2)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=edc1656d-26f0-95c2-ee8f-50518fd5affd,2,384,metaxalone,1,Oral,15459,CID15459,both,CC1=CC(=CC(=C1)OCC2CNC(=O)O2)C
LT00845,5878,oxandrolone,1964,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,,,,,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(COC(=O)C4)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8e6af85f-e44e-4c47-8a1a-7c5cb7893167,1,385,oxandrolone,1,Oral,5878,CID5878,both,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(COC(=O)C4)C
LT00847,4616,oxazepam,1965,Less-DILI-Concern,5,Adverse reactions,,Ambiguous DILI-concern,,,,,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e2ccffa0-039d-b77d-5b10-c3e485ab2b99,2,386,oxazepam,0,Oral,4616,CID4616,both,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O
LT00848,4976,protriptyline,1967,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a6be6521-7179-442f-8c45-69711a2c3290,2,387,protriptyline,0,Oral,4976,CID4976,both,CNCCCC1C2=CC=CC=C2C=CC3=CC=CC=C13
LT00855,16129617,cosyntropin,1970,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(C)[C@@H](C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N3CCC[C@H]3C(=O)O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC8=CNC=N8)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CC9=CC=C(C=C9)O)NC(=O)C(CO)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=746856e9-3930-4f6a-b8e6-a03845d6dd0b,2,388,cosyntropin,0,Intravenous,16129617,CID16129617,both,CC(C)[C@@H](C(=O)NCC(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N3CCC[C@H]3C(=O)O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC7=CC=CC=C7)NC(=O)[C@H](CC8=CNC=N8)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CC9=CC=C(C=C9)O)NC(=O)C(CO)N
LT00857,3354,flavoxate,1970,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9422e67e-d64c-3ba1-b2b9-ca9d3eeda743,1,389,flavoxate,0,Oral,3354,CID3354,both,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4
LT00859,3821,ketamine,1970,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,,,,,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=505dc937-694d-4a3a-befa-aae20071b4c7,1,390,ketamine,1,Intravenous,3821,CID3821,both,CNC1(CCCCC1=O)C2=CC=CC=C2Cl
LT00867,27350,pancuronium,1972,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1[N+]4(CCCCC4)C)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-].[Br-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a95893be-9df7-4f3e-ad72-3298dab8b187,2,391,pancuronium,0,Intravenous,441289,CID441289,both,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1[N+]4(CCCCC4)C)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-].[Br-]
LT00869,444007,pentagastrin,1974,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(C)COC(=O)NCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=abc92ef1-f9c3-4eac-a273-9b8705b36c29,2,392,pentagastrin,0,Intravenous,9853654,CID9853654,both,CC(C)COC(=O)NCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N
LT00870,5826,dextroamphetamine,1975,No-DILI-concern,0,No match,,vNo-DILI-Concern,HH,,Positive,,C[C@@H](CC1=CC=CC=C1)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a37b6ef9-78b4-4b18-8797-ecb583502500 ,2,393,dextroamphetamine,0,Oral,5826,CID5826,both,C[C@@H](CC1=CC=CC=C1)N
LT00877,5403,terbutaline,1974,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=382dcebb-6e41-4335-818d-b5822e3fb884,2,394,terbutaline,1,Oral,5403,CID5403,both,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O
LT00878,16133812,calcitonin salmon,1978,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f9d5a587-e2bc-4001-987d-9b04731303cb,2,395,calcitonin salmon,0,Subcutaneous,16133812,CID16133812,both,C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CO)CC(C)C)CC(=O)N)CO)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N5CCC[C@H]5C(=O)N)O
LT00879,3053,pentetic acid,1976,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C(CN(CC(=O)O)CC(=O)O)N(CCN(CC(=O)O)CC(=O)O)CC(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=becdab53-f7a7-7280-6930-21f3a61b99e7,2,396,pentetic acid,0,Intravenous,3053,CID3053,both,C(CN(CC(=O)O)CC(=O)O)N(CCN(CC(=O)O)CC(=O)O)CC(=O)O
LT00880,11963622,nitroprusside,1974,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.[Fe+4],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6a44bcac-a0e1-4069-5691-db7b83dbb4b7,2,397,nitroprusside,0,Intravenous,23644556,CID23644556,both,[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.[Fe+4]
LT00881,62816,colestipol,1977,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C1C(O1)CCl.C(CNCCNCCNCCN)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa6c3e11-84e9-433d-aa74-7cd34336bbed,2,398,colestipol,0,Oral,62816,CID62816,both,C1C(O1)CCl.C(CNCCNCCNCCN)N
LT00886,11333,lactulose,1976,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@@]([C@H]2O)(CO)O)CO)O)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3a5249b6-ede1-473d-a618-49b075af78b3,1,399,lactulose,0,Oral,11333,CID11333,both,C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@@]([C@H]2O)(CO)O)CO)O)O)O)O
LT00894,16850,fluorescein,1976,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a1823be3-a739-48bc-a3ea-ceb7cc5105ce,2,401,fluorescein,0,Intravenous,16850,CID16850,both,C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O
LT00895,441350,metyrosine,1979,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,,C[C@](CC1=CC=C(C=C1)O)(C(=O)O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=32fb2f2f-34b5-4cd5-9145-c3ab37c5ca92,1,402,metyrosine,0,Oral,441350,CID441350,both,C[C@](CC1=CC=C(C=C1)O)(C(=O)O)N
LT00898,5284525,carboprost tromethamine,1979,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCCCC[C@@](C)(/C=C/[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C/CCCC(=O)O)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3d282998-ff0c-480a-bd80-155606ef0a65,2,403,carboprost tromethamine,0,Intramuscular,5281074,CID5281074,both,CCCCC[C@@](C)(/C=C/[C@H]1[C@@H](C[C@@H]([C@@H]1C/C=C/CCCC(=O)O)O)O)O
LT00899,134070,calcitriol,1978,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@H](C[C@@H](C3=C)O)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=167a669f-7b7e-46ea-9331-567bf19d8787,2,404,calcitriol,0,Oral,5280453,CID5280453,both,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@H](C[C@@H](C3=C)O)O)C
LT00905,5288826,morphine,1984,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=405b7997-1e47-4904-96d0-72c241ed8195,2,405,morphine,0,Oral,5288826,CID5288826,both,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3[C@H](C=C4)O
LT00910,5284592,nabilone,1985,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCCCCCC(C)(C)C1=CC2=C([C@@H]3CC(=O)CC[C@H]3C(O2)(C)C)C(=C1)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb582d64-0f51-11df-8a39-0800200c9a66,2,406,nabilone,0,Oral,5284592,CID5284592,both,CCCCCCC(C)(C)C1=CC(=C2[C@@H]3CC(=O)CC[C@H]3C(OC2=C1)(C)C)O
LT00916,39764,vecuronium,1984,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CCCCC4)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=10b6e166-58ea-4b78-9ca2-471f19737101,2,407,vecuronium,0,Intravenous,39765,CID39765,both,CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@@H]([C@]2(C[C@@H]1N4CCCCC4)C)CC[C@]5([C@H]3C[C@@H]([C@@H]5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-]
LT00917,47319,atracurium,1983,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de1c2dcd-295b-47ce-b7a1-a8be59939a54,1,408,atracurium,0,Intravenous,47319,CID47319,both,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C
LT00919,5284570,hydromorphone,1984,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,non-hepatotixic,,Negative,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)CC4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=22e635cb-98c0-e4f9-6a71-62d7487a0a6c,2,409,hydromorphone,0,Oral,5284570,CID5284570,both,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)O)O[C@H]3C(=O)CC4
LT00920,41693,sufentanil,1984,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,Negative,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=52fc28b9-464a-4173-9d0d-000ed0dbf265,2,410,sufentanil,0,Intravenous,41693,CID41693,both,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC
LT00923,5526,tranexamic acid,1986,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,Negative,C1CC(CCC1CN)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=add851b1-0f2d-46e9-b122-f4f5ff216539,1,411,tranexamic acid,0,Oral,5526,CID5526,both,C1CC(CCC1CN)C(=O)O
LT00925,51263,alfentanil,1986,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,Negative,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9781f06d-485e-41f0-84aa-ee177f0ad137,2,412,alfentanil,0,Intravenous,51263,CID51263,both,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC
LT00926,6433328,ethanolamine oleate,1988,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCCCCCCC/C=C/CCCCCCCC(=O)O.C(CO)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9c1d8c5-443e-400e-a42c-16a25fb47231,1,413,ethanolamine oleate,0,Intravenous,5282489,CID5282489,both,CCCCCCCC/C=C/CCCCCCCC(=O)O.C(CO)N
LT00928,71357,rubidium chloride rb-82,1989,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee95aa18-9f2f-40eb-9b4c-583bea6f36bf,2,414,rubidium chloride rb-82,0,Intravenous,71357,CID71357,both,[Cl-].[82Rb+]
LT00929,62819,urofollitropin,1986,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)C(C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9bb87daf-d156-504e-adaf-4c21383f8d16,2,415,urofollitropin,0,Subcutaneous,62819,CID62819,both,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)N1)CC2=CC=C(C=C2)O)N)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)C(C)O
LT00932,16133850,teriparatide,2002,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aae667c5-381f-4f92-93df-2ed6158d07b0,2,416,teriparatide,0,Subcutaneous,16133850,CID16133850,both,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CNC=N2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC5=CNC=N5)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC6=CC=CC=C6)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)N
LT00935,55466,gadopentetate dimeglumine**,1988,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.C(CN(CC(=O)O)CC(=O)[O-])N(CCN(CC(=O)O)CC(=O)[O-])CC(=O)[O-].[Gd+3],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be234024-ed43-404e-a40e-a3c1572a9726,2,417,gadopentetate dimeglumine,0,Intravenous,146159982,CID146159982,both,CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.C(CN(CC(=O)O)CC(=O)[O-])N(CCN(CC(=O)O)CC(=O)[O-])CC(=O)[O-].[Gd+3]
LT00937,5071,rimantadine,1993,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(C12CC3CC(C1)CC(C3)C2)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=08d7b0df-a353-49a0-92ac-64028d4084b7,2,418,rimantadine,0,Oral,5071,CID5071,both,CC(C12CC3CC(C1)CC(C3)C2)N
LT00944,3341,fenoldopam,1997,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=df4cd207-c3b8-4008-5290-02f296c2b4a6,2,420,fenoldopam,0,Intravenous,3341,CID3341,both,C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O
LT00947,6116,calcium acetate,1990,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(=O)[O-].CC(=O)[O-].[Ca+2],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=85fd41f8-2823-44ca-a15e-f1f2e5d0ff94,2,421,calcium acetate,0,Oral,6116,CID6116,both,CC(=O)[O-].CC(=O)[O-].[Ca+2]
LT00950,5281042,mivacurium,1992,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C[N+]1(CCC2=CC(=C(C=C2[C@H]1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)CCCOC(=O)CC/C=C/CCC(=O)OCCC[N+]4(CCC5=CC(=C(C=C5[C@H]4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=98ca2c17-43e2-49af-abbc-f870877e5786,2,422,mivacurium,0,Intravenous,5281042,CID5281042,both,C[N+]1(CCC2=CC(=C(C=C2[C@H]1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)CCCOC(=O)CC/C=C/CCC(=O)OCCC[N+]4(CCC5=CC(=C(C=C5[C@H]4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)C
LT00952,60714,gadoteridol,1992,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])O.[Gd+3],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=778aee03-7d4c-481a-be8a-a75db0702f5a,2,423,gadoteridol,0,Intravenous,60714,CID60714,both,CC(CN1CCN(CCN(CCN(CC1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])O.[Gd+3]
LT00955,107807,perindopril,1993,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,Negative,CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbc5b3c3-4d2c-4fa0-adbb-8ddf42e881c5,2,425,perindopril,0,Oral,107807,CID107807,both,CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O
LT00957,441290,rocuronium,1994,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b73f192c-2912-4ec3-9b4f-05a58d9b35ba,2,426,rocuronium,0,Intravenous,441290,CID441290,both,CC(=O)O[C@H]1[C@H](C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C[C@@H]([C@H](C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C
LT00967,6432052,ferumoxides,1996,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=82ceb312-3aaa-4a5c-9849-7f246cc06ded,2,429,ferumoxides,0,Intravenous,6432052,CID6432052,both,[O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3]
LT00972,57166,porfimer**,1995,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C(C)OC(C)C6=C(C7=CC8=C(C(=C(N8)C=C9C(=C(C(=N9)C=C1C(=C(C(=N1)C=C6N7)C)CCC(=O)O)CCC(=O)O)C)C)C(C)O)C)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C(C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5c4841b4-fbc0-4163-8ee1-cb28629cbfbf,2,430,porfimer,0,Intravenous,137321858,CID137321858,both,CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C(C)OC(C)C6=C(C7=CC8=C(C(=C(N8)C=C9C(=C(C(=N9)C=C1C(=C(C(=N1)C=C6N7)C)CCC(=O)O)CCC(=O)O)C)C)C(C)O)C)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C(C)O
LT00974,60753,ibutilide,1995,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c25d21e7-6136-4a7a-b139-12f53116fc3d,2,431,ibutilide,0,Intravenous,60753,CID60753,both,CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O
LT00978,62886,cisatracurium besylate,1995,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,Negative,C[N@@+]1(CCC2=CC(=C(C=C2[C@H]1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N@+]4(CCC5=CC(=C(C=C5[C@H]4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3db3b76c-3e5a-456e-46a8-456fde1e6195,2,432,cisatracurium besylate,0,Intravenous,62886,CID62886,both,C[N@@+]1(CCC2=CC(=C(C=C2[C@H]1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N@+]4(CCC5=CC(=C(C=C5[C@H]4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
LT00979,5284603,oxycodone,1998,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5243e601-42c2-48c7-8600-8806cea4185d,2,433,oxycodone,0,Oral,5284603,CID5284603,both,CN1CC[C@]23[C@@H]4C(=O)CC[C@]2([C@H]1CC5=C3C(=C(C=C5)OC)O4)O
LT00980,2088,alendronate,1995,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,,,,,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4b2adbfa-a28e-442e-8047-cda45c4731da,1,434,alendronate,1,Oral,2088,CID2088,both,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN
LT00982,129211,tamsulosin,1997,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,,,,,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d742707b-4c17-4b08-a9d0-491ba2bf6415,1,435,tamsulosin,1,Oral,129211,CID129211,both,CCOC1=CC=CC=C1OCCN[C@H](C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N
LT00986,60654,dolasetron,1997,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,Negative,C1[C@@H]2CC(CC3N2CC(=O)C1C3)OC(=O)C4=CNC5=CC=CC=C54,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3df5f9f0-d374-425f-8a6d-e58fbfb8ea04,2,436,dolasetron,0,Oral,3033818,CID3033818,both,C1[C@@H]2CC(CC3N2CC(=O)C1C3)OC(=O)C4=CNC5=CC=CC=C54
LT00987,60815,remifentanil,1996,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dbc63b6e-f8c5-4fd0-8ec3-4f5e19125313,2,437,remifentanil,1,Intravenous,60815,CID60815,both,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC
LT00988,5210,sibutramine,1997,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c0333e62-bb00-4722-27b6-dca6ab4d1eb1,2,438,sibutramine,1,Oral,5210,CID5210,both,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C
LT00989,60648,tiagabine,1997,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(=O)O)C3=C(C=CS3)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=25225511-70b8-4377-ad4f-6629025ac75f,2,439,tiagabine,0,Oral,60648,CID60648,both,CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(=O)O)C3=C(C=CS3)C
LT00990,5095,ropinirole,1997,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ec0612a1-ccb1-bb51-8881-04faf491e093,2,440,ropinirole,1,Oral,5095,CID5095,both,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1
LT00991,59868,pramipexole,1997,Less-DILI-Concern,2,Adverse reactions,,Ambiguous DILI-concern,,,,,CCCN[C@@H]1CCC2=C(C1)SC(=N2)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=60167d7c-469f-455a-a113-561841af5e59,2,441,pramipexole,0,Oral,119570,CID119570,both,CCCN[C@@H]1CCC2=C(C1)SC(=N2)N
LT00992,441314,miglitol,1996,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1[C@@H]([C@H]([C@@H]([C@H](N1CCO)CO)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=75711d16-2d27-476e-a312-d5af448a0e25,2,442,miglitol,0,Oral,441314,CID441314,both,C1[C@@H]([C@H]([C@@H]([C@H](N1CCO)CO)O)O)O
LT00996,5625,delavirdine,1997,Less-DILI-Concern,5,Adverse reactions,,Ambiguous DILI-concern,,,,,CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eb28dcd2-c457-4137-9eec-00062e5a601b,2,444,delavirdine,0,Oral,5625,CID5625,both,CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C
LT00998,60937,tiludronate,1997,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1=CC(=CC=C1SC(P(=O)(O)O)P(=O)(O)O)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=25369752-9d6c-4802-823c-c4205339a525,2,445,tiludronate,0,Oral,60937,CID60937,both,C1=CC(=CC=C1SC(P(=O)(O)O)P(=O)(O)O)Cl
LT00999,123610,eptifibatide,1998,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5ad82e30-50d8-450c-8a2a-b4b507ed1ce2,2,446,eptifibatide,0,Intravenous,448812,CID448812,both,C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N
LT01001,60879,eprosartan,1997,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,WE,,Negative,,CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)C=C(CC3=CC=CS3)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7cde57a7-eded-4c22-b1c7-98afc5546997,2,447,eprosartan,0,Oral,5281037,CID5281037,both,CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)C=C(CC3=CC=CS3)C(=O)O
LT01002,65981,repaglinide,1997,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d6d6c0df-adbf-46a4-a709-091183a56ec2,2,448,repaglinide,1,Oral,65981,CID65981,both,CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
LT01005,3749,irbesartan,1997,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,WE,,Negative,,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7885b2a8-be4e-48ab-8113-4e6ab791eb98,2,449,irbesartan,1,Oral,3749,CID3749,both,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
LT01007,4440,naratriptan,1998,Less-DILI-Concern,4,Adverse reactions,,Ambiguous DILI-concern,,,,,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ec5b909e-3406-4154-90aa-19b996e632a8,2,450,naratriptan,0,Oral,4440,CID4440,both,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C
LT01010,441240,zolmitriptan,1997,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@@H]3COC(=O)N3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=df93b636-103f-4fb5-26b6-50f639e29b1d,2,451,zolmitriptan,0,Oral,60857,CID60857,both,CN(C)CCC1=CNC2=C1C=C(C=C2)C[C@@H]3COC(=O)N3
LT01011,60774,tolterodine,1998,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC1=CC(=C(C=C1)O)[C@@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=55a35eb9-44ff-4762-8779-1a6ed5c90423,2,452,tolterodine,0,Oral,443879,CID443879,both,CC1=CC(=C(C=C1)O)[C@@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2
LT01012,64143,nelfinavir,1997,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,Postive,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@@H](CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e72c2bc6-9462-4a2e-8e1d-b97592376cbd,2,453,nelfinavir,1,Oral,64143,CID64143,both,CC1=C(C=CC=C1O)C(=O)N[C@@H](CSC2=CC=CC=C2)[C@@H](CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C)O
LT01016,77991,rivastigmine,2000,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1e28b44-3897-4788-9659-f5d6bce4d91e,2,454,rivastigmine,1,Oral,77991,CID77991,both,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
LT01017,60854,ziprasidone,2001,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=315e24c2-2f8c-47d9-b1b1-ce006646098a,2,455,ziprasidone,1,Oral,60854,CID60854,both,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54
LT01020,5245,risedronate,1998,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,non-hepatotixic,,,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24ed00e0-25e2-49a8-97fc-66c1b417dc0b,2,456,risedronate,0,Oral,5245,CID5245,both,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O
LT01022,2541,candesartan,1998,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,WE,,Negative,,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a73e1339-9643-4eea-2cbe-e879c88fb50e,2,457,candesartan,1,Oral,2541,CID2541,both,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O
LT01023,60606,clopidogrel,1997,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,,,,Negative,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=01af55ee-a92f-4e67-a14f-3621da3ed3f5,2,458,clopidogrel,1,Oral,60606,CID60606,both,COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3
LT01026,5078,rizatriptan,1998,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,Negative,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=65fdf523-6b3a-4b96-8e6f-891383acfd8c,2,459,rizatriptan,0,Oral,5078,CID5078,both,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
LT01027,16129704,bivalirudin,2000,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]5CCCN5C(=O)[C@@H](CC6=CC=CC=C6)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=799d3b00-809b-4abc-989c-05faccec49f8,2,460,bivalirudin,0,Intravenous,16129704,CID16129704,both,CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]5CCCN5C(=O)[C@@H](CC6=CC=CC=C6)N
LT01028,9444,azacitidine,2004,Most-DILI-concern,8,Warnings and precautions,,Ambiguous DILI-concern,HH,,Positive,,C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3495a71a-cc04-4776-851f-f185956f32af,2,461,azacitidine,0,Intravenous,9444,CID9444,both,C1=NC(=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)N
LT01029,3385,fluorouracil,1962,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,HH,,Positive,Postive,C1=C(C(=O)NC(=O)N1)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b90e0da7-f702-4f09-9488-74f2bb20e9ac,2,462,fluorouracil,1,Intravenous,3385,CID3385,both,C1=C(C(=O)NC(=O)N1)F
LT01030,152951,argatroban,2000,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NC[C@@H](C3)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9c9616c0-a299-4fd5-c8ae-79e6db453595,2,463,argatroban,0,Intravenous,92722,CID92722,both,C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NC[C@@H](C3)C
LT01033,5212,sildenafil,1998,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=39a5247d-f173-499d-9e4d-d17cf3dff63e,2,464,sildenafil,1,Oral,135398744,CID135398744,both,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C
LT01034,441184,acarbose,1995,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)O)O)CO)CO)O)O)N[C@H]4C=C([C@@H]([C@@H]([C@H]4O)O)O)CO,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dbb04848-93e2-42ca-a709-6a396913507e,1,465,acarbose,1,Oral,41774,CID41774,both,C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]3[C@H](O[C@H]([C@@H]([C@H]3O)O)O)CO)CO)O)O)N[C@H]4C=C([C@@H]([C@@H]([C@H]4O)O)O)CO
LT01035,1978,acebutolol,1984,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=201b752c-64b4-4687-acc1-3a92bfda864e,2,466,acebutolol,1,Oral,1978,CID1978,both,CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C
LT01037,60947,tirofiban,1998,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCCCS(=O)(=O)N[C@@H](CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fe0ced75-ccbf-4d2e-bd0d-b57e60ab913f,2,467,tirofiban,0,Intravenous,60947,CID60947,both,CCCCS(=O)(=O)N[C@@H](CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O
LT01039,3085017,sevelamer,1998,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C=CCN.C1C(O1)CCl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e6328460-a57b-450b-a48c-6dcd4b476360,2,468,sevelamer,0,Oral,3085017,CID3085017,both,C=CCN.C1C(O1)CCl
LT01040,71329,dofetilide,1999,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=02438044-d6a3-49e9-a1ac-3aad21ef2c8c,2,469,dofetilide,0,Oral,71329,CID71329,both,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C
LT01041,12035,acetylcysteine,1963,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,Negative,CC(=O)N[C@@H](CS)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8fd7b5d8-f6b1-4d0a-9ec6-446c5f89762a,2,470,acetylcysteine,0,Oral,12035,CID12035,both,CC(=O)N[C@@H](CS)C(=O)O
LT01042,6437841,acitretin,1996,Most-DILI-Concern,5,Box warning,Yes,vMost-DILI-Concern,HH,,Positive,Postive,CC1=CC(=C(C(=C1/C=C/C(=C/C=C/C(=C\C(=O)O)/C)/C)C)C)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cec7851f-c7af-4e9e-a5e4-a585c70510d2,1,471,acitretin,1,Oral,5284513,CID5284513,both,CC1=CC(=C(C(=C1/C=C/C(=C/C=C/C(=C\C(=O)O)/C)/C)C)C)OC
LT01044,444013,gadoversetamide,1999,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=20372fd0-cd3c-47b2-bfc1-f5b8bc03ec0a,2,472,gadoversetamide,0,Intravenous,444013,CID444013,both,COCCNC(=O)CN(CCN(CCN(CC(=O)NCCOC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
LT01047,60961,adenosine,1989,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,C1=NC2=C(C(=N1)N)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ca4520ad-7f42-4632-8065-5b88a0ca7f2f,2,473,adenosine,0,Intravenous,60961,CID60961,both,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N
LT01051,2083,salbutamol,1981,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=87b8cd3c-2849-4b50-b63e-9ea379165c07,1,474,salbutamol,0,Oral,2083,CID2083,both,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O
LT01053,123606,almotriptan,2001,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=886c13fa-4547-4411-88aa-8e23a7a698f6,2,475,almotriptan,0,Oral,123606,CID123606,both,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3
LT01054,77992,frovatriptan,2001,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=294d60f3-005b-40d9-a404-cdd77f62b820,2,476,frovatriptan,0,Oral,77992,CID77992,both,CN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N
LT01056,34312,oxcarbazepine,2000,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,Postive,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa610e56-1d1d-11e1-8bc2-0800200c9a66,2,477,oxcarbazepine,1,Oral,34312,CID34312,both,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N
LT01057,6323497,rifapentine,1998,Most-DILI-Concern,4,Warnings and precautions,,Ambiguous DILI-concern,,,,,C[C@H]1/C=C/C=C(\C(=O)NC\2=C(C3=C(C(=C4C(=C3C(=O)/C2=C/NN5CCN(CC5)C6CCCC6)C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f768e337-a948-420a-9fbe-9be359c7a170,2,478,rifapentine,0,Oral,135403821,CID135403821,both,C[C@H]1/C=C/C=C(\C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C=N/N5CCN(CC5)C6CCCC6)/C
LT01059,441341,levetiracetam,1999,Less-DILI-Concern,8,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC[C@H](C(=O)N)N1CCCC1=O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5ac8a774-e9e9-497e-9b2a-5166a3b41888,2,479,levetiracetam,1,Oral,5284583,CID5284583,both,CC[C@H](C(=O)N)N1CCCC1=O
LT01060,54897,alpidem,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,HH,Hepatotoxic,Positive,,CCCN(CCC)C(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl,,1,480,alpidem,1,Oral,54897,CID54897,both,CCCN(CCC)C(=O)CC1=C(N=C2N1C=C(C=C2)Cl)C3=CC=C(C=C3)Cl
LT01064,82146,bexarotene,1999,Most-DILI-Concern,8,Warnings and precautions,Yes(literature),vMost-DILI-Concern,,,,,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1fe10df7-f710-419d-9035-3b4936ada303,2,481,bexarotene,1,Oral,82146,CID82146,both,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C
LT01065,6432,perflutren,2001,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C(C(F)(F)F)(C(F)(F)F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ab9c79c-1b5c-4e86-899c-cc74686f070a,2,482,perflutren,0,Intravenous,6432,CID6432,both,C(C(F)(F)F)(C(F)(F)F)(F)F
LT01067,2141,amifostine,1995,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C(CN)CNCCSP(=O)(O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=db42eca3-274a-43d3-a0be-e5209747bedc,1,483,amifostine,0,Intravenous,2141,CID2141,both,C(CN)CNCCSP(=O)(O)O
LT01068,37768,amikacin,1981,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6ec3129b-c53b-4bdb-913d-a2d0060fa140,2,484,amikacin,0,Intravenous,37768,CID37768,both,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1NC(=O)[C@H](CCN)O)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N
LT01070,2099,alosetron,2000,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=526ba44c-a476-4675-a63c-4d0a72b723f5,2,485,alosetron,1,Oral,2099,CID2099,both,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C
LT01071,564,aminocaproic acid,1964,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,Negative,C(CCC(=O)O)CCN,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2238c70f-b0b5-4755-896b-45b28777b217,2,486,aminocaproic acid,0,Oral,564,CID564,both,C(CCC(=O)O)CCN
LT01072,5819,levothyroxine,2000,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6182a0e9-ea40-41fc-be24-822b165af1bb,2,487,levothyroxine,1,Oral,5819,CID5819,both,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)O)N
LT01077,441401,linezolid,2000,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6e70e63b-bfd5-478d-a8ee-8ba22c9efabd,2,488,linezolid,1,Intravenous,441401,CID441401,both,CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F
LT01080,160051,colesevelam,2000,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b9df447c-b65b-45b9-873a-07a2ab6e2d1f,2,489,colesevelam,0,Oral,160051,CID160051,both,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-]
LT01084,5464436,gemifloxacin,2003,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,,CO/N=C\1/CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=54c4b48b-cad7-4889-808f-f741352a2c97,2,490,gemifloxacin,1,Oral,9571107,CID9571107,both,CO/N=C\1/CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F
LT01085,124087,desloratadine,2001,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eb25ecc8-5989-48c7-847e-e51f942a82ff,2,491,desloratadine,1,Oral,124087,CID124087,both,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4
LT01086,9651,galantamine,2001,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=63bad97b-3df6-4e8f-b183-95f1e9801c8f,2,492,galantamine,0,Oral,9651,CID9651,both,CN1CC[C@@]23C=C[C@@H](C[C@@H]2OC4=C(C=CC(=C34)C1)OC)O
LT01087,9571074,cefditoren,2001,Less-DILI-Concern,2,Adverse reactions,,Ambiguous DILI-concern,,,,,CC1=C(SC=N1)/C=C\C2=C(N3[C@@H](C(C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e26a9881-a09e-41f5-8fad-6dfccbff6bf8,2,493,cefditoren,0,Oral,9870843,CID9870843,both,CC1=C(SC=N1)/C=C\C2=C(N3[C@@H](C(C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O
LT01088,68740,zoledronate,2001,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,,,,,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f0cdfa57-95e5-416b-bc2f-cde2491c2fd0,2,494,zoledronate,1,Intravenous,68740,CID68740,both,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
LT01089,468682,caspofungin,2001,Most-DILI-Concern,7,Warnings and precautions,,Ambiguous DILI-concern,,,,,CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H]([C@H](C4=CC=C(C=C4)O)O)O)[C@@H](CCN)O)O)NCCN)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3bad23a6-09a6-4194-9182-093ed61bc71c,2,495,caspofungin,0,Intravenous,2826718,CID2826718,both,CCC(C)CC(C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H]([C@H](C4=CC=C(C=C4)O)O)O)[C@@H](CCN)O)O)NCCN)O
LT01096,74989,atovaquone,1992,Most-DILI-Concern,8,Warnings and precautions,,Ambiguous DILI-concern,,,,,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=697948e4-9807-4dc0-acc9-b9a3b5fa2f12,2,496,atovaquone,0,Oral,74989,CID74989,both,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
LT01097,71616,voriconazole,2002,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1889599-be14-49af-8781-5594e9bd026b,2,497,voriconazole,1,Oral,71616,CID71616,both,C[C@@H](C1=NC=NC=C1F)[C@](CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O
LT01100,3516,guaifenesin,2002,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,,COC1=CC=CC=C1OCC(CO)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbb23060-d2c0-11de-9d3c-0002a5d5c51b,2,498,guaifenesin,0,Oral,3516,CID3516,both,COC1=CC=CC=C1OCC(CO)O
LT01102,130881,olmesartan,2002,Less-DILI-Concern,4,Adverse reactions,,Ambiguous DILI-concern,,non-hepatotixic,Negative,,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=33770d80-754f-11de-8dba-0002a5d5c51b,2,499,olmesartan,0,Oral,158781,CID158781,both,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O
LT01107,2092,alfuzosin,2003,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f075a897-7bef-4799-b7e2-7e051c461443,2,500,alfuzosin,1,Oral,2092,CID2092,both,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC
LT01110,5362041,aztreonam,1986,Less-DILI-Concern,5,Adverse reactions,,Ambiguous DILI-concern,NE,non-hepatotixic,Negative,,C[C@H]1[C@@H](C(=O)N1S(=O)(=O)[O-])NC(=O)/C(=N/OC(C)(C)C(=O)O)/C2=CSC(=N2)[NH3+],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d598f95b-92dd-4ef5-ae97-d68972258e44,2,501,aztreonam,0,Intravenous,5742832,CID5742832,both,C[C@H]1[C@@H](C(=O)N1S(=O)(=O)O)NC(=O)/C(=N\OC(C)(C)C(=O)O)/C2=CSC(=N2)N
LT01112,152945,dutasteride,2001,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C[C@]12CCC3[C@H]([C@@H]1CC[C@@H]2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CC[C@@H]5[C@@]3(C=CC(=O)N5)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dc330e70-a1d3-400b-3aaf-46067e3fd090,2,502,dutasteride,0,Oral,6918296,CID6918296,both,C[C@]12CCC3[C@H]([C@@H]1CC[C@@H]2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CC[C@@H]5[C@@]3(C=CC(=O)N5)C
LT01113,2284,baclofen,1977,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0aac77fa-30c2-46c8-a04d-e6b8333ddd81,2,503,baclofen,1,Oral,2284,CID2284,both,C1=CC(=CC=C1C(CC(=O)O)CN)Cl
LT01116,5362124,benazepril,1991,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,WE,,Negative,,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c51a3704-c5b3-471f-afcb-0602da0f3dce,2,504,benazepril,1,Oral,5362124,CID5362124,both,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCC3=CC=CC=C3N(C2=O)CC(=O)O
LT01117,2313,bendazac,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=N2)OCC(=O)O,,1,505,bendazac,1,Oral,2313,CID2313,both,C1=CC=C(C=C1)CN2C3=CC=CC=C3C(=N2)OCC(=O)O
LT01120,255968,benzarone,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC=C(C=C3)O,,1,506,benzarone,1,Oral,255968,CID255968,both,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC=C(C=C3)O
LT01121,6237,benziodarone,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)O)I,,1,507,benziodarone,1,Oral,6237,CID6237,both,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)O)I
LT01122,150610,ertapenem,2001,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)[C@@H](C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=33f3b99b-fa82-42e0-26bf-f49891ae3d22,2,508,ertapenem,0,Intravenous,150610,CID150610,both,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)[C@@H](C)O
LT01123,6832,benztropine,1954,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CN1[C@@H]2CC[C@@H]1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=37eef247-c418-4cbe-aff2-d74d032ede1c,1,509,benztropine,0,Oral,1201549,CID1201549,both,CN1[C@@H]2CC[C@@H]1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4
LT01125,636380,fondaparinux sodium,2001,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ec235119-cb58-4939-942c-11d3923d289f,2,510,fondaparinux sodium,1,Subcutaneous,636380,CID636380,both,CO[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)COS(=O)(=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](O2)C(=O)[O-])O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COS(=O)(=O)[O-])O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)[O-])O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COS(=O)(=O)[O-])O)O)NS(=O)(=O)[O-])O)O)OS(=O)(=O)[O-])NS(=O)(=O)[O-])O)OS(=O)(=O)[O-])O)NS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+]
LT01126,51634,miglustat,2003,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCCCN1C[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=817892d1-ee12-4632-85fc-57ccdf16d7b8,2,511,miglustat,0,Oral,51634,CID51634,both,CCCCN1C[C@@H]([C@H]([C@@H]([C@H]1CO)O)O)O
LT01127,6918204,gadobenate dimeglumine,2004,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.C1=CC=C(C=C1)COCC(C(=O)[O-])N(CCN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)[O-])CC(=O)O.[Gd+3],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f63abe56-46d9-4e32-afb1-f4e22370717d,2,512,gadobenate dimeglumine,0,Intravenous,6918204,CID6918204,both,CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.C1=CC=C(C=C1)COCC(C(=O)[O-])N(CCN(CCN(CC(=O)O)CC(=O)[O-])CC(=O)[O-])CC(=O)O.[Gd+3]
LT01128,6436173,rifaximin,2004,Less-DILI-Concern,7,Adverse reactions,,Ambiguous DILI-concern,,,,,C[C@H]1/C=C/C=C(\C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)/C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=523f0320-cc73-445a-a48d-7a181c182307,2,513,rifaximin,0,Oral,6436173,CID6436173,both,C[C@H]1/C=C/C=C(\C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)O[C@@](C4=O)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)/C
LT01129,110635,tadalafil,2003,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CN1CC(=O)N2[C@@H](C1=O)CC3=C([C@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7178f6c0-bc15-49e1-bb65-1a8fe6f94191,2,514,tadalafil,0,Oral,110635,CID110635,both,CN1CC(=O)N2[C@@H](C1=O)CC3=C([C@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
LT01130,148211,palonosetron,2003,Less-DILI-Concern,4,Adverse reactions,,Ambiguous DILI-concern,,,,Negative,C1C[C@H]2CN(C(=O)C3=C2C(=CC=C3)C1)[C@@H]4CN5CCC4CC5,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1b51c34d-9631-4520-83af-6f6fb21a58a4,2,515,palonosetron,0,Intravenous,6337614,CID6337614,both,C1C[C@H]2CN(C(=O)C3=CC=CC(=C23)C1)[C@@H]4CN5CCC4CC5
LT01132,2369,betaxolol,1985,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bf716efe-0a9f-43b1-9d8a-c69330b82e18,2,516,betaxolol,0,Oral,2369,CID2369,both,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O
LT01135,110634,vardenafil,2003,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a01def95-c0ef-43b9-bd9e-5565b2385ad3,2,517,vardenafil,0,Oral,135400189,CID135400189,both,CCCC1=NC(=C2N1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C
LT01136,2405,bisoprolol,1992,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,Negative,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a1dc3675-ca21-4fdc-bc4d-e82381e31851,1,518,bisoprolol,0,Oral,2405,CID2405,both,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
LT01138,5360373,bleomycin,1973,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=905e0984-2ce3-481c-b1a0-0ef0a616479a,2,519,bleomycin,0,Intravenous,5360373,CID5360373,both,CC1=C(N=C(N=C1N)[C@H](CC(=O)N)NC[C@@H](C(=O)N)N)C(=O)N[C@@H]([C@H](C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)N[C@H](C)[C@H]([C@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O
LT01139,54841,atomoxetine,2002,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,,Positive,Postive,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=309de576-c318-404a-bc15-660c2b1876fb,2,520,atomoxetine,1,Oral,54841,CID54841,both,CC1=CC=CC=C1O[C@H](CCNC)C2=CC=CC=C2
LT01140,104865,bosentan,2001,Most-DILI-Concern,7,Box warning,Yes,vMost-DILI-Concern,HH,,Positive,,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=749e42fb-2fe0-45dd-9268-b43bb3f4081c,1,521,bosentan,1,Oral,104865,CID104865,both,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
LT01141,71158,acamprosate,2004,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,Negative,CC(=O)NCCCS(=O)(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1c427b06-32d4-482f-bb83-71e386c1e203,2,522,acamprosate,1,Oral,71158,CID71158,both,CC(=O)NCCCS(=O)(=O)O
LT01143,60795,aripiprazole,2002,Less-DILI-Concern,5,Adverse reactions,,Ambiguous DILI-concern,,,,,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c005ffe2-ed95-4254-9cfe-4073a09cd718,2,523,aripiprazole,0,Oral,60795,CID60795,both,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl
LT01144,63006,budesonide,1994,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,Negative,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=98a4eca1-904c-4355-957a-b5a141573cc2,2,524,budesonide,0,Oral,5281004,CID5281004,both,CCC[C@H]1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C
LT01145,2471,bumetanide,1983,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,HH,,Positive,,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=925b309a-8a0b-4bcd-bdf4-1ec42780ecc2,2,525,bumetanide,0,Oral,2471,CID2471,both,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2
LT01148,2477,buspirone,1986,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,NE,non-hepatotixic,Negative,,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3451ced4-f2a3-476e-a279-b96c8c3f0acf,1,526,buspirone,0,Oral,2477,CID2477,both,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4
LT01149,150310,eplerenone,2002,Less-DILI-Concern,4,Adverse reactions,,Ambiguous DILI-concern,,,,,C[C@]12CCC(=O)C=C1C[C@H](C3[C@]24C(O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d988699-95c2-46b9-8266-23fe7016f33b,2,527,eplerenone,0,Oral,443872,CID443872,both,C[C@]12CCC(=O)C=C1C[C@H](C3[C@]24C(O4)C[C@]5([C@H]3CC[C@@]56CCC(=O)O6)C)C(=O)OC
LT01151,5361092,butorphanol,1978,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,Postive,C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9822ca3f-aee2-46e5-8a96-495400e65d10,2,528,butorphanol,0,Intravenous,5361092,CID5361092,both,C1CC[C@]2([C@H]3CC4=C([C@]2(C1)CCN3CC5CCC5)C=C(C=C4)O)O
LT01152,54746,cabergoline,1996,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=74b61e8a-7ae9-4996-85ec-df23c56de16f,2,529,cabergoline,0,Oral,54746,CID54746,both,CCNC(=O)N(CCCN(C)C)C(=O)[C@@H]1C[C@H]2[C@@H](CC3=CNC4=CC=CC2=C34)N(C1)CC=C
LT01153,150311,ezetimibe,2002,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,Postive,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a773b0b2-d31c-4ff4-b9e8-1eb2d3a4d62a,2,530,ezetimibe,1,Oral,150311,CID150311,both,C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O
LT01154,5486971,pregabalin,2004,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,,,,Postive,CC(C)C[C@@H](CC(=O)O)CN,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce1a4b9d-3127-4416-8bf2-fee5899fc0ba,2,531,pregabalin,1,Oral,5486971,CID5486971,both,CC(C)C[C@@H](CC(=O)O)CN
LT01155,60871,adefovir,2002,Less-DILI-Concern,2,Warnings and precautions,Yes,vLess-DILI-Concern,,,,,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a60adac4-57c2-4089-aefc-1a77a48676fc,2,532,adefovir,1,Oral,60172,CID60172,both,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C
LT01156,60852,ibandronate,2003,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f94d9c49-245a-8081-42c4-785113fce498,2,533,ibandronate,0,Oral,60852,CID60852,both,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O
LT01159,20824,carbenicillin,1972,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)C(=O)O)C(=O)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=02010995-9826-4a67-945b-f3022e6081df,2,534,carbenicillin,1,Oral,20824,CID20824,both,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)C(=O)O)C(=O)O)C
LT01160,34359,carbidopa,1977,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,NE,,Negative,Negative,C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d5204e5e-10ef-4758-8fc6-cb710048c687 ,2,535,carbidopa,0,Oral,34359,CID34359,both,C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN
LT01161,969472,eszopiclone,2004,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CN1CCN(CC1)C(=O)O[C@H]2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=52deb8f7-abaf-46ec-9f15-13e30d558769,2,536,eszopiclone,0,Oral,969472,CID969472,both,CN1CCN(CC1)C(=O)O[C@H]2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
LT01166,40958,cefaclor,1979,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,Postive,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac5e34a9-994b-4611-aa41-3d1ed58a91c0,2,537,cefaclor,1,Oral,51039,CID51039,both,C1C(=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
LT01167,2610,cefadroxil,1978,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,Postive,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17123057-58c7-401a-b87d-8c4c0764bbf6,2,538,cefadroxil,1,Oral,47965,CID47965,both,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O
LT01169,16130199,enfuvirtide,2003,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC7=CC=CC=C7)C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC8=CN=CN8)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC9=CC=C(C=C9)O)NC(=O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6935e846-d5a1-49e5-89a2-f8ebe4d5590d,2,539,enfuvirtide,0,Subcutaneous,24847866,CID24847866,both,CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC5=CNC6=CC=CC=C65)C(=O)N[C@@H](CC7=CC=CC=C7)C(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC8=CN=CN8)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC9=CC=C(C=C9)O)NC(=O)C
LT01171,656510,cefazolin,1973,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,Postive,CC1=NN=C(S1)SCC2=C(N3C([C@@H](C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a43260a4-f4ec-4331-aa80-02e584be7af5,2,540,cefazolin,1,Intravenous,33255,CID33255,both,CC1=NN=C(S1)SCC2=C(N3C([C@@H](C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O
LT01172,5479537,cefepime,1996,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,Postive,C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a96295cf-e652-4f10-9e25-9f2a2cc036f6,2,541,cefepime,1,Intravenous,5479537,CID5479537,both,C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)[O-]
LT01173,54362,cefixime,1989,Less-DILI-Concern,4,Adverse reactions,,Ambiguous DILI-concern,,,,,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)C(=NOCC(=O)O)C3=CSC(=N3)N)SC1)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=69234c9d-fc0f-49b1-8345-e0fe48ed0699,2,542,cefixime,0,Oral,5362065,CID5362065,both,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)C(=NOCC(=O)O)C3=CSC(=N3)N)SC1)C(=O)O
LT01176,44185,cefoperazone,1982,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,NE,non-hepatotixic,Negative,,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=C(C=C2)O)C(=O)N[C@H]3[C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fc5c6923-7f62-405f-ad9a-b60901eb5c99,2,543,cefoperazone,1,Intravenous,44187,CID44187,both,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=C(C=C2)O)C(=O)N[C@H]3[C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O
LT01177,456256,cefotaxime,1981,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ed23b6bc-32c7-4c50-a53d-313ae78e5623,2,544,cefotaxime,1,Intravenous,5742673,CID5742673,both,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O
LT01179,441199,cefoxitin,1978,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,HH,,Positive,,CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7ae80b51-b62d-4adf-be6a-9d320cd97c76,2,545,cefoxitin,0,Intravenous,441199,CID441199,both,CO[C@@]1([C@@H]2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3
LT01180,6335986,cefpodoxime,1992,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,COCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4587a7c1-cd6c-4946-a0dd-fcfe0c8504b9,2,546,cefpodoxime,0,Oral,6335986,CID6335986,both,COCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OC)/C3=CSC(=N3)N)SC1)C(=O)O
LT01181,9887054,oxaliplatin,2002,Most-DILI-Concern,4,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)[O-])[O-].[Pt+2],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3c740b43-f396-4998-bc66-6964a21f7161,2,547,oxaliplatin,1,Intravenous,43805,CID43805,both,C1CC[C@H]([C@@H](C1)N)N.C(=O)(C(=O)[O-])[O-].[Pt+2]
LT01182,5281006,cefprozil,1991,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C/C=C/C1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)SC1)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8e3943b5-8c30-4c81-bcfa-aeaaa1d75fb4,2,548,cefprozil,1,Oral,5281006,CID5281006,both,C/C=C/C1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=C(C=C3)O)N)SC1)C(=O)O
LT01183,5282241,ceftibuten,1995,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C1C=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)/C(=C\CC(=O)O)/C3=CSC(=N3)N)C(=O)O.O.O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=756d627b-021d-4609-aa08-af6cab80a812,2,549,ceftibuten,0,Oral,5282242,CID5282242,both,C1C=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)/C(=C\CC(=O)O)/C3=CSC(=N3)N)C(=O)O.O.O
LT01184,41684,nitazoxanide,2002,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=56b1575a-dff4-4c5a-a159-2f858e7a0cb8,2,550,nitazoxanide,0,Oral,41684,CID41684,both,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-]
LT01185,5361919,ceftriaxone,1984,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,HH,non-hepatotixic,Positive,Postive,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N/OC)/C4=CSC(=N4)N)SC2)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7c6b995b-264f-494c-8c10-6c12b02c214e,2,551,ceftriaxone,1,Intravenous,5479530,CID5479530,both,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N/OC)/C4=CSC(=N4)N)SC2)C(=O)O
LT01186,5361202,cefuroxime,1983,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,,,,Postive,CO/N=C(\C1=CC=CO1)/C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8da31eca-51cf-4a01-9159-740f772b0f15,2,552,cefuroxime,1,Oral,5479529,CID5479529,both,CO/N=C(\C1=CC=CO1)/C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O
LT01187,3081921,micafungin,2005,Most-DILI-Concern,7,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)C(CC(=O)N)O)C)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a064c4a7-25ec-4a2c-afc2-703491a4a38b,2,553,micafungin,1,Intravenous,477468,CID477468,both,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)C(CC(=O)N)O)C)O)O)O
LT01188,444031,darifenacin,2004,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,Negative,C1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cec47488-ebad-4a3a-904c-e916b432e2cf,2,554,darifenacin,0,Oral,444031,CID444031,both,C1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5
LT01189,27447,cephalexin,1971,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)SC1)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cab0d668-f4a4-4848-ba93-fa2c2246096c,2,555,cephalexin,1,Oral,27447,CID27447,both,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)SC1)C(=O)O
LT01190,2678,cetirizine,1995,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dd9ae7a8-35dd-4c50-8be6-d06188f4c037,2,556,cetirizine,1,Oral,2678,CID2678,both,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
LT01191,216457,solifenacin,2004,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,Negative,C1CN2CCC1[C@H](C2)OC(=O)N3CCC4=CC=CC=C4[C@@H]3C5=CC=CC=C5.C(CC(=O)O)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9acee910-cdb2-4052-b8b3-c26aff1c8716,2,557,solifenacin,0,Oral,154059,CID154059,both,C1CN2CCC1[C@H](C2)OC(=O)N3CCC4=CC=CC=C4[C@@H]3C5=CC=CC=C5.C(CC(=O)O)C(=O)O
LT01192,56959,ranolazine,2006,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=beb482de-f251-476b-9d38-40577c36f5a3,2,558,ranolazine,0,Oral,56959,CID56959,both,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
LT01196,298,chloramphenicol,1950,No-DILI-concern,0,No match,,vNo-DILI-Concern,HH,,Positive,,C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aed29594-211d-49ef-813f-131975a8d0e3,2,559,chloramphenicol,0,Intravenous,5959,CID5959,both,C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-]
LT01198,2712,chlordiazepoxide,1960,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e3ff8641-ae8a-4016-acb1-cb1b7890f5ed,2,560,chlordiazepoxide,1,Oral,2712,CID2712,both,CN=C1CN(C(=C2C=C(C=CC2=N1)Cl)C3=CC=CC=C3)O
LT01199,148192,atazanavir,2003,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,,CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=165cff62-b284-4a27-a65d-9ec8a5bfcdd8,2,561,atazanavir,1,Oral,148192,CID148192,both,CC(C)(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)[C@H](CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)[C@H](C(C)(C)C)NC(=O)OC)O)NC(=O)OC
LT01200,16129629,daptomycin,2003,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)NC3C(OC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a7975871-46a6-4e9b-a8b5-38bfcb465f0e,2,562,daptomycin,1,Intravenous,16134395,CID16134395,both,CCCCCCCCCC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)NC3C(OC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C
LT01201,2717,chlormezanone,1960,Most-DILI-Concern,8,Withdrawn,Yes,vMost-DILI-Concern,,,,Postive,CN1C(S(=O)(=O)CCC1=O)C2=CC=C(C=C2)Cl,,1,563,chlormezanone,1,Oral,2717,CID2717,both,CN1C(S(=O)(=O)CCC1=O)C2=CC=C(C=C2)Cl
LT01202,93860,bortezomib,2003,Most-DILI-Concern,7,Warnings and precautions,Yes,vMost-DILI-Concern,,,,Postive,B([C@@H](CC(C)C)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1521d321-e724-4ffc-adad-34bf4f44fac7,2,564,bortezomib,1,Intravenous,387447,CID387447,both,B([C@@H](CC(C)C)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
LT01203,166548,anidulafungin,2006,Most-DILI-Concern,7,Warnings and precautions,,Ambiguous DILI-concern,,,,,CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC=C(C=C7)O)O)O)[C@@H](C)O)C)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a88d9010-55fb-4a02-baff-042cd27688ea,2,565,anidulafungin,0,Intravenous,166548,CID166548,both,CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)N[C@H]4C[C@H]([C@H](NC(=O)[C@@H]5[C@H]([C@H](CN5C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]6C[C@H](CN6C(=O)[C@@H](NC4=O)[C@@H](C)O)O)[C@@H]([C@H](C7=CC=C(C=C7)O)O)O)[C@@H](C)O)C)O)O)O
LT01204,3052776,rasagiline,2006,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C#CCN[C@@H]1CCC2=CC=CC=C12,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a40d0e73-3f9f-4b01-979d-402c9cdaeb60,2,566,rasagiline,0,Oral,3052776,CID3052776,both,C#CCN[C@@H]1CCC2=CC=CC=C12
LT01207,2719,chloroquine,1949,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,WE,non-hepatotixic,Negative,,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eb02c52d-907c-43fb-aa8f-2f378a9087e7,1,567,chloroquine,1,Oral,2719,CID2719,both,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl
LT01208,2720,chlorothiazide,1958,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bd936e35-1af8-42da-bcc0-f22489d68574,2,568,chlorothiazide,1,Oral,2720,CID2720,both,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2
LT01209,156419,cinacalcet,2004,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C[C@H](C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c94c1206-97cb-4088-b8a1-adf08b938755,2,569,cinacalcet,0,Oral,156419,CID156419,both,C[C@H](C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F
LT01210,151171,conivaptan,2005,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=87713d73-5dcc-4158-8890-60efdbd28c05,2,570,conivaptan,0,Intravenous,151171,CID151171,both,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6
LT01212,71301,nebivolol,2007,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=673f5ad2-c09b-4a89-9407-efdadd007917,2,571,nebivolol,0,Oral,71301,CID71301,both,C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O
LT01213,2732,chlorthalidone,1960,Less-DILI-Concern,2,Adverse reactions,,Ambiguous DILI-concern,,,,,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e2eb7dad-3ea3-439c-dcbb-d1d61aa49dfc,2,572,chlorthalidone,0,Oral,2732,CID2732,both,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O
LT01214,176870,erlotinib,2004,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=57bccb29-1c47-4c64-ab6a-77960a91cc20,2,573,erlotinib,1,Oral,176870,CID176870,both,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC
LT01215,5488548,alvimopan,2008,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=77a67dc6-35d3-48ff-9d18-292d4d442f70,2,574,alvimopan,0,Oral,5488548,CID5488548,both,C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(=O)O
LT01216,60613,cidofovir,1996,Less-DILI-Concern,5,Adverse reactions,,Ambiguous DILI-concern,,,,,C1=CN(C(=O)N=C1N)C[C@@H](CO)OCP(=O)(O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=56541229-8c1a-4550-8951-2415ed08e7e9,2,575,cidofovir,0,Intravenous,60613,CID60613,both,C1=CN(C(=O)N=C1N)C[C@@H](CO)OCP(=O)(O)O
LT01217,208902,ramelteon,2005,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCC(=O)NCC[C@@H]1CCC2=C1C3=C(C=C2)OCC3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b6fe9db3-cf46-4b2b-a097-9c96f9c30908,2,576,ramelteon,0,Oral,208902,CID208902,both,CCC(=O)NCC[C@@H]1CCC2=C1C3=C(C=C2)OCC3
LT01218,2756,cimetidine,1977,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,WE,Hepatotoxic,Negative,,CC1=C(N=CN1)CSCCNC(=NC)NC#N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c1694b2d-6fbb-b800-370b-0bf31220cb35,1,577,cimetidine,1,Oral,2756,CID2756,both,CC1=C(N=CN1)CSCCNC(=NC)NC#N
LT01219,8593,cinchophen,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,HH,,Positive,,C1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=C2)C(=O)O,,1,578,cinchophen,1,Oral,8593,CID8593,both,C1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=C2)C(=O)O
LT01220,65027,tipranavir,2005,Most-DILI-Concern,8,Box warning,,vMost-DILI-Concern,,,,,CCC[C@]1(CC(=O)C(=C(O1)O)[C@H](CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=08982e49-d2eb-4b25-b01a-1be52fd669ef,1,579,tipranavir,1,Oral,54682461,CID54682461,both,CCC[C@]1(CC(=C(C(=O)O1)[C@H](CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4
LT01222,54686904,tigecycline,2005,Most-DILI-Concern,8,Warnings and precautions,,Ambiguous DILI-concern,,,,,CC(C)(C)NCC(=O)NC1=C(C2=C(C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C2O)O)O)C(=O)N)N(C)C)C(=C1)N(C)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2ccdb48e-c14a-4eeb-348c-4920ccfd7465,2,580,tigecycline,0,Intravenous,54686904,CID54686904,both,CC(C)(C)NCC(=O)NC1=CC(=C2C[C@H]3C[C@H]4[C@@H](C(=O)C(=C([C@]4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C
LT01224,20279,cladribine,1993,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,NE,,Negative,Negative,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C2N=C(N=C3N)Cl)CO)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3591aac5-61fc-411c-91fb-93a0bde3961f,2,581,cladribine,0,Intravenous,20279,CID20279,both,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O
LT01225,29029,clindamycin,1970,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,,Positive,Postive,CCC[C@@H]1C[C@H](N(C1)C)C(=O)NC([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)C(C)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab7233b1-b68e-458b-9e1d-4fc3fa15e8b6,2,582,clindamycin,1,Oral,446598,CID446598,both,CCC[C@@H]1C[C@H](N(C1)C)C(=O)NC([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)C(C)Cl
LT01228,33176,clometacin,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,CC1=C(C2=C(N1CC(=O)O)C=C(C=C2)OC)C(=O)C3=CC=C(C=C3)Cl,,1,583,clometacin,1,Oral,33176,CID33176,both,CC1=C(C2=C(N1CC(=O)O)C=C(C=C2)OC)C(=O)C3=CC=C(C=C3)Cl
LT01231,2803,clonidine,1974,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,HH,,Positive,,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=316f9345-118c-4bc3-adea-a46e3fe6dc48,1,585,clonidine,0,Oral,2803,CID2803,both,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl
LT01233,3011155,nelarabine,2005,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,,,,,COC1=NC(=NC2=C1N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=893c95d7-d9b6-4064-db97-91dd21ce7e40,2,586,nelarabine,1,Intravenous,3011155,CID3011155,both,COC1=NC(=NC2=C1N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N
LT01235,6098,cloxacillin,1974,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,,Positive,,CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,,2,587,cloxacillin,1,Oral,6098,CID6098,both,CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O
LT01238,216326,lenalidomide,2005,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5fa97bf5-28a2-48f1-8955-f56012d296be,2,588,lenalidomide,1,Oral,216326,CID216326,both,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N
LT01240,656719,lubiprostone,2006,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCCCC([C@]1(CC[C@H]2[C@H](O1)CC(=O)[C@H]2CCCCCCC(=O)O)O)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d474ac6a-444d-4aa6-9986-24be6fcf811d,2,589,lubiprostone,0,Oral,157920,CID157920,both,CCCCC([C@]1(CC[C@H]2[C@H](O1)CC(=O)[C@H]2CCCCCCC(=O)O)O)(F)F
LT01241,216239,sorafenib,2005,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b50667e4-5ebc-4968-a646-d605058dbef0,2,590,sorafenib,1,Oral,216239,CID216239,both,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
LT01242,5310966,varenicline,2006,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C1[C@@H]2CNC[C@H]1C3=CC4=NC=CN=C4C=C23,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f0ff4f27-5185-4881-a749-c6b7a0ca5696,2,591,varenicline,1,Oral,170361,CID170361,both,C1[C@@H]2CNC[C@H]1C3=CC4=NC=CN=C4C=C23
LT01243,213039,darunavir,2006,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,,,Postive,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=814301f9-c990-46a5-b481-2879a521a16f,2,592,darunavir,1,Oral,213039,CID213039,both,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CO[C@@H]3[C@H]2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
LT01244,5493444,aliskiren,2007,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,,,,,CC(C)[C@@H](CC1=CC(=C(C=C1)OC)OCCCOC)C[C@@H]([C@H](C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=833c7a0b-5f64-4363-94d5-9a179049113a,2,593,aliskiren,1,Oral,5493444,CID5493444,both,CC(C)[C@@H](CC1=CC(=C(C=C1)OC)OCCCOC)C[C@@H]([C@H](C[C@@H](C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N
LT01248,3062316,dasatinib,2006,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4764f37b-c9e6-4ede-bcc2-8a03b7c521df,2,594,dasatinib,1,Oral,3062316,CID3062316,both,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
LT01249,2895,cyclobenzaprine,1977,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a88fa950-23d9-49fd-9340-b38a357760bf,2,595,cyclobenzaprine,1,Oral,2895,CID2895,both,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31
LT01250,2898,cyclofenil,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,CC(=O)OC1=CC=C(C=C1)C(=C2CCCCC2)C3=CC=C(C=C3)OC(=O)C,,1,596,cyclofenil,1,Oral,2898,CID2898,both,CC(=O)OC1=CC=C(C=C1)C(=C2CCCCC2)C3=CC=C(C=C3)OC(=O)C
LT01251,4369359,sitagliptin,2006,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f85a48d0-0407-4c50-b0fa-7673a160bf01,2,597,sitagliptin,1,Oral,4369359,CID4369359,both,C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N
LT01252,115237,paliperidone,2006,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7b8e5b26-b9e4-4704-921b-3c3c0d159916,2,598,paliperidone,0,Oral,115237,CID115237,both,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
LT01254,147912,posaconazole,2006,Most-DILI-Concern,8,Warnings and precautions,,Ambiguous DILI-concern,,,,,CC[C@@H]([C@H](C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b073b082-7b57-4423-8c06-4fd4263d6f84,2,599,posaconazole,0,Oral,468595,CID468595,both,CC[C@@H]([C@H](C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5C[C@](OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
LT01255,2913,cyproheptadine,1961,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=12cf01c7-bb0b-47db-8401-fd43d8dce1ff,2,600,cyproheptadine,1,Oral,2913,CID2913,both,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1
LT01261,6918289,temsirolimus,2007,No-DILI-concern,0,No match,,vNo-DILI-Concern,,,,,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OC(=O)C(C)(CO)CO)C)/C)O)OC)C)C)/C)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=95b7dc92-2180-42f1-8699-3c28f609e674 ,2,601,temsirolimus,0,Intravenous,6918289,CID6918289,both,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OC(=O)C(C)(CO)CO)C)/C)O)OC)C)C)/C)OC
LT01262,1125,tetrahydrobiopterin,2007,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(C(C1CNC2=C(N1)C(=O)N=C(N2)N)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=af38711e-8873-4790-a92d-4d583e23fb89,2,602,tetrahydrobiopterin,0,Oral,135402045,CID135402045,both,CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O
LT01263,65833,milnacipran,2009,Most-DILI-Concern,7,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=16a4a314-f97e-4e91-95e9-576a3773d284,2,603,milnacipran,1,Oral,65833,CID65833,both,CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2
LT01265,2995,desipramine,1964,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,WE,,Negative,,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7017228d-3cd8-470b-b642-3634ddda500c,1,604,desipramine,0,Oral,2995,CID2995,both,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31
LT01266,9578005,dexlansoprazole,2009,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC1=C(C=CN=C1C[S@@](=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9819f033-3bbe-442e-8e92-45fec77b237d,2,605,dexlansoprazole,1,Oral,9578005,CID9578005,both,CC1=C(C=CN=C1C[S@@](=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F
LT01267,6442177,everolimus,2009,Less-DILI-Concern,4,Adverse reactions,,Ambiguous DILI-concern,,,,,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e082a024-7850-400b-a5c2-2a140612562a,2,606,everolimus,0,Oral,6442177,CID6442177,both,C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC
LT01269,5284371,codeine,2009,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa3ed180-298a-4f9d-9d05-15182d7218bf,2,607,codeine,0,Oral,5284371,CID5284371,both,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](C=C4)O
LT01275,216258,colistimethate,1970,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCC(C)CCCCC(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC(C(C)O)C(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCNCS(=O)(=O)[O-])CC(C)C)CC(C)C)CCNCS(=O)(=O)[O-])CCNCS(=O)(=O)[O-])C(C)O.[Na+].[Na+].[Na+].[Na+].[Na+],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6a335659-03b0-4a2d-9cd4-7dcf7da96fe6,1,608,colistimethate,0,Intravenous,216258,CID216258,both,CCC(C)CCCCC(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC(C(C)O)C(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCNCS(=O)(=O)[O-])CC(C)C)CC(C)C)CCNCS(=O)(=O)[O-])CCNCS(=O)(=O)[O-])C(C)O.[Na+].[Na+].[Na+].[Na+].[Na+]
LT01276,119212,benzylpenicilloyl polylysine,1974,No-DILI-concern,0,No match,,vNo-DILI-Concern,,,,,CC1(C(NC(S1)C(C(=O)NCCCCCC(=O)O)NC(=O)CC2=CC=CC=C2)C(=O)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2fbcc40c-f102-4abe-bce5-a93de95874fe ,2,609,benzylpenicilloyl polylysine,0,Subcutaneous,45266800,CID45266800,both,CC1(C(NC(S1)C(C(=O)NCCCCCC(=O)O)NC(=O)CC2=CC=CC=C2)C(=O)O)C
LT01279,38103,cephradine,1974,Less-DILI-Concern,4,Adverse reactions,,Ambiguous DILI-concern,NE,,Negative,,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CCC=CC3)N)SC1)C(=O)O,,2,610,cephradine,0,Oral,38103,CID38103,both,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)[C@@H](C3=CCC=CC3)N)SC1)C(=O)O
LT01281,6533629,ceftizoxime,1983,Less-DILI-Concern,4,Adverse reactions,,Ambiguous DILI-concern,,,,,CO/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=CCS3)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3574df06-fec5-4888-8080-3b817addfb02,2,611,ceftizoxime,0,Intravenous,6533629,CID6533629,both,CO/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=CCS3)C(=O)O
LT01285,50599,didanosine,1991,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2NC=NC3=O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d4401ca0-98ae-af38-84c7-2f615d0706b9,1,612,didanosine,1,Oral,135398739,CID135398739,both,C1C[C@@H](O[C@@H]1CO)N2C=NC3=C2N=CNC3=O
LT01288,5281078,mycophenolate mofetil,1995,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b414303f-e6f3-4e22-a537-96be352b59a4,2,613,mycophenolate mofetil,1,Oral,5281078,CID5281078,both,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)O
LT01289,6915944,cefdinir,1997,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\O)/C3=CSC(=N3)N)SC1)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8640931e-317a-42b4-806a-146f00ddf2a6,2,614,cefdinir,1,Oral,6915944,CID6915944,both,C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\O)/C3=CSC(=N3)N)SC1)C(=O)O
LT01291,5702105,polymyxin b sulfate,1964,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a14373aa-c5fa-4f90-8e8f-fc9e2219039c,2,615,polymyxin b sulfate,0,Intravenous,5702105,CID5702105,both,CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC2=CC=CC=C2)CC(C)C)CCN)CCN)C(C)O.OS(=O)(=O)O
LT01292,39186,diltiazem,1982,Most-DILI-Concern,4,Warnings and precautions,Yes,vMost-DILI-Concern,,non-hepatotixic,Negative,Postive,CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a662fc04-c296-4c24-8e36-ce7f9bcbd2ed,2,616,diltiazem,1,Oral,39186,CID39186,both,CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC
LT01294,962,sterile water,2006,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cc749269-d234-4e59-b2f6-09026c130741,2,617,sterile water,0,Intravenous,962,CID962,both,O
LT01302,3114,disopyramide,1977,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=11a68e26-d2e4-48f6-ba0f-9bdd5778f25a,2,618,disopyramide,1,Oral,3114,CID3114,both,CC(C)N(CCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)C(C)C
LT01306,71306834,interferon alfa-2b,1986,Most-DILI-Concern,8,Warnings and precautions,Yes(literature),vMost-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fd653d74-48ab-49e4-a42d-ec1cbc59badb,2,621,interferon alfa-2b,1,Intravenous,71306834,CID71306834,both,CCCN(CCOC1=C(C=C(C=C1Cl)Cl)Cl)C(=O)N2C=CN=C2.C(S(=O)(=O)[O-])(I)I.[Na+]
LT01308,36811,dobutamine,1978,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6b17b98b-e06d-42ed-925f-69aa2699dead,1,622,dobutamine,0,Intravenous,36811,CID36811,both,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O
LT01309,148124,docetaxel,1996,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,Postive,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a0ec4bcc-93ea-4c41-a4b6-95ec19491807,1,623,docetaxel,1,Intravenous,148124,CID148124,both,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O
LT01313,3157,doxazosin,1990,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4d0c38b0-8089-45b1-613f-563176c53e43,2,625,doxazosin,0,Oral,3157,CID3157,both,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC
LT01314,667477,doxepin,1969,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f350afed-120b-422d-9e6e-3aaa0f72a5fb,2,626,doxepin,1,Oral,667477,CID667477,both,CN(C)CC/C=C/1\C2=CC=CC=C2COC3=CC=CC=C31
LT01316,127893,epoetin alfa**,1989,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1=CC=C(C=C1)CC(CC(=O)CNC(=O)C2=CC=CC=C2)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5,2,628,epoetin alfa,0,Intravenous,92043599,CID92043599,both,C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CCO)C)O[C@H]4C[C@@]([C@H]([C@@H](O4)C)O)(C)O
LT01317,3168,droperidol,1970,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,Negative,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=54c9ad21-5051-4263-948a-db651b5fd05d,2,629,droperidol,0,Intravenous,3168,CID3168,both,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F
LT01318,65679,droxicam,,Most-DILI-Concern,8,Withdrawn,Yes,vMost-DILI-Concern,,,,,CN1C2=C(C3=CC=CC=C3S1(=O)=O)OC(=O)N(C2=O)C4=CC=CC=N4,,1,630,droxicam,1,Oral,65679,CID65679,both,CN1C2=C(C3=CC=CC=C3S1(=O)=O)OC(=O)N(C2=O)C4=CC=CC=N4
LT01323,64139,efavirenz,1998,Most-DILI-Concern,7,Warnings and precautions,Yes,vMost-DILI-Concern,,,,Postive,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=32d6371e-ba56-4294-b732-6d43627c5c47,2,633,efavirenz,1,Oral,64139,CID64139,both,C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
LT01333,59768,esmolol,1986,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=595cc3d5-1306-4828-aefa-5595219ffd62,1,638,esmolol,0,Intravenous,59768,CID59768,both,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O
LT01334,3261,estazolam,1990,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=50914a46-eab6-4c83-97cf-6ab0234c8126,2,639,estazolam,0,Oral,3261,CID3261,both,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4
LT01342,18140,estramustine,1981,Most-DILI-Concern,4,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9b01bc6-95ac-46f9-befa-d845a74d53c1,2,642,estramustine,1,Oral,259331,CID259331,both,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl
LT01345,3279,ethambutol,1967,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,,,Postive,CCC(CO)NCCNC(CC)CO,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d7cf3a73-bfd3-438a-952d-71cf0ec61628,1,643,ethambutol,1,Oral,14052,CID14052,both,CCC(CO)NCCNC(CC)CO
LT01348,2761171,ethionamide,1965,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,,CCC1=NC=CC(=C1)C(=S)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=04a413fe-95f4-47a7-42ac-283a9e78297d,2,645,ethionamide,1,Oral,2761171,CID2761171,both,CCC1=NC=CC(=C1)C(=S)N
LT01355,3305,etidronic acid,1977,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,,CC(O)(P(=O)(O)O)P(=O)(O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=60a2009d-cb3e-429b-95cd-dea7ed5c90fb,1,651,etidronic acid,0,Oral,3305,CID3305,both,CC(O)(P(=O)(O)O)P(=O)(O)O
LT01357,36339,etomidate,1982,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6dfd9a2a-540d-4a8e-9b92-b78e89480d39,2,653,etomidate,0,Intravenous,667484,CID667484,both,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2
LT01359,40399,exifone,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,C1=CC(=C(C(=C1C(=O)C2=CC(=C(C(=C2)O)O)O)O)O)O,,1,654,exifone,1,Oral,40399,CID40399,both,C1=CC(=C(C(=C1C(=O)C2=CC(=C(C(=C2)O)O)O)O)O)O
LT01370,3348,fexofenadine,1996,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6cf8da77-4272-4f88-9e5c-e83cfd80e9e9,2,659,fexofenadine,0,Oral,3348,CID3348,both,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O
LT01371,50313,fialuridine,,Most-DILI-Concern,8,Discontinued,,vMost-DILI-Concern,HH,,Positive,,C1=C(C(=O)NC(=O)N1[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)F)I,,1,660,fialuridine,1,Oral,50313,CID50313,both,C1=C(C(=O)NC(=O)N1[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)F)I
LT01372,3351,fipexide,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,HH,,Positive,,C1CN(CCN1CC2=CC3=C(C=C2)OCO3)C(=O)COC4=CC=C(C=C4)Cl,,1,661,fipexide,1,Oral,3351,CID3351,both,C1CN(CCN1CC2=CC3=C(C=C2)OCO3)C(=O)COC4=CC=C(C=C4)Cl
LT01373,139595263,anakinra,2001,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d9d74915-6606-4570-9c52-c4001d3177de,2,662,anakinra,1,Subcutaneous,139595263,CID139595263,both,CC(C)(C)C(=O)OCON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C=C)C(=O)O
LT01375,3356,flecainide,1985,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,Negative,C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4f6b78d4-8ac8-464b-bb78-ee70cbc97898,2,664,flecainide,1,Oral,3356,CID3356,both,C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F
LT01380,22879211,pegfilgrastim**,2002,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CN(C)C1=CC(=C(C=C1)OC)CN[C@H]2CCCN[C@H]2C3=CC=CC=C3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fdfe5d72-6b80-435a-afa4-c5d74dd852ce,2,667,pegfilgrastim,0,Subcutaneous,70683024,CID70683024,both,CN(C)C1=CC(=C(C=C1)OC)CN[C@H]2CCCN[C@H]2C3=CC=CC=C3
LT01381,3366,flucytosine,1971,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,HH,,Positive,,C1=NC(=O)NC(=C1F)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=820e2477-e247-4349-86fc-144c4a6a289c,2,668,flucytosine,0,Oral,3366,CID3366,both,C1=NC(=O)NC(=C1F)N
LT01382,30751,fludarabine,1991,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N=C(N=C2N)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30bac07f-86bd-4a03-8ea1-7ab2d42d3ea3,2,669,fludarabine,0,Oral,657237,CID657237,both,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)F)N
LT01384,3373,flumazenil,1991,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=436f5616-9626-4b6a-9deb-2986444179d0,2,670,flumazenil,0,Intravenous,3373,CID3373,both,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C
LT01394,3393,flurazepam,1970,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=576e0a98-996d-425a-be7c-6ab1528539a9,2,676,flurazepam,1,Oral,3393,CID3393,both,CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F
LT01396,3404,fluvoxamine,1994,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,HH,non-hepatotixic,Positive,,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e57814e3-9507-4a2f-858f-a845ad18f029,2,677,fluvoxamine,0,Oral,5324346,CID5324346,both,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F
LT01397,3415,foscarnet,1991,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,NE,,Negative,,C(=O)(O)P(=O)(O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a09299d5-9c55-4cef-aed0-3a6a45532289,2,678,foscarnet,0,Intravenous,3415,CID3415,both,C(=O)(O)P(=O)(O)O
LT01398,446987,fosfomycin,1996,Less-DILI-Concern,6,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C[C@H]1[C@H](O1)P(=O)(O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ad155d62-9b49-4a50-a2ae-d3aad8155936,2,679,fosfomycin,1,Oral,446987,CID446987,both,C[C@H]1[C@H](O1)P(=O)(O)O
LT01399,55891,fosinopril,1991,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2C[C@@H](C[C@H]2C(=O)O)C3CCCCC3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3c91edcd-b11a-4289-a1c5-d5054b18f54d,2,680,fosinopril,1,Oral,55891,CID55891,both,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2C[C@@H](C[C@H]2C(=O)O)C3CCCCC3
LT01400,56339,fosphenytoin,1996,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,,,Negative,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c92df63b-5140-4213-8d43-8327ff6230b7,2,681,fosphenytoin,1,Intramuscular,56339,CID56339,both,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3
LT01407,60750,gemcitabine,1996,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dc02a23b-3ff9-4441-aa91-8e9e629a7315,2,685,gemcitabine,1,Intravenous,60750,CID60750,both,C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F
LT01433,3639,hydrochlorothiazide,1959,Less-DILI-Concern,2,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,Postive,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=babb1b20-fe82-40ba-8e7a-0c56fe433b4a,2,694,hydrochlorothiazide,1,Oral,3639,CID3639,both,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl
LT01440,42890,idarubicin,1990,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,NE,,Negative,,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a5a6d93-cc1e-4d7f-8da1-446c134503b3,2,695,idarubicin,0,Intravenous,42890,CID42890,both,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O
LT01444,3702,indapamide,1983,Less-DILI-Concern,5,Adverse reactions,,Ambiguous DILI-concern,,,,,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de43a844-ad67-41d0-bb9b-935d925e3b3d,2,696,indapamide,0,Oral,3702,CID3702,both,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N
LT01446,5362440,indinavir,1996,Most-DILI-Concern,8,Warnings and precautions,,Ambiguous DILI-concern,,Hepatotoxic,Negative,,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=83aeddf8-6fed-487c-858b-2240f0a0e8af,1,697,indinavir,0,Oral,5362440,CID5362440,both,CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5
LT01454,3739,iodipamide meglumine,1954,No-DILI-concern,0,No match,,vNo-DILI-Concern,,,,,C1=C(C(=C(C(=C1I)NC(=O)CCCCC(=O)NC2=C(C=C(C(=C2I)C(=O)O)I)I)I)C(=O)O)I,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=430c343b-bad6-4584-8c63-05bca0b203a2,2,698,iodipamide meglumine,0,Intravenous,636408,CID636408,both,C1=C(C(=C(C(=C1I)NC(=O)CCCCC(=O)NC2=C(C=C(C(=C2I)C(=O)O)I)I)I)C(=O)O)I
LT01466,60838,irinotecan,1996,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CCC1=C2C=C(C=CC2=NC3=C1CN4C3=CC5=C(C4=O)COC(=O)[C@@]5(CC)O)OC(=O)N6CCC(CC6)N7CCCCC7,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e98886aa-933c-430f-bb56-f1eb3862aae4,2,699,irinotecan,1,Intravenous,60838,CID60838,both,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7
LT01468,6137,l-methionine,,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CSCC[C@@H](C(=O)O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=253ca66e-3c25-0483-e054-00144ff8d46c,2,700,l-methionine,0,Oral,6137,CID6137,both,CSCC[C@@H](C(=O)O)N
LT01475,3784,isradipine,1990,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c5745462-fab9-4916-acee-1bc6f9e63560,2,701,isradipine,1,Oral,3784,CID3784,both,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC
LT01477,6032,kanamycin,1973,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d4865638-1259-4eef-a73c-fe919af6e850,1,702,kanamycin,0,Intravenous,6032,CID6032,both,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N
LT01479,6759,riboflavin,,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)C[C@H]([C@H]([C@H](CO)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=39082010-47e1-4bb1-a580-0f054bfaf3a0,2,703,riboflavin,0,Oral,493570,CID493570,both,CC1=CC2=C(C=C1C)N(C3=NC(=O)NC(=O)C3=N2)C[C@H]([C@H]([C@H](CO)O)O)O
LT01481,3878,lamotrigine,1994,Most-DILI-Concern,7,Warnings and precautions,Yes,vMost-DILI-Concern,,Hepatotoxic,,Postive,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=14799df4-c425-4946-9168-9028c1f2e571,2,704,lamotrigine,1,Oral,3878,CID3878,both,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N
LT01486,10917,l-carnitine,1985,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,Negative,C[N+](C)(C)C[C@@H](CC(=O)[O-])O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b2cbc620-59fd-47b6-9e4b-7e3e31533a1c,1,705,l-carnitine,0,Oral,10917,CID10917,both,C[N+](C)(C)C[C@@H](CC(=O)[O-])O
LT01488,149096,levofloxacin,1996,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,non-hepatotixic,,Postive,C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a1684987-d9c6-498b-a2a1-fc5cecc1a52c,2,706,levofloxacin,1,Oral,149096,CID149096,both,C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
LT01489,13109,levonorgestrel,1990,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b1e51bd-4496-4f65-9f1d-40fb2ac5016c,2,707,levonorgestrel,0,Oral,13109,CID13109,both,CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34
LT01492,5362119,lisinopril,1987,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,Postive,C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N[C@@H](CCC2=CC=CC=C2)C(=O)O)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9c52ca06-463b-479f-ad14-48f3d57fea14,2,708,lisinopril,1,Oral,5362119,CID5362119,both,C1C[C@H](N(C1)C(=O)[C@H](CCCCN)N[C@@H](CCC2=CC=CC=C2)C(=O)O)C(=O)O
LT01497,3956,loracarbef,1991,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,NE,,Negative,,C1CC(=C(N2C1C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,http://www.accessdata.fda.gov/drugsatfda_docs/nda/96/050667ap.pdf,2,709,loracarbef,1,Oral,5284585,CID5284585,both,C1CC(=C(N2C1C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl
LT01498,3957,loratadine,1993,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cd21751e-e62f-40f3-a254-f2db7cf9c101,2,710,loratadine,0,Oral,3957,CID3957,both,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1
LT01499,3961,losartan,1995,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,HH,non-hepatotixic,Positive,,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f3b370c-ca97-e0a5-dbd2-870d7c7782cf,2,711,losartan,1,Oral,3961,CID3961,both,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl
LT01501,3964,loxapine,1975,Less-DILI-Concern,5,Adverse reactions,,Ambiguous DILI-concern,,,,,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8920d77-5d6e-4dc3-ad80-8b54861d93f8,2,712,loxapine,0,Oral,3964,CID3964,both,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
LT01508,6179,mebanazine,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,CC(C1=CC=CC=C1)NN,,1,713,mebanazine,1,Oral,6179,CID6179,both,CC(C1=CC=CC=C1)NN
LT01509,4033,mechlorethamine,1949,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,CN(CCCl)CCCl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=00838b4d-c4d4-4277-8f22-6f57d49ade3f,2,714,mechlorethamine,0,Intravenous,4033,CID4033,both,CN(CCCl)CCCl
LT01514,4046,mefloquine,1989,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=09716a24-d7da-42b2-af29-c03a1b6670bd,2,715,mefloquine,1,Oral,4046,CID4046,both,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O
LT01516,14985,vitamin e,,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC1=C(C(=C2CC[C@@](OC2=C1C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6643f2a1-8621-4c01-a242-f491e6eeb2e1,2,716,vitamin e,0,Oral,14985,CID14985,both,CC1=C(C2=C(CC[C@@](O2)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=C1O)C)C
LT01517,4053,melphalan,1964,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,,,,Postive,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ff913271-0090-4832-a0fe-5154fe8f97b9,2,717,melphalan,1,Oral,460612,CID460612,both,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl
LT01521,4064,meprobamate,1955,No-DILI-Concern,0,No match,,vNo-DILI-Concern,HH,,Positive,,CCCC(C)(COC(=O)N)COC(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a27d7877-38e4-4437-afd3-3d570c0dead1,2,718,meprobamate,0,Oral,4064,CID4064,both,CCCC(C)(COC(=O)N)COC(=O)N
LT01525,64778,meropenem,1996,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,Hepatotoxic,,,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3CC[C@H](N3)C(=O)N(C)C)C(=O)O)[C@@H](C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=12714f80-d6e5-4453-b66c-62f57c16ddfc,2,719,meropenem,1,Intravenous,441130,CID441130,both,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3CC[C@H](N3)C(=O)N(C)C)C(=O)O)[C@@H](C)O
LT01532,4100,methazolamide,1959,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b27d92ef-8386-4113-9836-d7c13b6efa2c,2,720,methazolamide,1,Oral,4100,CID4100,both,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C
LT01537,4114,methoxsalen,1954,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae951dc4-9031-43bf-943c-cb2366951f23,2,721,methoxsalen,1,Oral,4114,CID4114,both,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2
LT01545,4158,methylphenidate,1955,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,Postive,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a88218c-5b18-4220-8f56-526de1a276cd,2,722,methylphenidate,1,Oral,4158,CID4158,both,COC(=O)C(C1CCCCN1)C2=CC=CC=C2
LT01547,4120,methylscopolamine bromide,1953,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9607b733-0f3a-4a2c-8057-41d0a5df070d,2,723,methylscopolamine bromide,0,Oral,23724781,CID23724781,both,C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4)C
LT01549,4168,metoclopramide,1979,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2ad82e21-44b6-4a2f-a62f-05ca37347ea5,2,724,metoclopramide,1,Oral,4168,CID4168,both,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl
LT01553,4178,mexiletine,1985,Most-DILI-Concern,3,Box warning,Yes,vMost-DILI-Concern,HH,,Positive,,CC1=C(C(=CC=C1)C)OCC(C)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=693da40b-26d4-40d6-87d1-158e256f40ab,1,725,mexiletine,1,Oral,4178,CID4178,both,CC1=C(C(=CC=C1)C)OCC(C)N
LT01557,4192,midazolam,1985,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,Negative,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=20b0cdfa-e2ed-4df3-9ea8-00cc05319bfa,2,726,midazolam,0,Oral,4192,CID4192,both,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F
LT01558,4195,midodrine,1996,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2b24f75c-539b-4a96-802e-f3cc3b55dae2,2,727,midodrine,0,Oral,4195,CID4195,both,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O
LT01560,4205,mirtazapine,1996,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8b3c5f72-20eb-4e07-9ddf-f4e6b6dfa795,2,728,mirtazapine,1,Oral,4205,CID4205,both,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
LT01564,4211,mitotane,1970,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9fba7d4-a0ec-4bfa-9b5b-ec97a9710fd3,2,729,mitotane,0,Oral,4211,CID4211,both,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl
LT01565,4212,mitoxantrone,1987,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,,Positive,,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=79d6dee4-5927-458d-a8af-228328a37db3,2,730,mitoxantrone,1,Intravenous,4212,CID4212,both,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO
LT01567,91270,moexipril,1995,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC(=C(C=C3C[C@H]2C(=O)O)OC)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5d4078f3-b621-475f-a4e6-005de2e62b32,2,731,moexipril,0,Oral,91270,CID91270,both,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC(=C(C=C3C[C@H]2C(=O)O)OC)OC
LT01574,4260,moxisylyte,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,Postive,CC1=CC(=C(C=C1OC(=O)C)C(C)C)OCCN(C)C,,1,732,moxisylyte,1,Oral,4260,CID4260,both,CC1=CC(=C(C=C1OC(=O)C)C(C)C)OCCN(C)C
LT01580,6037,folic acid,1947,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8fe09f0-b32b-43e3-8de7-ed38593b33b4,1,733,folic acid,0,Oral,135398658,CID135398658,both,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N
LT01581,4409,nabumetone,1991,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cf96d189-5417-4181-a5fb-169b269560a2,2,734,nabumetone,0,Oral,4409,CID4409,both,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC
LT01582,39147,nadolol,1979,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,NE,,Negative,Negative,CC(C)(C)NCC(COC1=CC=CC2=C1C[C@@H]([C@@H](C2)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d208918b-a356-4924-91d9-9593981fe0a6,2,735,nadolol,0,Oral,39147,CID39147,both,CC(C)(C)NCC(COC1=CC=CC2=C1C[C@@H]([C@@H](C2)O)O)O
LT01583,8982,nafcillin,1965,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,WE,,Negative,,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=90717878-64cb-4ffc-90bc-7b4e81e3d1cd,2,736,nafcillin,1,Intravenous,8982,CID8982,both,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O
LT01586,5360630,nalbuphine,1979,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,,C1CC(C1)CN2CC[C@]34C5[C@H](CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=87d32eb5-6806-4aa4-8976-e3ba0fe871df,2,737,nalbuphine,0,Intravenous,5311304,CID5311304,both,C1CC(C1)CN2CC[C@]34C5[C@H](CC[C@]3([C@H]2CC6=C4C(=C(C=C6)O)O5)O)O
LT01594,4472,nialamide,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2,,1,738,nialamide,1,Oral,4472,CID4472,both,C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2
LT01595,4474,nicardipine,1988,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,HH,,Positive,,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b8f147b8-955f-4733-9178-2cfa0beb60d6,2,739,nicardipine,0,Oral,4474,CID4474,both,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC
LT01601,4497,nimodipine,1988,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,HH,,Positive,,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d6a161d9-7e7a-4711-ba0e-c9040c42268d,2,740,nimodipine,0,Oral,4497,CID4497,both,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC
LT01602,3033952,niperotidine,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,CN(C)CC1=CC=C(O1)CSCCN/C(=C\[N+](=O)[O-])/NCC2=CC3=C(C=C2)OCO3,,1,741,niperotidine,1,Oral,3033952,CID3033952,both,CN(C)CC1=CC=C(O1)CSCCN/C(=C\[N+](=O)[O-])/NCC2=CC3=C(C=C2)OCO3
LT01608,4510,nitroglycerin,1981,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5e5ff3a5-9633-55cc-d309-8f06c47a90ef,2,742,nitroglycerin,0,Oral,4510,CID4510,both,C(C(CO[N+](=O)[O-])O[N+](=O)[O-])O[N+](=O)[O-]
LT01611,4528,nomifensine,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,HH,,Positive,Postive,CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3,,1,743,nomifensine,1,Oral,4528,CID4528,both,CN1CC(C2=C(C1)C(=CC=C2)N)C3=CC=CC=C3
LT01614,4539,norfloxacin,1986,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,Postive,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=36087c76-5da9-4fab-e88f-da1d5a579d8e,2,744,norfloxacin,1,Oral,4539,CID4539,both,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O
LT01615,4543,nortriptyline,1964,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,,Positive,,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b58d473a-b19f-4d2a-b1ae-dd398d7a29e1,1,745,nortriptyline,1,Oral,4543,CID4543,both,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31
LT01618,383414,octreotide,1988,Less-DILI-Concern,2,Warnings and precautions,Yes,vLess-DILI-Concern,,,,Postive,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f278f0d8-4062-420a-97c3-3a8b88253a08,2,746,octreotide,1,Intravenous,448601,CID448601,both,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
LT01619,4595,ondansetron,1991,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=91eddc2b-50d6-4f5b-8916-62525fbdc375,2,747,ondansetron,1,Oral,4595,CID4595,both,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C
LT01620,4583,ofloxacin,1990,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,WE,Hepatotoxic,,,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=95b9fc17-9c94-4762-910c-df0bb0b2aa85,2,748,ofloxacin,1,Oral,4583,CID4583,both,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O
LT01623,13505,diphenoxylate,,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2b171be-ac59-48ec-84da-03d3f2d34ca6,2,749,diphenoxylate,0,Oral,13505,CID13505,both,CCOC(=O)C1(CCN(CC1)CCC(C#N)(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4
LT01624,6196,oxacillin,1971,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,Postive,CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f3bee4d7-82d8-4e2d-8fc8-4446e6fbf999,2,750,oxacillin,1,Intravenous,6196,CID6196,both,CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O
LT01629,2131,ambenonium,1956,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC2=CC=CC=C2Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d323d428-97c7-495d-8f65-58b5f0e8afda,2,751,ambenonium,0,Oral,2131,CID2131,both,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC2=CC=CC=C2Cl
LT01637,4680,papaverine,,Most-DILI-Concern,5,Warnings and precautions,Yes(literature),vMost-DILI-Concern,,,,,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9e5e2ce4-7a57-4c61-a826-64c8d11d038e,2,752,papaverine,1,Intravenous,4680,CID4680,both,COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC
LT01644,37464,penbutolol,1987,No-DILI-Concern,0,No match,,vNo-DILI-Concern,HH,,Positive,,CC(C)(C)NC[C@@H](COC1=CC=CC=C1C2CCCC2)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d241fc80-2c55-4dbb-bdb2-44f731afa137,1,753,penbutolol,0,Oral,37464,CID37464,both,CC(C)(C)NC[C@@H](COC1=CC=CC=C1C2CCCC2)O
LT01646,5904,penicillin g,1947,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Negative,,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=012d46f1-d0a0-4676-a879-cd320297ab16,2,754,penicillin g,1,Intravenous,5904,CID5904,both,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C
LT01648,6869,penicillin v,1958,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,Postive,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3111ca84-6f8e-45ea-91a1-9cb99c63607e,2,755,penicillin v,0,Oral,6869,CID6869,both,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C
LT01650,441278,pentazocine,1967,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C[C@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1d225639-c326-4d9e-bc8d-e380e7958b8f,2,756,pentazocine,0,Intravenous,441278,CID441278,both,C[C@H]1[C@H]2CC3=C([C@@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
LT01651,40926,pentostatin,1991,Most-DILI-Concern,3,Box warning,Yes,vMost-DILI-Concern,,,,Negative,C1[C@H](C2=C(NC=N1)N(C=N2)C3CC(C(O3)CO)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=666ae812-b137-4577-9b50-7ba955a03b5b,2,757,pentostatin,1,Intravenous,439693,CID439693,both,C1[C@H](C2=C(NC=N1)N(C=N2)C3CC(C(O3)CO)O)O
LT01655,4748,perphenazine,1957,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0958af4c-87ef-41fd-90a1-ec3e57146945,2,758,perphenazine,1,Oral,4748,CID4748,both,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO
LT01657,3675,phenelzine,1961,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,NE,Hepatotoxic,Negative,,C1=CC=C(C=C1)CCNN,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=afd48e96-a64e-4e5a-ba21-504a53855397,2,759,phenelzine,1,Oral,3675,CID3675,both,C1=CC=C(C=C1)CCNN
LT01666,9294,ephedrine,,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C[C@@H]([C@@H](C1=CC=CC=C1)O)NC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=73b55902-273a-4734-8deb-af6eb68b5523,2,760,ephedrine,0,Intravenous,9294,CID9294,both,C[C@@H]([C@@H](C1=CC=CC=C1)O)NC
LT01672,16362,pimozide,1984,No-DILI-concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fd9729c3-545f-4d34-9bc7-72b61e028fc4,2,761,pimozide,0,Oral,16362,CID16362,both,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F
LT01673,4828,pindolol,1982,No-DILI-concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=05dfb38c-b832-4ae0-b28b-d271008e670b,2,762,pindolol,0,Oral,4828,CID4828,both,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O
LT01675,43672,piperacillin,1981,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,Postive,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fac0c875-111e-4af2-d186-ed4d4ee9de59,2,763,piperacillin,0,Intravenous,43672,CID43672,both,CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=CC=C2)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O
LT01679,5280452,piroxicam,1982,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,Hepatotoxic,Positive,,CN1/C(=C(\NC2=CC=CC=N2)/O)/C(=O)C3=CC=CC=C3S1(=O)=O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3fa3d666-3154-23a7-1c69-915cd6f6a87c,1,764,piroxicam,1,Oral,54676228,CID54676228,both,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3
LT01680,35935,pirprofen,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,HH,Hepatotoxic,Positive,,CC(C1=CC(=C(C=C1)N2CC=CC2)Cl)C(=O)O,,1,765,pirprofen,1,Oral,35935,CID35935,both,CC(C1=CC(=C(C=C1)N2CC=CC2)Cl)C(=O)O
LT01684,5161,salsalate,,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,Postive,C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=64a0968a-c33a-47c0-9f4e-67eac4672584,2,766,salsalate,1,Oral,5161,CID5161,both,C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O
LT01688,4870,polythiazide,1961,Less-DILI-Concern,2,Adverse reactions,,Ambiguous DILI-concern,,,,,CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CSCC(F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=abd6ecf0-dc8e-41de-89f2-1e36ed9d6535,2,767,polythiazide,0,Oral,4870,CID4870,both,CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CSCC(F)(F)F
LT01698,4911,probenecid,1951,Less-DILI-Concern,6,Adverse reactions,,Ambiguous DILI-concern,WE,,Negative,Negative,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9eeedc83-f6cc-4383-83ec-d7992a96b7b4,2,768,probenecid,0,Oral,4911,CID4911,both,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O
LT01699,4913,procainamide,1950,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17e47845-daad-434c-a784-6d3875b0d704,2,769,procainamide,1,Intravenous,4913,CID4913,both,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N
LT01705,4932,propafenone,1989,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,NE,,Negative,Postive,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e4412a6a-ed4d-410d-8abb-86e1d7b72a3c,2,770,propafenone,1,Oral,4932,CID4932,both,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O
LT01706,4946,propranolol,1967,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,NE,non-hepatotixic,Negative,,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ff1404ea-430b-4c79-8ada-576a351c9dc6,1,771,propranolol,0,Oral,4946,CID4946,both,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O
LT01708,4943,propofol,1989,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,NE,,Negative,Postive,CC(C)C1=C(C(=CC=C1)C(C)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b6d54dc1-b73d-43de-ab9e-6c5ae420f683,2,772,propofol,1,Intravenous,4943,CID4943,both,CC(C)C1=C(C(=CC=C1)C(C)C)O
LT01713,708857,pyrantel,,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CN1CCCN=C1/C=C/C2=CC=CS2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8c37db7c-a73e-4d99-a8a9-d55da1a74a3e,2,773,pyrantel,0,Oral,708857,CID708857,both,CN1CCCN=C1/C=C/C2=CC=CS2
LT01716,4993,pyrimethamine,1953,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,,Positive,Postive,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3e4d5027-7939-480f-ae19-82e764d9fa97 ,2,774,pyrimethamine,1,Oral,4993,CID4993,both,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl
LT01721,4999,quazepam,1985,No-DILI-concern,0,No match,,vNo-DILI-Concern,,,,,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6a8e1aff-a1ac-4f47-af33-d2fd23c631d6 ,2,775,quazepam,0,Oral,4999,CID4999,both,C1C(=S)N(C2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F)CC(F)(F)F
LT01723,54892,quinapril,1991,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,Postive,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=894aff93-5dfa-3012-73dc-9270bead34b2,2,776,quinapril,1,Oral,54892,CID54892,both,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3=CC=CC=C3C[C@H]2C(=O)O
LT01725,441074,quinidine,1950,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,HH,Hepatotoxic,Positive,,COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a90a03b0-ffbe-4cf6-90b5-bfb0412a1cb2,2,777,quinidine,1,Oral,441074,CID441074,both,COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O
LT01726,5362129,ramipril,1991,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=245d3580-77c6-4c0f-b324-c8514b792c59,2,778,ramipril,1,Oral,5362129,CID5362129,both,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O
LT01729,5770,reserpine,1955,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3a4d74d7-2e63-4789-b50e-af17ced92462,2,779,reserpine,0,Oral,5770,CID5770,both,CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC
LT01730,37542,ribavirin,1985,Less-DILI-Concern,7,Adverse reactions,,Ambiguous DILI-concern,WE,,Negative,,C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f59980f4-8103-45ea-9643-13a133e14415,1,780,ribavirin,0,Oral,37542,CID37542,both,C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N
LT01731,5070,riluzole,1995,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,,Positive,,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e49d207d-8e32-4183-94ba-cd264f124090,2,781,riluzole,1,Oral,5070,CID5070,both,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N
LT01735,5073,risperidone,1993,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a0a21bec-68f0-444e-a611-d0602859410c,2,782,risperidone,1,Oral,5073,CID5073,both,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F
LT01737,392622,ritonavir,1996,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,,Positive,,CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2849298e-de6e-47bb-8194-56e075b33fc3,1,783,ritonavir,1,Oral,392622,CID392622,both,CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O
LT01746,60787,saquinavir,1995,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,,Positive,,CC(C)(C)NC(=O)[C@@H]1CC2CCCCC2CN1C[C@H]([C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c00d1607-ac36-457b-a34b-75ad74f9cf0a,1,784,saquinavir,1,Oral,441243,CID441243,both,CC(C)(C)NC(=O)[C@@H]1CC2CCCCC2CN1C[C@H]([C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O
LT01749,26757,selegiline,1989,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,,C[C@H](CC1=CC=CC=C1)N(C)CC#C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59c9bf80-b46e-e302-4eb7-4f751ecd1fee,2,785,selegiline,0,Oral,26757,CID26757,both,C[C@H](CC1=CC=CC=C1)N(C)CC#C
LT01766,9354,succimer,1991,Less-DILI-Concern,2,Warnings and precautions,Yes,vLess-DILI-Concern,,,,Postive,C(C(C(=O)O)S)(C(=O)O)S,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0103deca-7f23-40bf-bf39-b89b16b599b2,2,786,succimer,1,Oral,2724354,CID2724354,both,C(C(C(=O)O)S)(C(=O)O)S
LT01779,5358,sumatriptan,1992,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,NE,,Negative,,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=584abe73-8290-4484-ff8e-5890831c095e,2,787,sumatriptan,0,Oral,5358,CID5358,both,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C
LT01785,5391,temazepam,1981,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce2748a3-72ab-407a-ac63-86ce1a126e18,2,788,temazepam,0,Oral,5391,CID5391,both,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3
LT01786,34698,teniposide,1992,Less-DILI-Concern,3,Warnings and precautions,Yes(literature),vLess-DILI-Concern,,,,,COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)O[C@H]6[C@@H]([C@H]([C@H]7[C@H](O6)COC(O7)C8=CC=CS8)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3231dc15-5ce2-cf61-7d1f-bd86704269ae,2,789,teniposide,1,Intravenous,452548,CID452548,both,COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)O[C@H]6[C@@H]([C@H]([C@H]7[C@H](O6)COC(O7)C8=CC=CS8)O)O
LT01787,5401,terazosin,1987,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=21c6bec7-4767-4113-8561-38497dae50d0,2,790,terazosin,0,Oral,5401,CID5401,both,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC
LT01804,5453,thiotepa,1959,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,,C1CN1P(=S)(N2CC2)N3CC3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89a11272-62a6-45d6-9ace-ea55de178dc3,2,791,thiotepa,1,Intravenous,5453,CID5453,both,C1CN1P(=S)(N2CC2)N3CC3
LT01815,33624,timolol,1978,Less-DILI-Concern,5,Adverse reactions,,Ambiguous DILI-concern,HH,,Positive,Negative,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=57c62928-63d8-4505-9b9e-c085a3a12c95,2,792,timolol,0,Oral,33624,CID33624,both,CC(C)(C)NC[C@@H](COC1=NSN=C1N2CCOCC2)O
LT01816,5354,suloctidil,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,CCCCCCCCNC(C)C(C1=CC=C(C=C1)SC(C)C)O,,1,793,suloctidil,1,Oral,5354,CID5354,both,CCCCCCCCNC(C)C(C1=CC=C(C=C1)SC(C)C)O
LT01820,5509,tolmetin,1976,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,,CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=332731f4-6625-4b6c-9d8f-36e8a11d2d0d,2,794,tolmetin,1,Oral,5509,CID5509,both,CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)O
LT01822,53359,tolrestat,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,Positive,,CN(CC(=O)O)C(=S)C1=CC=CC2=C1C=CC(=C2C(F)(F)F)OC,,1,795,tolrestat,1,Oral,53359,CID53359,both,CN(CC(=O)O)C(=S)C1=CC=CC2=C1C=CC(=C2C(F)(F)F)OC
LT01824,60700,topotecan,1996,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=140399d0-4b28-4100-b792-3d1aa3c3e29c,2,796,topotecan,0,Oral,60700,CID60700,both,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O
LT01827,33741,tramadol,1995,Less-DILI-Concern,7,Adverse reactions,,Ambiguous DILI-concern,,,,Negative,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=485af94f-5ecd-4f25-9774-61ce4cff0921,2,797,tramadol,0,Oral,33741,CID33741,both,CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O
LT01828,5484727,trandolapril,1996,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCCC[C@@H]3C[C@H]2C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8143a6cf-dadc-4ef7-a8db-d16d7150ad34,2,798,trandolapril,1,Oral,5484727,CID5484727,both,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCCC[C@@H]3C[C@H]2C(=O)O
LT01829,441233,tranylcypromine,1961,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,NE,,Negative,,C1[C@H](C1C2=CC=CC=C2)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2e7350bd-ab32-4619-a3f9-12fdf56fc5e2,2,799,tranylcypromine,1,Oral,19493,CID19493,both,C1[C@H](C1C2=CC=CC=C2)N
LT01830,5533,trazodone,1981,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4006d439-e2de-4590-82e9-fc9d56e3ec1b,1,800,trazodone,1,Oral,5533,CID5533,both,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl
LT01833,5546,triamterene,1964,Less-DILI-Concern,5,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C1=CC=C(C=C1)C2=NC3=C(N=C2N)N=C(N=C3N)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5012f997-9fb2-4c3d-99fd-4f7efd7c39af,2,801,triamterene,1,Oral,5546,CID5546,both,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N
LT01834,5556,triazolam,1982,Less-DILI-Concern,4,Adverse reactions,,Ambiguous DILI-concern,,,,,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=db564864-17fc-4ba5-a438-a467ef57a0ca,2,802,triazolam,0,Oral,5556,CID5556,both,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl
LT01839,5572,trihexyphenidyl,1949,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a84452ff-6da1-4315-b850-4ce46829f2da,2,803,trihexyphenidyl,0,Oral,5572,CID5572,both,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O
LT01841,5577,trimethobenzamide,1974,Less-DILI-Concern,5,Adverse reactions,,Ambiguous DILI-concern,HH,,Positive,,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C(=C2)OC)OC)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=34cd4cf0-5990-48b3-10ec-206e2e33f7fe,2,804,trimethobenzamide,0,Oral,5577,CID5577,both,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C(=C2)OC)OC)OC
LT01842,5578,trimethoprim,1980,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,HH,non-hepatotixic,Positive,Postive,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24daed1d-d20b-4b39-bfa3-efaf05c00380,2,805,trimethoprim,1,Oral,5578,CID5578,both,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N
LT01846,28858,fenclozic acid,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,C1=CC(=CC=C1C2=NC(=CS2)CC(=O)O)Cl,,1,806,fenclozic acid,1,Oral,28858,CID28858,both,C1=CC(=CC=C1C2=NC(=CS2)CC(=O)O)Cl
LT01849,65869,ebrotidine,,Most-DILI-Concern,8,Withdrawn,Yes,vMost-DILI-Concern,,,,,C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br,,1,807,ebrotidine,1,Oral,65869,CID65869,both,C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br
LT01853,71771,aceclofenac,,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,,,,,C1=CC=C(C(=C1)CC(=O)OCC(=O)O)NC2=C(C=CC=C2Cl)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8a023942-01e8-4849-aa3c-1a640ffc7fd3,2,808,aceclofenac,1,Oral,71771,CID71771,both,C1=CC=C(C(=C1)CC(=O)OCC(=O)O)NC2=C(C=CC=C2Cl)Cl
LT01854,71900,nitrefazole,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,CC1=NC(=CN1C2=CC=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,1,809,nitrefazole,1,Oral,71900,CID71900,both,CC1=NC(=CN1C2=CC=C(C=C2)[N+](=O)[O-])[N+](=O)[O-]
LT01856,60773,valaciclovir,1995,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,Postive,CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2d38cbdb-4e4d-4174-461d-7a3b6475e6a5,2,810,valaciclovir,1,Oral,135398742,CID135398742,both,CC(C)[C@@H](C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N
LT01857,60846,valsartan,1996,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,WE,non-hepatotixic,Negative,Postive,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5ddba454-f3e6-43c2-a7a6-58365d297213,2,811,valsartan,1,Oral,60846,CID60846,both,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O
LT01858,114965,tetrabamate,,Most-DILI-Concern,8,Withdrawn,Yes,vMost-DILI-Concern,,,,,CCCCOCC(CN1C(=O)C(C(=O)NC1=O)(CC)C2=CC=CC=C2)OC(=O)N.CCCCOCC(CN1C(=O)C(C(=O)N(C1=O)CC(COCCCC)OC(=O)N)(CC)C2=CC=CC=C2)OC(=O)N.CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,,1,812,tetrabamate,1,Oral,57394584,CID57394584,both,CCCCOCC(CN1C(=O)C(C(=O)NC1=O)(CC)C2=CC=CC=C2)OC(=O)N.CCCCOCC(CN1C(=O)C(C(=O)N(C1=O)CC(COCCCC)OC(=O)N)(CC)C2=CC=CC=C2)OC(=O)N.CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2
LT01862,5978,vincristine,1963,Less-DILI-Concern,8,Adverse reactions,Yes,vLess-DILI-Concern,HH,,Positive,,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=01cee93f-3ab9-44fa-8c9a-dd5958fd2db9,2,813,vincristine,1,Intravenous,5978,CID5978,both,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O
LT01867,239062,xenazoic acid,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,CCOC(C(=O)C1=CC=C(C=C1)C2=CC=CC=C2)NC3=CC=C(C=C3)C(=O)O,,1,814,xenazoic acid,1,Oral,239062,CID239062,both,CCOC(C(=O)C1=CC=C(C=C1)C2=CC=CC=C2)NC3=CC=C(C=C3)C(=O)O
LT01869,5717,zafirlukast,1996,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,Hepatotoxic,Positive,Postive,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5550433b-8c9c-4378-058f-6bb724c4f18c,1,815,zafirlukast,1,Oral,5717,CID5717,both,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC
LT01870,6918508,falnidamol ,,Most-DILI-Concern,8,Discontinued,,vMost-DILI-Concern,,,,,CN1CCC(CC1)NC2=NC=C3C(=N2)C(=NC=N3)NC4=CC(=C(C=C4)F)Cl,,1,816,falnidamol,1,Oral,6918508,CID6918508,both,CN1CCC(CC1)NC2=NC=C3C(=N2)C(=NC=N3)NC4=CC(=C(C=C4)F)Cl
LT01874,41987,zimelidine,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,CN(C)CC=C(C1=CC=C(C=C1)Br)C2=CN=CC=C2,,1,817,zimelidine,1,Oral,5365247,CID5365247,both,CN(C)CC=C(C1=CC=C(C=C1)Br)C2=CN=CC=C2
LT01888,2519,caffeine,1999,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,non-hepatotixic,Negative,,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fbcd234e-57e1-4da2-a96c-e3f7b7cf6ec0,2,818,caffeine,0,Intravenous,2519,CID2519,both,CN1C=NC2=C1C(=O)N(C(=O)N2C)C
LT01889,3000502,capreomycin,1971,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,NE,,,,C[C@H]1C(=O)N[C@H](C(=O)N/C(=C/NC(=O)N)/C(=O)N[C@H](C(=O)NC[C@@H](C(=O)N1)N)[C@H]2CCN=C(N2)N)CNC(=O)C[C@H](CCCN)N.C1CN=C(N[C@H]1[C@H]2C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N/C(=C/NC(=O)N)/C(=O)N2)CNC(=O)C[C@H](CCCN)N)CO)N)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=808e4421-2b9c-41e1-a82c-39256b112ae8,2,819,capreomycin,0,Intravenous,135483770,CID135483770,both,C[C@H]1C(=O)N[C@H](C(=O)N/C(=C/NC(=O)N)/C(=O)N[C@H](C(=O)NC[C@@H](C(=O)N1)N)[C@H]2CCN=C(N2)N)CNC(=O)C[C@H](CCCN)N.C1CN=C(N[C@H]1[C@H]2C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N/C(=C/NC(=O)N)/C(=O)N2)CNC(=O)C[C@H](CCCN)N)CO)N)N
LT01905,3676,lidocaine,1948,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=165845cf-c59c-4dbe-af8f-ecb92a1fcdc6,2,820,lidocaine,0,Oral,3676,CID3676,both,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C
LT01908,4054,memantine,2003,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,NE,,Negative,,CC12CC3CC(C1)(CC(C3)(C2)N)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=17b61eb2-2498-4d2e-9e1f-b0c2c21c9347,2,821,memantine,1,Oral,4054,CID4054,both,CC12CC3CC(C1)(CC(C3)(C2)N)C
LT01916,4674,pamidronate,1991,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,NE,non-hepatotixic,,,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ebd26191-b497-4904-b158-ca3b0bcd178b,2,822,pamidronate,0,Intravenous,4674,CID4674,both,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O
LT01923,8549,quinine,2005,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,,Positive,,COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3CC4CCN3C[C@@H]4C=C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce2ffee3-3048-43a0-ac45-ee32ce0c4c33,2,823,quinine,1,Oral,3034034,CID3034034,both,COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3CC4CCN3C[C@@H]4C=C)O
LT01928,6439133,rosuvastatin,2003,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,Postive,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb0f3b5e-4bc6-41c9-66b9-6257e2513512,2,824,rosuvastatin,1,Oral,446157,CID446157,both,CC(C)C1=NC(=NC(=C1/C=C/[C@@H](C[C@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
LT01933,5328,sulfamethizole,1953,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,HH,,Positive,,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=be27854a-a805-4300-9729-accd1b7f226f,2,825,sulfamethizole,1,Oral,5328,CID5328,both,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N
LT01944,5462516,telithromycin,2004,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,HH,,Positive,Postive,CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ba1cca98-f350-4655-88e3-6ef990779fb9,2,826,telithromycin,1,Oral,3002190,CID3002190,both,CC[C@@H]1[C@@]2([C@@H]([C@H](C(=O)[C@@H](C[C@]([C@@H]([C@H](C(=O)[C@H](C(=O)O1)C)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C
LT01968,5281081,entacapone,1999,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,WE,,Negative,,CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=01ea62f4-bfac-485a-bb4b-a9abb345749f,2,827,entacapone,1,Oral,5281081,CID5281081,both,CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N
LT01971,119607,valdecoxib,2001,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,Postive,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=caf64301-262c-45ca-acd1-a9d6696c584e,2,828,valdecoxib,1,Oral,119607,CID119607,both,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
LT01972,4678,dexpanthenol,,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,Negative,CC(C)(CO)C(C(=O)NCCCO)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0ed47f4b-5182-40b7-a440-9e7b06819d95,2,829,dexpanthenol,0,Intravenous,131204,CID131204,both,CC(C)(CO)C(C(=O)NCCCO)O
LT01974,5184,scopolamine,1979,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b85b3ca0-89ce-44fe-b748-62e160e8c349,2,830,scopolamine,0,Intravenous,3000322,CID3000322,both,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4
LT01980,1054,pyridoxine,1972,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,Negative,Negative,CC1=NC=C(C(=C1O)CO)CO,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a56d11c0-b033-4201-85ff-fc710506481a,2,831,pyridoxine,0,Intravenous,1054,CID1054,both,CC1=NC=C(C(=C1O)CO)CO
LT01981,1130,thiamine,1972,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ca4899c6-cea1-48d6-b0ae-9efcf67f6fcb,2,832,thiamine,0,Intravenous,1130,CID1130,both,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO
LT02002,5462245,cyanocobalamin,1949,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,,,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3C(C([C@@H](O3)CO)OP(=O)(O)OC(C)CNC(=O)CC[C@@]\4([C@H](C5[C@]6([C@@]([C@@H](C(=N6)/C(=C\7/[C@@]([C@@H](C(=N7)/C=C\8/C([C@@H](C(=N8)/C(=C4\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acff4ff3-4435-4995-a117-dbfcdf72334a,1,833,cyanocobalamin,0,Subcutaneous,5311498,CID5311498,both,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3C(C([C@@H](O3)CO)OP(=O)(O)OC(C)CNC(=O)CC[C@@]\4([C@H](C5[C@]6([C@@]([C@@H](C(=N6)/C(=C\7/[C@@]([C@@H](C(=N7)/C=C\8/C([C@@H](C(=N8)/C(=C4\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3]
LT02004,27686,cromoglicate,1982,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,NE,non-hepatotixic,Negative,,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=813b30e9-cfc3-4e21-a4e4-852ed9fd8b5a,1,834,cromoglicate,1,Oral,2882,CID2882,both,C1=CC2=C(C(=C1)OCC(COC3=CC4=C(C=C3)OC(=CC4=O)C(=O)O)O)C(=O)C=C(O2)C(=O)O
LT02007,5281040,montelukast,1998,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,WE,non-hepatotixic,Negative,,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4eabe2b1-7f4d-4720-bf70-191e6df67c79,1,835,montelukast,1,Oral,5281040,CID5281040,both,CC(C)(C1=CC=CC=C1CC[C@H](C2=CC=CC(=C2)/C=C/C3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O
LT02008,152946,moxifloxacin,1999,Less-DILI-Concern,8,Adverse reactions,Yes,vLess-DILI-Concern,,,,Postive,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=56b4f979-bf20-4908-9d7c-5536221d77f8,2,836,moxifloxacin,1,Oral,152946,CID152946,both,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O
LT02009,54678501,vitamin c,,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,Negative,C([C@@H](C1C(=C(C(=O)O1)O)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a6c36a36-28ee-4a1b-86fe-98ef94064b68,2,837,vitamin c,0,Intravenous,54670067,CID54670067,both,C([C@@H](C1C(=C(C(=O)O1)O)O)O)O
LT02010,82170,sorbitol,1978,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,C([C@H]([C@@H]([C@H]([C@H](CO)O)O)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6285e38c-40bf-415d-bf68-68b38e318ab5,2,838,sorbitol,0,Oral,5780,CID5780,both,C([C@H]([C@@H]([C@H]([C@H](CO)O)O)O)O)O
LT02018,60953,capecitabine,1998,Less-DILI-Concern,2,Warnings and precautions,,Ambiguous DILI-concern,,,,,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6b76b5bb-1d69-43f9-99c6-f39a0b6d8a26,2,839,capecitabine,0,Oral,60953,CID60953,both,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O
LT02019,3911,leuprolide,1985,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,non-hepatotixic,,,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=28a7b3ee-d0b9-499e-b5f1-7f69a552c4ee,2,840,leuprolide,1,Subcutaneous,657181,CID657181,both,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
LT02024,77993,eletriptan,2002,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CN1CCC[C@@H]1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=85745375-fcb6-4edc-b6db-a77b4a5f3e8c,2,841,eletriptan,0,Oral,77993,CID77993,both,CN1CCC[C@@H]1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4
LT02026,3652,hydroxychloroquine,1955,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,,,,Postive,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=71a8ea7d-e71d-4b71-871e-b592dd7ad047,2,842,hydroxychloroquine,1,Oral,3652,CID3652,both,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO
LT02033,9574101,ximelagatran,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,Positive,,CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N2CC[C@H]2C(=O)NCC3=CC=C(C=C3)/C(=N/O)/N,,1,843,ximelagatran,1,Oral,9574101,CID9574101,both,CCOC(=O)CN[C@H](C1CCCCC1)C(=O)N2CC[C@H]2C(=O)NCC3=CC=C(C=C3)/C(=N/O)/N
LT02035,60835,duloxetine,2004,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,,,Postive,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2f7d4d67-10c1-4bf4-a7f2-c185fbad64ba,2,844,duloxetine,1,Oral,60835,CID60835,both,CNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
LT02037,2576,carisoprodol,1959,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CCCC(C)(COC(=O)N)COC(=O)NC(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=76a36c15-38d3-442e-84a0-b0649a213d13,2,845,carisoprodol,0,Oral,2576,CID2576,both,CCCC(C)(COC(=O)N)COC(=O)NC(C)C
LT02041,18381,dicloxacillin,1968,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,,Positive,Postive,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8478f242-c715-4984-ac1d-dc79dc28665e,2,846,dicloxacillin,1,Oral,18381,CID18381,both,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O
LT02046,4170,metolazone,1973,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,HH,,Positive,,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4813f476-3637-4f0f-abdd-c76c4074f8ae,2,847,metolazone,0,Oral,4170,CID4170,both,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl
LT02055,11806,pamabrom,,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(C)(CO)N.CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Br,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=22122002-c367-480b-b9f5-0504f918cc98,2,848,pamabrom,0,Oral,11806,CID11806,both,CC(C)(CO)N.CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Br
LT02056,5360696,dextromethorphan,1982,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5daa0727-02ba-4f8e-86a9-2286716648bc,2,849,dextromethorphan,0,Oral,5360696,CID5360696,both,CN1CC[C@@]23CCCC[C@@H]2[C@@H]1CC4=C3C=C(C=C4)OC
LT02059,439542,bacitracin,1948,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,CCC(C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H](C(C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)C2CN=C(S2)[C@H](C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=746cdb33-65cb-49db-8642-5bdda7b30de6,1,850,bacitracin,0,Intramuscular,439542,CID439542,both,CCC(C)[C@H]1C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)NCCCC[C@@H](C(=O)N[C@@H](C(=O)N1)CCCN)NC(=O)[C@H](C(C)CC)NC(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)C2CN=C(S2)[C@H](C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4
LT02061,165580,paromomycin,1969,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=22494bde-a53e-4b3c-a89b-0ccda341f28f,1,851,paromomycin,0,Oral,165580,CID165580,both,C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)N)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O[C@@H]4[C@@H]([C@H]([C@@H]([C@@H](O4)CN)O)O)N)O)O)N
LT02063,65999,telmisartan,1998,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,WE,,Negative,,CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cfb9309f-e0df-4a55-9542-0e869fce05fb,2,852,telmisartan,1,Oral,65999,CID65999,both,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C
LT02067,25517,ammonium chloride,1978,No-DILI-concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,[NH4+].[Cl-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=20931ed8-62d9-4988-819f-31fc4711cd3e,2,853,ammonium chloride,0,Intravenous,25517,CID25517,both,[NH4+].[Cl-]
LT02070,16231,amiloride,1981,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,NE,,Negative,Postive,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=135f9cb8-17b6-e99a-57c3-2d992eddb8ef,2,854,amiloride,1,Oral,16231,CID16231,both,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N
LT02072,9681,methysergide,1962,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3fae28ee-700e-4d4f-a040-02ef01a2aeb4,1,855,methysergide,0,Oral,9681,CID9681,both,CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C
LT02074,8226,methylergonovine,1946,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fde7483c-1c37-43f0-b905-c68fcc05a6fd,2,856,methylergonovine,0,Oral,8226,CID8226,both,CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C
LT02076,6834,brompheniramine,1957,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,Negative,,CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=74b92bdf-5447-4932-a265-39891a4557a4,2,857,brompheniramine,0,Oral,6834,CID6834,both,CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2
LT02077,6322,l-arginine,1973,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,C(C[C@@H](C(=O)O)N)CN=C(N)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6accf33f-9841-4327-8923-93c42020ef12,2,858,l-arginine,0,Intravenous,6322,CID6322,both,C(C[C@@H](C(=O)O)N)CN=C(N)N
LT02081,4991,pyridostigmine,1955,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,non-hepatotixic,Negative,,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6f9eafd2-753d-457a-a1c5-4af4b39f9ef3,2,859,pyridostigmine,0,Oral,4991,CID4991,both,C[N+]1=CC=CC(=C1)OC(=O)N(C)C
LT02082,4768,phenoxybenzamine,1953,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,non-hepatotixic,Negative,Negative,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4fcdf9ca-78a8-4e4b-958e-2f795bbbf9ca,1,860,phenoxybenzamine,0,Oral,4768,CID4768,both,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2
LT02084,4634,oxybutynin,1975,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,non-hepatotixic,Negative,Negative,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=36cc9115-bef3-48fa-93ff-bcda24cf26e2,1,861,oxybutynin,0,Oral,4634,CID4634,both,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
LT02085,4601,orphenadrine,1957,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,non-hepatotixic,Negative,,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8408d24e-3948-548d-bb12-b1edf0c05e12,2,862,orphenadrine,0,Oral,4601,CID4601,both,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C
LT02087,3955,loperamide,1976,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5c4a072e-88e6-4c35-adf2-fe81f3bcf4c9,2,863,loperamide,0,Oral,3955,CID3955,both,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4
LT02089,3783,isoxsuprine,,No-DILI-concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e6582e24-9414-43b8-ac6f-b1422e3197cf,2,864,isoxsuprine,0,Oral,3783,CID3783,both,CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O
LT02092,3474,glafenine,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,HH,Hepatotoxic,Positive,,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC(=CC3=NC=C2)Cl,,1,865,glafenine,1,Oral,3474,CID3474,both,C1=CC=C(C(=C1)C(=O)OCC(CO)O)NC2=C3C=CC(=CC3=NC=C2)Cl
LT02096,187,acetylcholine chloride,1973,No-DILI-concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,CC(=O)OCC[N+](C)(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=076587d3-46a0-48e5-9425-f5e1f5847ee3,2,866,acetylcholine chloride,0,Oral,6060,CID6060,both,CC(=O)OCC[N+](C)(C)C
LT02100,3007,amphetamine,1976,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,,,,Postive,CC(CC1=CC=CC=C1)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb12811f-4cce-4010-aa48-d17c46ca1d3a,2,867,amphetamine,1,Oral,3007,CID3007,both,CC(CC1=CC=CC=C1)N
LT02110,6075,mepazine,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,CN1CCCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42,,1,868,mepazine,1,Oral,6075,CID6075,both,CN1CCCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42
LT02121,9904,nandrolone decanoate,1959,Most-DILI-Concern,7,Warnings and precautions,Yes(literature),vMost-DILI-Concern,,,,,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@H]34,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3f059e04-1ebc-40bb-a49c-f9d90d41b1cb,2,869,nandrolone decanoate,1,Intramuscular,9677,CID9677,both,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@H]34
LT02166,6918453,auranofin,1985,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,HH,,Positive,,CCP(CC)CC.CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=05c34ddf-a0f7-4267-83f5-d02be3defc37,2,870,auranofin,1,Oral,24199313,CID24199313,both,CCP(CC)CC.CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+]
LT02171,6433516,simethicone,1998,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CO[Si](C)(C)O[Si](C)(C)C.O=[Si]=O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9c6270d6-6456-42a6-9840-156e6c4683aa,2,871,simethicone,0,Oral,6433516,CID6433516,both,CO[Si](C)(C)O[Si](C)(C)C.O=[Si]=O
LT02189,247,betaine,1996,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,,C[N+](C)(C)CC(=O)[O-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=84f7c21f-d0af-4ae6-9cd5-d5af96ade329,1,872,betaine,0,Oral,247,CID247,both,C[N+](C)(C)CC(=O)[O-]
LT02190,2391,bisacodyl,,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9448e8ba-b73a-4d2a-b58c-afdcd19f8e12,2,873,bisacodyl,0,Oral,2391,CID2391,both,CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3
LT02192,54575,leucovorin,1952,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,Negative,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@H](CCC(=O)O)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=94669fc8-3c1c-4228-be27-09a1cd468c36,2,874,leucovorin,0,Oral,135403648,CID135403648,both,C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
LT02204,208908,lapatinib,2007,Most-DILI-Concern,8,Box warning,Yes,vMost-DILI-Concern,,,Positive,Postive,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=63319b01-cad6-4d0a-c39b-938fa951a808,1,875,lapatinib,1,Oral,208908,CID208908,both,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl
LT02210,65028,oseltamivir,1999,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee3c9555-60f2-4f82-a760-11983c86e97b,1,876,oseltamivir,0,Oral,65028,CID65028,both,CCC(CC)O[C@@H]1C=C(C[C@@H]([C@H]1NC(=O)C)N)C(=O)OCC
LT02213,2081,alaproclate,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N,,1,877,alaproclate,1,Oral,2081,CID2081,both,CC(C(=O)OC(C)(C)CC1=CC=C(C=C1)Cl)N
LT02216,3034010,orlistat,1999,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,,,Postive,CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5bbdc95b-82a1-4ba5-8185-6504ff68cc06,1,878,orlistat,1,Oral,3034010,CID3034010,both,CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
LT02217,6005,apomorphine,2004,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CN1CCC2=CC=CC3=C2[C@H]1CC4=C3C(=C(C=C4)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3235535d-9ef9-4657-8b2a-176a807d091c,2,879,apomorphine,0,Subcutaneous,6005,CID6005,both,CN1CCC2=C3[C@H]1CC4=C(C3=CC=C2)C(=C(C=C4)O)O
LT02218,10531,dihydroergotamine,1946,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,Negative,C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fe826e6a-75c8-43ed-9c36-f8263ec35aff,1,880,dihydroergotamine,0,Intravenous,10531,CID10531,both,C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C
LT02219,4919,procyclidine,1955,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1CCC(CC1)C(CCN2CCCC2)(C3=CC=CC=C3)O,http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/009818s018lbl.pdf,1,881,procyclidine,0,Oral,4919,CID4919,both,C1CCC(CC1)C(CCN2CCCC2)(C3=CC=CC=C3)O
LT02222,26987,clemastine,1977,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,non-hepatotixic,Negative,,C[C@@](C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCC[C@H]3CCCN3C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b7e88fa7-fa92-48be-86ab-7e375d710251,1,882,clemastine,0,Oral,26987,CID26987,both,C[C@@](C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCC[C@H]3CCCN3C
LT02224,464205,tenofovir,2001,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,,C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e122435e-cd0b-4c90-940a-b7a0d090d866,1,883,tenofovir,1,Oral,464205,CID464205,both,C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O
LT02269,541197,norethindrone acetate,1982,No-DILI-concern,0,No match,,vNo-DILI-Concern,,,,,CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=69f5bc4b-758d-471b-ad8d-17c94f8e0963 ,2,884,norethindrone acetate,0,Oral,5832,CID5832,both,CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C
LT02329,9552071,exametazime,,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C[C@@H](NCC(CN[C@@H](/C(=N/O)/C)C)(C)C)/C(=N/O)/C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6ea1fd48-c649-4e05-856e-bb123ce40a3f,2,885,exametazime,0,Intravenous,9552071,CID9552071,both,C[C@@H](NCC(CN[C@@H](/C(=N/O)/C)C)(C)C)/C(=N/O)/C
LT02331,8230,Argipressin,,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=977ab16e-c2c1-4aa2-98cb-af065b37c944,2,887,Argipressin,0,Intravenous,644077,CID644077,both,C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)N)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
LT02337,516892,sodium bicarbonate,2005,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C(=O)(O)[O-].[Na+],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=77698221-a01d-4568-a7bc-d3d4e982875d,2,888,sodium bicarbonate,0,Intravenous,516892,CID516892,both,C(=O)(O)[O-].[Na+]
LT02340,65015,plerixafor,2008,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a56b1b78-0ae2-41b4-9c76-98ad9d439199,2,889,plerixafor,0,Subcutaneous,65015,CID65015,both,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3
LT02356,5610,tyramine,,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1=CC(=CC=C1CCN)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=81ffe61c-2b0c-4a56-b02b-8463300e218e,2,890,tyramine,0,Oral,5610,CID5610,both,C1=CC(=CC=C1CCN)O
LT02382,24846132,Hetastarch,,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=82f0c87e-57f1-4ffb-8d55-f2ff999d5788,2,891,Hetastarch,0,Intravenous,24846132,CID24846132,both,CC1C(C(C(C(O1)CO)OC2C(C(C(C(O2)COC3C(C(C(C(O3)CO)OC)O)O)OC4C(C(C(C(O4)CO)OC)O)OCCO)O)O)O)O
LT02404,91754427,gadolinium ethoxybenzyl DTPA,2008,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6218b1e1-cbc3-4c14-bec7-528ac163a561,2,894,gadolinium ethoxybenzyl DTPA,0,Intravenous,91754427,CID91754427,both,CCOC1=CC=C(C=C1)CC(CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Gd+3]
LT02437,143,Levoleucovorin,2008,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=49be5b16-dab5-4a95-b202-bfb13d730d83,2,896,Levoleucovorin,0,Intravenous,135398559,CID135398559,both,C1[C@@H](N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
LT02442,15341110,levomefolate calcium,,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,CN1[C@H](CNC2=C1C(=O)N=C(N2)N)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-].[Ca+2],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=621608cc-9842-4765-9bff-2c19a2370b0e,2,897,levomefolate calcium,0,Oral,135564391,CID135564391,both,CN1[C@H](CNC2=C1C(=O)NC(=N2)N)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)[O-])C(=O)[O-].[Ca+2]
LT02449,216235,sitaxsentan,,Most-DILI-Concern,8,Withdrawn,,vMost-DILI-Concern,,,,,CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)NC4=C(C(=NO4)C)Cl)OCO2,,2,898,sitaxsentan,1,Oral,216235,CID216235,both,CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)NC4=C(C(=NO4)C)Cl)OCO2
LT02909,154101,dexmethylphenidate,2001,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,,,,,COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=694ebbf3-966b-4c0d-8d3c-ed95ee0dc8cb ,2,899,dexmethylphenidate,1,Oral,154101,CID154101,both,COC(=O)[C@@H]([C@H]1CCCCN1)C2=CC=CC=C2
,5790,Floxuridine,,,,,,,,,,,,,,902,Floxuridine,1,Intra-arterial,5790,CID5790,right_only,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)F)CO)O
,21319,Flucloxacillin,,,,,,,,,,,,,,903,Flucloxacillin,1,oral,21319,CID21319,right_only,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O
,3562,Halothane,,,,,,,,,,,,,,904,Halothane,1,Respiratory (inhalation),3562,CID3562,right_only,C(C(F)(F)F)(Cl)Br
,1989,Acetohexamide,,,,,,,,,,,,,,907,Acetohexamide,1,oral,1989,CID1989,right_only,CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2
,216210,Dabigatran,,,,,,,,,,,,,,908,Dabigatran,1,oral,216210,CID216210,right_only,CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N
,3475,Gliclazide,,,,,,,,,,,,,,909,Gliclazide,1,Oral,3475,CID3475,right_only,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2
,104838,Imipenem,,,,,,,,,,,,,,910,Imipenem,1,Intravenous,104838,CID104838,right_only,C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O
,92727,Lopinavir,,,,,,,,,,,,,,911,Lopinavir,1,Oral,92727,CID92727,right_only,CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)N4CCCNC4=O)O
,23897,Molindone,,,,,,,,,,,,,,912,Molindone,1,Oral,23897,CID23897,right_only,CCC1=C(NC2=C1C(=O)C(CC2)CN3CCOCC3)C
,163659,Plicamycin,,,,,,,,,,,,,,913,Plicamycin,1,,163659,CID163659,right_only,C[C@@H]1[C@H]([C@@H](C[C@@H](O1)O[C@@H]2C[C@@H](O[C@@H]([C@H]2O)C)OC3=CC4=CC5=C(C(=O)[C@H]([C@@H](C5)[C@@H](C(=O)[C@H]([C@@H](C)O)O)OC)O[C@H]6C[C@H]([C@@H]([C@H](O6)C)O)O[C@H]7C[C@H]([C@H]([C@H](O7)C)O)O[C@H]8C[C@]([C@@H]([C@H](O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O
,6451164,Rilpivirine,,,,,,,,,,,,,,914,Rilpivirine,1,Oral,6451164,CID6451164,right_only,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)/C=C/C#N
,444008,Tibolone,,,,,,,,,,,,,,915,Tibolone,1,,444008,CID444008,right_only,C[C@@H]1CC2=C(CCC(=O)C2)[C@@H]3[C@@H]1[C@@H]4CC[C@]([C@]4(CC3)C)(C#C)O
,36294,Tobramycin,,,,,,,,,,,,,,916,Tobramycin,1,,36294,CID36294,right_only,C1[C@@H]([C@H]([C@@H]([C@H]([C@@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)N)O)O)O[C@@H]3[C@@H](C[C@@H]([C@H](O3)CN)O)N)N
,24776445,Vismodegib,,,,,,,,,,,,,,917,Vismodegib,1,Oral,24776445,CID24776445,right_only,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl
,5284569,Hydrocodone,,,,,,,,,,,,,,918,Hydrocodone,0,Oral,5284569,CID5284569,right_only,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3C(=O)CC4
,24066,Zalcitabine,,,,,,,,,,,,,,919,Zalcitabine,0,Oral,24066,CID24066,right_only,C1C[C@@H](O[C@@H]1CO)N2C=CC(=NC2=O)N
,5284514,Acrivastine,,,,,,,,,,,,,,920,Acrivastine,0,Oral,5284514,CID5284514,right_only,CC1=CC=C(C=C1)/C(=C\CN2CCCC2)/C3=CC=CC(=N3)/C=C/C(=O)O
,2164,Amobarbital,,,,,,,,,,,,,,921,Amobarbital,0,"Intramuscular; Intravenous, oral",2164,CID2164,right_only,CCC1(C(=O)NC(=O)NC1=O)CCC(C)C
,68911,Artemether,,,,,,,,,,,,,,922,Artemether,0,Oral,68911,CID68911,right_only,C[C@@H]1CC[C@H]2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC)C
,35330,Bitolterol,,,,,,,,,,,,,,923,Bitolterol,0,,35330,CID35330,right_only,CC1=CC=C(C=C1)C(=O)OC2=C(C=C(C=C2)C(CNC(C)(C)C)O)OC(=O)C3=CC=C(C=C3)C
,2481,Butalbital,,,,,,,,,,,,,,924,Butalbital,0,Oral,2481,CID2481,right_only,CC(C)CC1(C(=O)NC(=O)NC1=O)CC=C
,6473,Butobarbital,,,,,,,,,,,,,,925,Butobarbital,0,,6473,CID6473,right_only,CCCCC1(C(=O)NC(=O)NC1=O)CC
,2578,Carmustine,,,,,,,,,,,,,,926,Carmustine,0,Intravenous,2578,CID2578,right_only,C(CCl)NC(=O)N(CCCl)N=O
,2707,Chloral hydrate,,,,,,,,,,,,,,927,Chloral hydrate,0,Oral,2707,CID2707,right_only,C(C(Cl)(Cl)Cl)(O)O
,54675777,Chlortetracycline,,,,,,,,,,,,,,928,Chlortetracycline,0,Tropical,54675777,CID54675777,right_only,C[C@@]1([C@H]2C[C@H]3[C@@H](C(=O)C(=C([C@]3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)O)C(=O)N)N(C)C)O
,6435415,Cilastatin,,,,,,,,,,,,,,929,Cilastatin,0,Intravenous,6435415,CID6435415,right_only,CC1(C[C@@H]1C(=O)N/C(=C\CCCCSC[C@@H](C(=O)O)N)/C(=O)O)C
,6917698,Cisapride,,,,,,,,,,,,,,930,Cisapride,0,Oral,6917698,CID6917698,right_only,CO[C@H]1CN(CC[C@H]1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F
,25151504,Cobicistat,,,,,,,,,,,,,,931,Cobicistat,0,Oral,25151504,CID25151504,right_only,CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](CCN2CCOCC2)C(=O)N[C@H](CC[C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5
,11339,Docusate,,,,,,,,,,,,,,932,Docusate,0,oral,11339,CID11339,right_only,CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)O
,8223,Ergotamine,,,,,,,,,,,,,,933,Ergotamine,0,oral,8223,CID8223,right_only,C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@H]5CN([C@@H]6CC7=CNC8=CC=CC(=C78)C6=C5)C
LT01344,3278,ethacrynic acid,1967,Less-DILI-Concern,5,Adverse reactions,,Ambiguous DILI-concern,,,,,CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d65ed93d-77c8-45d1-af3d-06e9e5d65930,1,934,Ethacrynate,0,oral,3278,CID3278,both,CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl
,3345,Fentanyl,,,,,,,,,,,,,,935,Fentanyl,0,Sublingual,3345,CID3345,right_only,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3
,3410,Formoterol,,,,,,,,,,,,,,936,Formoterol,0,Respiratory (inhalation),3410,CID3410,right_only,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O
,3467,Gentamicin,,,,,,,,,,,,,,937,Gentamicin,0,Intramuscular; Intravenous,3467,CID3467,right_only,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
,5282593,Homatropine,,,,,,,,,,,,,,938,Homatropine,0,Ophthalmic,5282593,CID5282593,right_only,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C(C3=CC=CC=C3)O
,154417,Hyoscyamine,,,,,,,,,,,,,,939,Hyoscyamine,0,oral,154417,CID154417,right_only,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)[C@H](CO)C3=CC=CC=C3
,657309,Ipratropium,,,,,,,,,,,,,,940,Ipratropium,0,Oral; Respiratory (inhalation),657309,CID657309,right_only,CC(C)[N+]1([C@@H]2CC[C@H]1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C
,26879,Levamisole,,,,,,,,,,,,,,941,Levamisole,0,Oral,26879,CID26879,right_only,C1CSC2=N[C@H](CN21)C3=CC=CC=C3
,6047,Levodopa,,,,,,,,,,,,,,942,Levodopa,0,Oral,6047,CID6047,right_only,C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O
,16134956,Liraglutide,,,,,,,,,,,,,,943,Liraglutide,0,Subcutaneous,16134956,CID16134956,right_only,CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N)C(=O)O
LT01588,5284594,nalmefene hydrochloride,1995,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,NE,,Negative,,C=C1CC[C@]2([C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3CC6CC6)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=49fd02f8-12b8-460c-ae1f-f26738d86998,2,944,Nalmefene,0,Oral,5284594,CID5284594,both,C=C1CC[C@]2([C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3CC6CC6)O
,56603655,Pegaptanib,,,,,,,,,,,,,,945,Pegaptanib,0,Intravitreal,56603655,CID56603655,right_only,COCCOC(=O)NCCCC[C@@H](C(=O)NCCCCCCCOP(=O)(C)O)NC(=O)OCCOC
,6178111,Proguanil,,,,,,,,,,,,,,946,Proguanil,0,Oral,6178111,CID6178111,right_only,CC(C)N=C(N)/N=C(\N)/NC1=CC=C(C=C1)Cl
,5152,Salmeterol,,,,,,,,,,,,,,947,Salmeterol,0,Oral; Respiratory (inhalation),5152,CID5152,right_only,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O
,123630,Tazobactam,,,,,,,,,,,,,,948,Tazobactam,0,Intravenous; Parenteral,123630,CID123630,right_only,C[C@@]1([C@@H](N2[C@H](S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3
,3000715,Thiopental,,,,,,,,,,,,,,949,Thiopental,0,Intravenous,3000715,CID3000715,right_only,CCCC(C)C1(C(=O)NC(=S)NC1=O)CC
,36921,Ticarcillin,,,,,,,,,,,,,,950,Ticarcillin,0,Intramuscular; Intravenous,36921,CID36921,right_only,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C
,5487427,Tiotropium,,,,,,,,,,,,,,951,Tiotropium,0,Oral; Respiratory (inhalation),5487427,CID5487427,right_only,C[N+]1([C@@H]2CC(C[C@H]1[C@H]3[C@@H]2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C
,60855,Zanamivir,,,,,,,,,,,,,,952,Zanamivir,0,Oral; Respiratory (inhalation),60855,CID60855,right_only,CC(=O)N[C@@H]1[C@H](C=C(O[C@H]1[C@@H]([C@@H](CO)O)O)C(=O)O)N=C(N)N
,1981,ACEMETACIN,,,,,,,,,,,,,,953,ACEMETACIN,1,,1981,CID1981,right_only,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCC(=O)O
,1985,ACETARSOL,,,,,,,,,,,,,,954,ACETARSOL,1,Vaginal,1985,CID1985,right_only,CC(=O)NC1=C(C=CC(=C1)[As](=O)(O)O)O
,5574,Alimemazine,,,,,,,,,,,,,,956,Alimemazine,1,Oral,5574,CID5574,right_only,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)CN(C)C
,10635,ANDROSTANOLONE,,,,,,,,,,,,,,957,ANDROSTANOLONE,1,,10635,CID10635,right_only,C[C@]12CCC(=O)C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C
,68827,Artemisinin,,,,,,,,,,,,,,959,Artemisinin,1,,68827,CID68827,right_only,C[C@@H]1CC[C@H]2[C@H](C(=O)O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)C
,6917864,Artesunate,,,,,,,,,,,,,,960,Artesunate,1,,6917864,CID6917864,right_only,C[C@@H]1CC[C@H]2[C@H]([C@@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC(=O)CCC(=O)O)C
,2474,Bupivacaine,,,,,,,,,,,,,,962,Bupivacaine,1,Epidural; Infiltration; Intracaudal; Perineural,2474,CID2474,right_only,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C
,56955933,CALCIUM CARBIMIDE,,,,,,,,,,,,,,963,CALCIUM CARBIMIDE,1,Oral,56955933,CID56955933,right_only,C(=[N-])=[N-].[Ca+2]
,31072,CARBIMAZOLE,,,,,,,,,,,,,,964,CARBIMAZOLE,1,,31072,CID31072,right_only,CCOC(=O)N1C=CN(C1=S)C
,446156,Cerivastatin,,,,,,,,,,,,,,965,Cerivastatin,1,Oral,446156,CID446156,right_only,CC(C)C1=C(C(=C(C(=N1)C(C)C)COC)C2=CC=C(C=C2)F)/C=C/[C@H](C[C@H](CC(=O)O)O)O
,56330,CILAZAPRIL,,,,,,,,,,,,,,966,CILAZAPRIL,1,Oral,56330,CID56330,right_only,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CCCN3CCC[C@H](N3C2=O)C(=O)O
,68867,CINITAPRIDE,,,,,,,,,,,,,,967,CINITAPRIDE,1,,68867,CID68867,right_only,CCOC1=CC(=C(C=C1C(=O)NC2CCN(CC2)CC3CCC=CC3)[N+](=O)[O-])N
,10783,CLOMETHIAZOLE,,,,,,,,,,,,,,969,CLOMETHIAZOLE,1,,10783,CID10783,right_only,CC1=C(SC=N1)CCCl
,2811,CLOTIAZEPAM,,,,,,,,,,,,,,970,CLOTIAZEPAM,1,,2811,CID2811,right_only,CCC1=CC2=C(S1)N(C(=O)CN=C2C3=CC=CC=C3Cl)C
,446220,COCAINE,,,,,,,,,,,,,,971,COCAINE,1,"Nasal, Torpical",446220,CID446220,right_only,CN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC
,5284537,CYPROTERONE,,,,,,,,,,,,,,972,CYPROTERONE,1,"Oral, Intramuscular",5284537,CID5284537,right_only,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5C[C@@H]5[C@]34C)Cl)C)O
,5881,Dehydroepiandrosterone,,,,,,,,,,,,,,973,Dehydroepiandrosterone,1,,5881,CID5881,right_only,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CC[C@@H](C4)O)C
,42113,Desflurane,,,,,,,,,,,,,,974,Desflurane,1,Respiratory (inhalation),42113,CID42113,right_only,C(C(F)(F)F)(OC(F)F)F
,667550,DEXKETOPROFEN,,,,,,,,,,,,,,975,DEXKETOPROFEN,1,,667550,CID667550,right_only,C[C@@H](C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O
,54676038,DICOUMAROL,,,,,,,,,,,,,,977,DICOUMAROL,1,,54676038,CID54676038,right_only,C1=CC=C2C(=C1)C(=C(C(=O)O2)CC3=C(C4=CC=CC=C4OC3=O)O)O
,3191,EBASTINE,,,,,,,,,,,,,,978,EBASTINE,1,,3191,CID3191,right_only,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4
,3226,ENFLURANE,,,,,,,,,,,,,,979,ENFLURANE,1,Respiratory (inhalation),3226,CID3226,right_only,C(C(OC(F)F)(F)F)(F)Cl
,5756,ESTRIOL,,,,,,,,,,,,,,980,ESTRIOL,1,,5756,CID5756,right_only,C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)O)CCC4=C3C=CC(=C4)O
,5991,Ethinylestradiol,,,,,,,,,,,,,,981,Ethinylestradiol,1,"Oral, Transdermal",5991,CID5991,right_only,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O
,5282375,ETRETINATE,,,,,,,,,,,,,,982,ETRETINATE,1,,5282375,CID5282375,right_only,CCOC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C(=C(C=C1C)OC)C)C
,5281881,FLUPENTIXOL,,,,,,,,,,,,,,983,FLUPENTIXOL,1,"Oral, Intramuscular",5281881,CID5281881,right_only,C1CN(CCN1CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO
,3000226,Fusidic Acid,,,,,,,,,,,,,,984,Fusidic Acid,1,"Oral, Topical, Intravenous, optahlmic",3000226,CID3000226,right_only,C[C@H]1[C@@H]2CC[C@]3([C@H]([C@]2(CC[C@H]1O)C)[C@@H](C[C@@H]\4[C@@]3(C[C@@H](/C4=C(/CCC=C(C)C)\C(=O)O)OC(=O)C)C)O)C
,439213,GLUCOSAMINE,,,,,,,,,,,,,,986,GLUCOSAMINE,1,Topical,439213,CID439213,right_only,C([C@@H]1[C@H]([C@@H]([C@H](C(O1)O)N)O)O)O
,163093,Isaxonine phosphate,,,,,,,,,,,,,,992,Isaxonine phosphate,1,"Oral,Intramuscular; Intravenous",163093,CID163093,right_only,CC(C)NC1=NC=CC=N1.OP(=O)(O)O
,5282165,JOSAMYCIN,,,,,,,,,,,,,,993,JOSAMYCIN,1,,5282165,CID5282165,right_only,C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)OC(=O)C)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)OC(=O)CC(C)C)(C)O)N(C)C)O)CC=O)C)O
,72287,LEVOMEPROMAZINE,,,,,,,,,,,,,,994,LEVOMEPROMAZINE,1,"Oral,Intramuscular; Intravenous",72287,CID72287,right_only,C[C@@H](CN1C2=CC=CC=C2SC3=C1C=C(C=C3)OC)CN(C)C
,15387,Melperone,,,,,,,,,,,,,,995,Melperone,1,,15387,CID15387,right_only,CC1CCN(CC1)CCCC(=O)C2=CC=C(C=C2)F
,3111,METAMIZOLE,,,,,,,,,,,,,,996,METAMIZOLE,1,,3111,CID3111,right_only,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)O
,4116,Methoxyflurane,,,,,,,,,,,,,,997,Methoxyflurane,1,,4116,CID4116,right_only,COC(C(Cl)Cl)(F)F
,4488,NIFLUMIC ACID,,,,,,,,,,,,,,999,NIFLUMIC ACID,1,,4488,CID4488,right_only,C1=CC(=CC(=C1)NC2=C(C=CC=N2)C(=O)O)C(F)(F)F
,2349,PENICILLIN,,,,,,,,,,,,,,1002,PENICILLIN,1,,2349,CID2349,right_only,CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C
,115163,Pivmecillinam,,,,,,,,,,,,,,1004,Pivmecillinam,1,Oral,115163,CID115163,right_only,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)N=CN3CCCCCC3)C(=O)OCOC(=O)C(C)(C)C)C
,33572,RITODRINE,,,,,,,,,,,,,,1005,RITODRINE,1,"Oral, Intravenous",33572,CID33572,right_only,C[C@@H]([C@@H](C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O
,5090,ROFECOXIB,,,,,,,,,,,,,,1006,ROFECOXIB,1,Oral,5090,CID5090,right_only,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3
,6915744,ROXITHROMYCIN,,,,,,,,,,,,,,1007,ROXITHROMYCIN,1,,6915744,CID6915744,right_only,CC[C@@H]1[C@@]([C@@H]([C@H](/C(=N/OCOCCOC)/[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O
,25249,STANOZOLOL,,,,,,,,,,,,,,1008,STANOZOLOL,1,,25249,CID25249,right_only,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C)O)CC[C@@H]4[C@@]3(CC5=C(C4)NN=C5)C
,1935,TACRINE,,,,,,,,,,,,,,1011,TACRINE,1,,1935,CID1935,right_only,C1CCC2=NC3=CC=CC=C3C(=C2C1)N
,54677971,TENOXICAM,,,,,,,,,,,,,,1012,TENOXICAM,1,Oral,54677971,CID54677971,right_only,CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3
,5803,TIRATRICOL,,,,,,,,,,,,,,1013,TIRATRICOL,1,,5803,CID5803,right_only,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(=O)O)I)I)O
,25074470,TRIPTORELIN,,,,,,,,,,,,,,1014,TRIPTORELIN,1,"Subcutaneous, Intramuscular",25074470,CID25074470,right_only,CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)NC(=O)[C@@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8
,4754,phenacetin,,,,,,,,,,,,,,1015,phenacetin,1,,4754,CID4754,right_only,CCOC1=CC=C(C=C1)NC(=O)C
,2406,bithionol,,,,,,,,,,,,,,1016,bithionol,1,,2406,CID2406,right_only,C1=C(C=C(C(=C1SC2=C(C(=CC(=C2)Cl)Cl)O)O)Cl)Cl
,3598,hexachlorophene,,,,,,,,,,,,,,1017,hexachlorophene,1,Topical,3598,CID3598,right_only,C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)O)O)Cl
,4098,methapyrilene,,,,,,,,,,,,,,1018,methapyrilene,1,,4098,CID4098,right_only,CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2
,5587,tripelennamine,,,,,,,,,,,,,,1019,tripelennamine,1,"Topical, Oral, vaginal",5587,CID5587,right_only,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2
,1923,oxyquinoline,,,,,,,,,,,,,,1020,oxyquinoline,1,"oral, Topical,Vaginal, Dental",1923,CID1923,right_only,C1=CC2=C(C(=C1)O)N=CC=C2
,6087,meticillin,,,,,,,,,,,,,,1021,meticillin,1,,6087,CID6087,right_only,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C3=C(C=CC=C3OC)OC)C(=O)O)C
,2179,amsacrine,,,,,,,,,,,,,,1022,amsacrine,1,Intravenous,2179,CID2179,right_only,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42
,5323714,furazolidone,,,,,,,,,,,,,,1023,furazolidone,1,,5323714,CID5323714,right_only,C1COC(=O)N1/N=C/C2=CC=C(O2)[N+](=O)[O-]
,3634,hycanthone,,,,,,,,,,,,,,1024,hycanthone,1,,3634,CID3634,right_only,CCN(CC)CCNC1=C2C(=C(C=C1)CO)SC3=CC=CC=C3C2=O
,5905,idoxuridine,,,,,,,,,,,,,,1025,idoxuridine,1,"Opthalmic, Topical",5905,CID5905,right_only,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)I)CO)O
,54675769,novobiocin,,,,,,,,,,,,,,1026,novobiocin,1,,54675769,CID54675769,right_only,CC1=C(C=CC2=C1OC(=O)C(=C2O)NC(=O)C3=CC(=C(C=C3)O)CC=C(C)C)O[C@H]4[C@@H]([C@@H]([C@H](C(O4)(C)C)OC)OC(=O)N)O
,68870,tianeptine,,,,,,,,,,,,,,1027,tianeptine,1,,68870,CID68870,right_only,CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O
,54675785,methacycline,,,,,,,,,,,,,,1028,methacycline,1,,54675785,CID54675785,right_only,CN(C)[C@H]1[C@@H]2[C@H]([C@@H]3C(=C)C4=C(C(=CC=C4)O)C(=C3C(=O)[C@@]2(C(=C(C1=O)C(=O)N)O)O)O)O
,2351,bepridil,,,,,,,,,,,,,,1029,bepridil,1,,2351,CID2351,right_only,CC(C)COCC(CN(CC1=CC=CC=C1)C2=CC=CC=C2)N3CCCC3
,2366,betahistine,,,,,,,,,,,,,,1030,betahistine,1,Oral,2366,CID2366,right_only,CNCCC1=CC=CC=N1
,2763,ciprofibrate,,,,,,,,,,,,,,1031,ciprofibrate,1,,2763,CID2763,right_only,CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl
,3052,diethylcarbamazine,,,,,,,,,,,,,,1032,diethylcarbamazine,1,Oral,3052,CID3052,right_only,CCN(CC)C(=O)N1CCN(CC1)C
,3343,fenoterol,,,,,,,,,,,,,,1033,fenoterol,1,Oral; Respiratory (inhalation),3343,CID3343,right_only,CC(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O
,4781,phenylbutazone,,,,,,,,,,,,,,1034,phenylbutazone,1,Oral,4781,CID4781,right_only,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3
,9270,ethynodiol diacetate,,,,,,,,,,,,,,1035,ethynodiol diacetate,1,Oral,9270,CID9270,right_only,CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@]4([C@H]([C@@H]3CCC2=C1)CC[C@]4(C#C)OC(=O)C)C
,442004,atractyloside,,,,,,,,,,,,,,1036,atractyloside,1,,442004,CID442004,right_only,CC(C)CC(=O)O[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1O[C@@H]2C[C@H]([C@H]3CC[C@@]45C[C@@H](CC[C@H]4[C@@]3(C2)C)C(=C)[C@@H]5O)C(=O)O)CO)OS(=O)(=O)[O-])OS(=O)(=O)[O-].[K+].[K+]
,60021,temafloxacin,,,,,,,,,,,,,,1037,temafloxacin,1,,60021,CID60021,right_only,CC1CN(CCN1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=C(C=C(C=C4)F)F)F
,456255,cefamandole,,,,,,,,,,,,,,1038,cefamandole,1,Intramuscular; Intravenous,456255,CID456255,right_only,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)[C@@H](C4=CC=CC=C4)O)SC2)C(=O)O
,2165,amodiaquine,,,,,,,,,,,,,,1039,amodiaquine,1,,2165,CID2165,right_only,CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O
,3487,glutethimide,,,,,,,,,,,,,,1040,glutethimide,1,,3487,CID3487,right_only,CCC1(CCC(=O)NC1=O)C2=CC=CC=C2
,5333,sulfanilamide,,,,,,,,,,,,,,1041,sulfanilamide,1,Vaginal,5333,CID5333,right_only,C1=CC(=CC=C1N)S(=O)(=O)N
,5897,2-acetylaminofluorene,,,,,,,,,,,,,,1042,2-acetylaminofluorene,1,,5897,CID5897,right_only,CC(=O)NC1=CC2=C(C=C1)C3=CC=CC=C3C2
,5965,demecarium bromide,,,,,,,,,,,,,,1043,demecarium bromide,1,,5965,CID5965,right_only,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC2=CC=CC(=C2)[N+](C)(C)C.[Br-].[Br-]
,6024,cefalotin,,,,,,,,,,,,,,1044,cefalotin,1,Intramuscular; Intravenous,6024,CID6024,right_only,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)O
,6194,uracil mustard,,,,,,,,,,,,,,1045,uracil mustard,1,,6194,CID6194,right_only,C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl
,8271,methylphenobarbital,,,,,,,,,,,,,,1046,methylphenobarbital,1,,8271,CID8271,right_only,CCC1(C(=O)NC(=O)N(C1=O)C)C2=CC=CC=C2
,54676537,acenocoumarol,,,,,,,,,,,,,,1047,acenocoumarol,1,Oral,54676537,CID54676537,right_only,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(C3=CC=CC=C3OC2=O)O
,11080,1-naphthylisothiocyanate,,,,,,,,,,,,,,1048,1-naphthylisothiocyanate,1,,11080,CID11080,right_only,C1=CC=C2C(=C1)C=CC=C2N=C=S
,186907,aflatoxin b1,,,,,,,,,,,,,,1049,aflatoxin b1,1,,186907,CID186907,right_only,COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1
,42266,indacrinone,,,,,,,,,,,,,,1050,indacrinone,1,,42266,CID42266,right_only,CC1(CC2=CC(=C(C(=C2C1=O)Cl)Cl)OCC(=O)O)C3=CC=CC=C3
,43708,cefotiam,,,,,,,,,,,,,,1051,cefotiam,1,,43708,CID43708,right_only,CN(C)CCN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CC4=CSC(=N4)N)SC2)C(=O)O
,202225,troleandomycin,,,,,,,,,,,,,,1052,troleandomycin,1,,202225,CID202225,right_only,C[C@@H]1C[C@@H]([C@H]([C@@H](O1)O[C@H]2[C@H](C[C@@]3(CO3)C(=O)[C@@H]([C@H]([C@H]([C@H](OC(=O)[C@@H]([C@H]([C@@H]2C)O[C@H]4C[C@@H]([C@H]([C@@H](O4)C)OC(=O)C)OC)C)C)C)OC(=O)C)C)C)OC(=O)C)N(C)C
,5284439,perhexiline maleate,,,,,,,,,,,,,,1053,perhexiline maleate,1,,5284439,CID5284439,right_only,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3.C(=C\C(=O)O)\C(=O)O
,2750,ciglitazone,,,,,,,,,,,,,,1054,ciglitazone,1,,2750,CID2750,right_only,CC1(CCCCC1)COC2=CC=C(C=C2)CC3C(=O)NC(=O)S3
,3396,fluspirilene,,,,,,,,,,,,,,1055,fluspirilene,1,Intramuscular,3396,CID3396,right_only,C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F
,5943,carbon tetrachloride,,,,,,,,,,,,,,1057,carbon tetrachloride,1,,5943,CID5943,right_only,C(Cl)(Cl)(Cl)Cl
,454937,aurothioglucose,,,,,,,,,,,,,,1058,aurothioglucose,1,Intramuscular,454937,CID454937,right_only,C([C@@H]1[C@H]([C@@H]([C@H](C(O1)[S-])O)O)O)O.[Au+]
,7108,phenothiazine,,,,,,,,,,,,,,1059,phenothiazine,1,,7108,CID7108,right_only,C1=CC=C2C(=C1)NC3=CC=CC=C3S2
,7858,allyl alcohol,,,,,,,,,,,,,,1060,allyl alcohol,1,,7858,CID7858,right_only,C=CCO
,7961,bromobenzene,,,,,,,,,,,,,,1061,bromobenzene,1,,7961,CID7961,right_only,C1=CC=C(C=C1)Br
,19861,azatadine,,,,,,,,,,,,,,1062,azatadine,1,Oral,19861,CID19861,right_only,CN1CCC(=C2C3=CC=CC=C3CCC4=C2N=CC=C4)CC1
,61278,allyl formate,,,,,,,,,,,,,,1063,allyl formate,1,,61278,CID61278,right_only,C=CCOC=O
,9848818,tauroursodeoxycholic acid,,,,,,,,,,,,,,1064,tauroursodeoxycholic acid,1,,9848818,CID9848818,right_only,C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C
,3827,ketotifen,,,,,,,,,,,,,,1066,ketotifen,0,"Opthalmic, Topical",3827,CID3827,right_only,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1
,40326,permethrin,,,,,,,,,,,,,,1067,permethrin,0,Topical,40326,CID40326,right_only,CC1(C(C1C(=O)OCC2=CC(=CC=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C
,5749,oxyphenonium,,,,,,,,,,,,,,1068,oxyphenonium,0,,5749,CID5749,right_only,CC[N+](C)(CC)CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O
,1051,pyridoxal phosphate,,,,,,,,,,,,,,1069,pyridoxal phosphate,0,Oral,1051,CID1051,right_only,CC1=NC=C(C(=C1O)C=O)COP(=O)(O)O
,2145,aminoglutethimide,,,,,,,,,,,,,,1070,aminoglutethimide,0,Oral,2145,CID2145,right_only,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N
,5411,tetracaine,,,,,,,,,,,,,,1071,tetracaine,0,Topical,5411,CID5411,right_only,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C
,4189,miconazole,,,,,,,,,,,,,,1072,miconazole,0,Topical,4189,CID4189,right_only,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl
,727,lindane,,,,,,,,,,,,,,1073,lindane,0,Topical,727,CID727,right_only,C1(C(C(C(C(C1Cl)Cl)Cl)Cl)Cl)Cl
,2247,astemizole,,,,,,,,,,,,,,1074,astemizole,0,Oral,2247,CID2247,right_only,COC1=CC=C(C=C1)CCN2CCC(CC2)NC3=NC4=CC=CC=C4N3CC5=CC=C(C=C5)F
,2749,ciclopirox,,,,,,,,,,,,,,1075,ciclopirox,0,Topical,2749,CID2749,right_only,CC1=CC(=O)N(C(=C1)C2CCCCC2)O
,4826,pinacidil,,,,,,,,,,,,,,1076,pinacidil,0,,4826,CID4826,right_only,CC(C(C)(C)C)N=C(NC#N)NC1=CC=NC=C1
,5405,terfenadine,,,,,,,,,,,,,,1077,terfenadine,0,Oral,5405,CID5405,right_only,CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O
,6082,methoxamine,,,,,,,,,,,,,,1078,methoxamine,0,Intramuscular; Intravenous,6082,CID6082,right_only,CC(C(C1=C(C=CC(=C1)OC)OC)O)N
,20469,beclomethasone,,,,,,,,,,,,,,1079,beclomethasone,0,"Topical,Respiratory (inhalation)",20469,CID20469,right_only,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)Cl)C
,21704,vidarabine,,,,,,,,,,,,,,1080,vidarabine,0,,21704,CID21704,right_only,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N
,39042,bezafibrate,,,,,,,,,,,,,,1081,bezafibrate,0,oral,39042,CID39042,right_only,CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl
,54766,bambuterol,,,,,,,,,,,,,,1082,bambuterol,0,,54766,CID54766,right_only,CC(C)(C)NCC(C1=CC(=CC(=C1)OC(=O)N(C)C)OC(=O)N(C)C)O
,6172,gallamine triethiodide,,,,,,,,,,,,,,1083,gallamine triethiodide,0,Intravenous,6172,CID6172,right_only,CC[N+](CC)(CC)CCOC1=C(C(=CC=C1)OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-]
,896,melatonin,,,,,,,,,,,,,,1084,melatonin,0,Oral,896,CID896,right_only,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC
,4122,nocodazole,,,,,,,,,,,,,,1085,nocodazole,0,,4122,CID4122,right_only,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CS3
,5733,zomepirac,,,,,,,,,,,,,,1086,zomepirac,0,,5733,CID5733,right_only,CC1=C(N(C(=C1)CC(=O)O)C)C(=O)C2=CC=C(C=C2)Cl
,5781,alloxan,,,,,,,,,,,,,,1087,alloxan,0,,5781,CID5781,right_only,C1(=O)C(=O)NC(=O)NC1=O
,4688,pargyline,,,,,,,,,,,,,,1088,pargyline,0,,4688,CID4688,right_only,CN(CC#C)CC1=CC=CC=C1
,4912,probucol,,,,,,,,,,,,,,1089,probucol,0,Oral,4912,CID4912,right_only,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C
,6134,lactose,,,,,,,,,,,,,,1090,lactose,0,Oral,6134,CID6134,right_only,C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)O)O)CO)O)O)O)O
,8944,anileridine,,,,,,,,,,,,,,1091,anileridine,0,"Oral, Intramuscular; Intravenous; Subcutaneous",8944,CID8944,right_only,CCOC(=O)C1(CCN(CC1)CCC2=CC=C(C=C2)N)C3=CC=CC=C3
,13804,citicoline,,,,,,,,,,,,,,1092,citicoline,0,,13804,CID13804,right_only,C[N+](C)(C)CCOP(=O)([O-])OP(=O)(O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=NC2=O)N)O)O
,441335,mometasone,,,,,,,,,,,,,,1093,mometasone,0,"Topical,Respiratory (inhalation)",441335,CID441335,right_only,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)Cl)C
,1548943,capsaicin,,,,,,,,,,,,,,1094,capsaicin,0,Percutaneous; Topical; Transdermal,1548943,CID1548943,right_only,CC(C)/C=C/CCCCC(=O)NCC1=CC(=C(C=C1)O)OC
,443884,ergonovine,,,,,,,,,,,,,,1095,ergonovine,0,"Oral, Intramuscular; Intravenous",443884,CID443884,right_only,C[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C
,3198,econazole,,,,,,,,,,,,,,1096,econazole,0,Topical,3198,CID3198,right_only,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl
,65495,sulconazole nitrate,,,,,,,,,,,,,,1097,sulconazole nitrate,0,Topical,65495,CID65495,right_only,C1=CC(=CC=C1CSC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl.[N+](=O)(O)[O-]
,5319,sulfabenzamide,,,,,,,,,,,,,,1098,sulfabenzamide,0,,5319,CID5319,right_only,C1=CC=C(C=C1)C(=O)NS(=O)(=O)C2=CC=C(C=C2)N
,30699,cephapirin,,,,,,,,,,,,,,1099,cephapirin,0,,30699,CID30699,right_only,CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CSC3=CC=NC=C3)SC1)C(=O)O
,6479523,azlocillin,,,,,,,,,,,,,,1100,azlocillin,0,,6479523,CID6479523,right_only,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)O)C
,47472,butoconazole,,,,,,,,,,,,,,1101,butoconazole,0,Vaginal,47472,CID47472,right_only,C1=CC(=C(C(=C1)Cl)SC(CCC2=CC=C(C=C2)Cl)CN3C=CN=C3)Cl
,60663,mibefradil,,,,,,,,,,,,,,1102,mibefradil,0,,60663,CID60663,right_only,CC(C)[C@H]1C2=C(CC[C@@]1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F
,447458,ragaglitazar,,,,,,,,,,,,,,1103,ragaglitazar,0,,447458,CID447458,right_only,CCO[C@@H](CC1=CC=C(C=C1)OCCN2C3=CC=CC=C3OC4=CC=CC=C42)C(=O)O
,16682734,bismuth subsalicylate,,,,,,,,,,,,,,1104,bismuth subsalicylate,0,Oral,16682734,CID16682734,right_only,C1=CC=C2C(=C1)C(=O)O[Bi]O2.O
,54677972,isoxicam,,,,,,,,,,,,,,1105,isoxicam,0,,54677972,CID54677972,right_only,CC1=CC(=NO1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O
,892,inositol,,,,,,,,,,,,,,1106,inositol,0,"Oral, Vaginal",892,CID892,right_only,C1(C(C(C(C(C1O)O)O)O)O)O
,47499,latamoxef,,,,,,,,,,,,,,1107,latamoxef,0,,47499,CID47499,right_only,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)C(C4=CC=C(C=C4)O)C(=O)O)OC)OC2)C(=O)O
,132971,Abiraterone,,,,,,,,,,,,,,1108,Abiraterone,1,,132971,CID132971,right_only,C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC=C4C5=CN=CC=C5)C)O
,107751,Acetorphan,,,,,,,,,,,,,,1109,Acetorphan,1,,107751,CID107751,right_only,CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC2=CC=CC=C2
,5282181,Alfacalcidol,,,,,,,,,,,,,,1110,Alfacalcidol,1,,5282181,CID5282181,right_only,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C
,2132,Ambroxol,,,,,,,,,,,,,,1111,Ambroxol,1,,2132,CID2132,right_only,C1CC(CCC1NCC2=C(C(=CC(=C2)Br)Br)N)O
,137,Aminolevulinic acid,,,,,,,,,,,,,,1112,Aminolevulinic acid,1,,137,CID137,right_only,C(CC(=O)O)C(=O)CN
,2159,Amisulpride,,,,,,,,,,,,,,1113,Amisulpride,1,,2159,CID2159,right_only,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC
,2176,Ampiroxicam,,,,,,,,,,,,,,1114,Ampiroxicam,1,,2176,CID2176,right_only,CCOC(=O)OC(C)OC1=C(N(S(=O)(=O)C2=CC=CC=C21)C)C(=O)NC3=CC=CC=N3
,637563,Anethole,,,,,,,,,,,,,,1115,Anethole,1,,637563,CID637563,right_only,C/C=C/C1=CC=C(C=C1)OC
,68682,Arbekacin,,,,,,,,,,,,,,1116,Arbekacin,1,,68682,CID68682,right_only,C1C[C@H]([C@H](O[C@@H]1CN)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)NC(=O)[C@H](CCN)O)N)N
,6450551,Axitinib,,,,,,,,,,,,,,1117,Axitinib,1,,6450551,CID6450551,right_only,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4
,65948,Azelnidipine,,,,,,,,,,,,,,1118,Azelnidipine,1,,65948,CID65948,right_only,CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC(C)C
,441397,Bacampicillin,,,,,,,,,,,,,,1119,Bacampicillin,1,,441397,CID441397,right_only,CCOC(=O)OC(C)OC(=O)[C@H]1C(S[C@H]2N1C(=O)[C@H]2NC(=O)[C@@H](C3=CC=CC=C3)N)(C)C
,656668,Benidipine,,,,,,,,,,,,,,1120,Benidipine,1,,656668,CID656668,right_only,CC1=C([C@H](C(=C(N1)C)C(=O)O[C@@H]2CCCN(C2)CC3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC
,6917951,Beraprost,,,,,,,,,,,,,,1121,Beraprost,1,,6917951,CID6917951,right_only,CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C3=CC=CC(=C3O2)CCCC(=O)O)O)O
,10324367,Boceprevir,,,,,,,,,,,,,,1122,Boceprevir,1,,10324367,CID10324367,right_only,CC1([C@@H]2[C@H]1[C@H](N(C2)C(=O)[C@H](C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C
,2441,Bromazepam,,,,,,,,,,,,,,1123,Bromazepam,1,,2441,CID2441,right_only,C1C(=O)NC2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=N3
,2442,Bromhexine,,,,,,,,,,,,,,1124,Bromhexine,1,,2442,CID2442,right_only,CN(CC1=C(C(=CC(=C1)Br)Br)N)C2CCCCC2
,2447,Bromisoval,,,,,,,,,,,,,,1125,Bromisoval,1,,2447,CID2447,right_only,CC(C)C(C(=O)NC(=O)N)Br
,2451,Brotizolam,,,,,,,,,,,,,,1126,Brotizolam,1,,2451,CID2451,right_only,CC1=NN=C2N1C3=C(C=C(S3)Br)C(=NC2)C4=CC=CC=C4Cl
,656604,Bucillamine,,,,,,,,,,,,,,1127,Bucillamine,1,,656604,CID656604,right_only,CC(C)(C(=O)N[C@@H](CS)C(=O)O)S
,2467,Buflomedil,,,,,,,,,,,,,,1128,Buflomedil,1,,2467,CID2467,right_only,COC1=CC(=C(C(=C1)OC)C(=O)CCCN2CCCC2)OC
,644073,Buprenorphine,,,,,,,,,,,,,,1129,Buprenorphine,1,,644073,CID644073,right_only,C[C@]([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)(C(C)(C)C)O
,9854073,Cabazitaxel,,,,,,,,,,,,,,1130,Cabazitaxel,1,,9854073,CID9854073,right_only,CC1=C2[C@H](C(=O)[C@@]3([C@H](C[C@@H]4[C@]([C@H]3[C@@H]([C@@](C2(C)C)(C[C@@H]1OC(=O)[C@@H]([C@H](C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC
,6436055,Cefcapene,,,,,,,,,,,,,,1131,Cefcapene,1,,6436055,CID6436055,right_only,CC/C=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O
,42008,Cefmetazole,,,,,,,,,,,,,,1132,Cefmetazole,1,,42008,CID42008,right_only,CN1C(=NN=N1)SCC2=C(N3[C@@H]([C@@](C3=O)(NC(=O)CSCC#N)OC)SC2)C(=O)O
,9571080,Cefozopran,,,,,,,,,,,,,,1133,Cefozopran,1,,9571080,CID9571080,right_only,CO/N=C(/C1=NSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=C5C=CC=NN5C=C4)C(=O)[O-]
,5479539,Cefpirome,,,,,,,,,,,,,,1134,Cefpirome,1,,5479539,CID5479539,right_only,CO/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC5=C4CCC5)C(=O)[O-]
,2663,Celiprolol,,,,,,,,,,,,,,1135,Celiprolol,1,,2663,CID2663,right_only,CCN(CC)C(=O)NC1=CC(=C(C=C1)OCC(CNC(C)(C)C)O)C(=O)C
,5284533,Chlormadinone,,,,,,,,,,,,,,1136,Chlormadinone,1,,5284533,CID5284533,right_only,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)CC[C@]34C)Cl)C)O
,2747,Cibenzoline,,,,,,,,,,,,,,1137,Cibenzoline,1,,2747,CID2747,right_only,C1CN=C(N1)C2CC2(C3=CC=CC=C3)C4=CC=CC=C4
,5282138,Cilnidipine,,,,,,,,,,,,,,1138,Cilnidipine,1,,5282138,CID5282138,right_only,CC1=C(C(C(=C(N1)C)C(=O)OC/C=C/C2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC
,2789,Clobazam,,,,,,,,,,,,,,1139,Clobazam,1,,2789,CID2789,right_only,CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3
,5311051,Clobetasol,,,,,,,,,,,,,,1140,Clobetasol,1,,5311051,CID5311051,right_only,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CCl)O)C)O)F)C
,25419,Clodronic acid,,,,,,,,,,,,,,1141,Clodronic acid,1,,25419,CID25419,right_only,C(P(=O)(O)O)(P(=O)(O)O)(Cl)Cl
,2794,Clofazimine,,,,,,,,,,,,,,1142,Clofazimine,1,,2794,CID2794,right_only,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl
,2805,Cloperastine,,,,,,,,,,,,,,1143,Cloperastine,1,,2805,CID2805,right_only,C1CCN(CC1)CCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
,11626560,Crizotinib,,,,,,,,,,,,,,1144,Crizotinib,1,,11626560,CID11626560,right_only,C[C@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N
,969516,Curcumin,,,,,,,,,,,,,,1145,Curcumin,1,,969516,CID969516,right_only,COC1=C(C=CC(=C1)/C=C/C(=O)CC(=O)/C=C/C2=CC(=C(C=C2)O)OC)O
,62865,Cyamemazine,,,,,,,,,,,,,,1146,Cyamemazine,1,,62865,CID62865,right_only,CC(CN1C2=CC=CC=C2SC3=C1C=C(C=C3)C#N)CN(C)C
,2910,Cyclothiazide,,,,,,,,,,,,,,1147,Cyclothiazide,1,,2910,CID2910,right_only,C1C2CC(C1C=C2)C3NC4=CC(=C(C=C4S(=O)(=O)N3)S(=O)(=O)N)Cl
,40973,Desogestrel,,,,,,,,,,,,,,1148,Desogestrel,1,,40973,CID40973,right_only,CC[C@]12CC(=C)[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CCCC[C@H]34
,26248,Diacerein,,,,,,,,,,,,,,1149,Diacerein,1,,26248,CID26248,right_only,CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C2=O)C=C(C=C3OC(=O)C)C(=O)O
,5284543,Dihydrocodeine,,,,,,,,,,,,,,1150,Dihydrocodeine,1,,5284543,CID5284543,right_only,CN1CC[C@]23[C@@H]4[C@H]1CC5=C2C(=C(C=C5)OC)O[C@H]3[C@H](CC4)O
,6473883,Dirithromycin,,,,,,,,,,,,,,1151,Dirithromycin,1,,6473883,CID6473883,right_only,CC[C@@H]1[C@@]([C@H]2[C@H]([C@H]([C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)OC)C)O[C@H]4[C@@H]([C@H](C[C@H](O4)C)N(C)C)O)(C)O)C)N[C@H](O2)COCCOC)C)(C)O
,3151,Domperidone,,,,,,,,,,,,,,1152,Domperidone,1,,3151,CID3151,right_only,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O
,18343,Doxifluridine,,,,,,,,,,,,,,1153,Doxifluridine,1,,18343,CID18343,right_only,C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=C(C(=O)NC2=O)F)O)O
,92974,Droxidopa,,,,,,,,,,,,,,1154,Droxidopa,1,,92974,CID92974,right_only,C1=CC(=C(C=C1[C@H]([C@@H](C(=O)O)N)O)O)O
,9051,Dydrogesterone,,,,,,,,,,,,,,1155,Dydrogesterone,1,,9051,CID9051,right_only,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@@H]3[C@H]2C=CC4=CC(=O)CC[C@@]34C)C
,4021,Edaravone,,,,,,,,,,,,,,1156,Edaravone,1,,4021,CID4021,right_only,CC1=NN(C(=O)C1)C2=CC=CC=C2
,135449332,Eltrombopag,,,,,,,,,,,,,,1157,Eltrombopag,1,,135449332,CID135449332,right_only,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C
,3236,Eperisone,,,,,,,,,,,,,,1158,Eperisone,1,,3236,CID3236,right_only,CCC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2
,3241,Epinastine,,,,,,,,,,,,,,1159,Epinastine,1,,3241,CID3241,right_only,C1C2C3=CC=CC=C3CC4=CC=CC=C4N2C(=N1)N
,17755248,Eribulin Mesylate,,,,,,,,,,,,,,1160,Eribulin Mesylate,1,,17755248,CID17755248,right_only,C[C@@H]1C[C@@H]2CC[C@H]3C(=C)C[C@@H](O3)CC[C@]45C[C@@H]6[C@H](O4)[C@H]7[C@@H](O6)[C@@H](O5)[C@@H]8[C@@H](O7)CC[C@@H](O8)CC(=O)C[C@H]9[C@H](C[C@H](C1=C)O2)O[C@@H]([C@@H]9OC)C[C@@H](CN)O.CS(=O)(=O)O
,702,Ethanol,,,,,,,,,,,,,,1161,Ethanol,1,,702,CID702,right_only,CCO
,3299,Ethyl loflazepate,,,,,,,,,,,,,,1162,Ethyl loflazepate,1,,3299,CID3299,right_only,CCOC(=O)C1C(=O)NC2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3F
,174,Ethylene glycol,,,,,,,,,,,,,,1163,Ethylene glycol,1,,174,CID174,right_only,C(CO)O
,3307,Etizolam,,,,,,,,,,,,,,1164,Etizolam,1,,3307,CID3307,right_only,CCC1=CC2=C(S1)N3C(=NN=C3CN=C2C4=CC=CC=C4Cl)C
,123619,Etoricoxib,,,,,,,,,,,,,,1165,Etoricoxib,1,,123619,CID123619,right_only,CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C
,65864,Flomoxef,,,,,,,,,,,,,,1166,Flomoxef,1,,65864,CID65864,right_only,CO[C@@]1([C@@H]2N(C1=O)C(=C(CO2)CSC3=NN=NN3CCO)C(=O)O)NC(=O)CSC(F)F
,68942,Fluindione,,,,,,,,,,,,,,1167,Fluindione,1,,68942,CID68942,right_only,C1=CC=C2C(=C1)C(=O)C(C2=O)C3=CC=C(C=C3)F
,3380,Flunitrazepam,,,,,,,,,,,,,,1168,Flunitrazepam,1,,3380,CID3380,right_only,CN1C(=O)CN=C(C2=C1C=CC(=C2)[N+](=O)[O-])C3=CC=CC=C3F
,53276,Flupirtine,,,,,,,,,,,,,,1169,Flupirtine,1,,53276,CID53276,right_only,CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N
,3407,Fominoben,,,,,,,,,,,,,,1170,Fominoben,1,,3407,CID3407,right_only,CN(CC1=C(C=CC=C1Cl)NC(=O)C2=CC=CC=C2)CC(=O)N3CCOCC3
,214356,Fosfluconazole,,,,,,,,,,,,,,1171,Fosfluconazole,1,,214356,CID214356,right_only,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)OP(=O)(O)O
,134669,Fudosteine,,,,,,,,,,,,,,1172,Fudosteine,1,,134669,CID134669,right_only,C(CO)CSC[C@@H](C(=O)O)N
,9883933,Gabapentin Enacarbil,,,,,,,,,,,,,,1173,Gabapentin Enacarbil,1,,9883933,CID9883933,right_only,CC(C)C(=O)OC(C)OC(=O)NCC1(CCCCC1)CC(=O)O
,3447,Gabexate,,,,,,,,,,,,,,1174,Gabexate,1,,3447,CID3447,right_only,CCOC(=O)C1=CC=C(C=C1)OC(=O)CCCCCN=C(N)N
,124093,Garenoxacin,,,,,,,,,,,,,,1175,Garenoxacin,1,,124093,CID124093,right_only,C[C@@H]1C2=C(CN1)C=C(C=C2)C3=C(C4=C(C=C3)C(=O)C(=CN4C5CC5)C(=O)O)OC(F)F
,124886,Glutathione,,,,,,,,,,,,,,1176,Glutathione,1,,124886,CID124886,right_only,C(CC(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C(=O)O)N
,753,Glycerol,,,,,,,,,,,,,,1177,Glycerol,1,,753,CID753,right_only,C(C(CO)O)O
,14982,Glycyrrhizin,,,,,,,,,,,,,,1178,Glycyrrhizin,1,,14982,CID14982,right_only,C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O[C@@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)C(=O)O)O)O)O)C)(C)C(=O)O
,37393,Halofantrine,,,,,,,,,,,,,,1179,Halofantrine,1,,37393,CID37393,right_only,CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O
,3590,Heptaminol,,,,,,,,,,,,,,1180,Heptaminol,1,,3590,CID3590,right_only,CC(CCCC(C)(C)O)N
,3663,Hypericin,,,,,,,,,,,,,,1181,Hypericin,1,,3663,CID3663,right_only,CC1=CC(=O)C2=C(C3=C(C=C(C4=C3C5=C2C1=C6C(=CC(=O)C7=C(C8=C(C=C(C4=C8C5=C67)O)O)O)C)O)O)O
,3671,Ibudilast,,,,,,,,,,,,,,1182,Ibudilast,1,,3671,CID3671,right_only,CC(C)C1=NN2C=CC=CC2=C1C(=O)C(C)C
,5311181,Iloprost,,,,,,,,,,,,,,1183,Iloprost,1,,5311181,CID5311181,right_only,CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)O)/C2)O)O
,3752,Irsogladine,,,,,,,,,,,,,,1184,Irsogladine,1,,3752,CID3752,right_only,C1=CC(=C(C=C1Cl)C2=NC(=NC(=N2)N)N)Cl
,3037209,Isepamicin,,,,,,,,,,,,,,1185,Isepamicin,1,,3037209,CID3037209,right_only,C[C@@]1(CO[C@@H]([C@@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H]([C@H]([C@@H]2O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CN)O)O)O)N)NC(=O)[C@H](CN)O)O
,12597,Isosorbide,,,,,,,,,,,,,,1186,Isosorbide,1,,12597,CID12597,right_only,C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)O)O
,3792,Itopride,,,,,,,,,,,,,,1187,Itopride,1,,3792,CID3792,right_only,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C=C2)OC)OC
,5282136,Lafutidine,,,,,,,,,,,,,,1188,Lafutidine,1,,5282136,CID5282136,right_only,C1CCN(CC1)CC2=CC(=NC=C2)OC/C=C\CNC(=O)CS(=O)CC3=CC=CO3
LT00617,71349,lanreotide acetate,2007,Less-DILI-Concern,2,Adverse reactions,,Ambiguous DILI-concern,,,,,CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)C(=O)NC(C(C)O)C(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=18281cb0-e1bf-4db6-b009-eb6ea96a4f64,2,1189,Lanreotide,1,,71349,CID71349,both,CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)C(=O)NC(C(C)O)C(=O)N
,65866,Lercanidipine,,,,,,,,,,,,,,1190,Lercanidipine,1,,65866,CID65866,right_only,CC1=C(C(C(=C(N1)C)C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC
,72180,Lodenosine,,,,,,,,,,,,,,1192,Lodenosine,1,,72180,CID72180,right_only,C1[C@H](O[C@H]([C@H]1F)N2C=NC3=C(N=CN=C32)N)CO
,13314,Lormetazepam,,,,,,,,,,,,,,1193,Lormetazepam,1,,13314,CID13314,right_only,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3Cl
,54690031,Lornoxicam,,,,,,,,,,,,,,1194,Lornoxicam,1,,54690031,CID54690031,right_only,CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3
,3965,Loxoprofen,,,,,,,,,,,,,,1195,Loxoprofen,1,,3965,CID3965,right_only,CC(C1=CC=C(C=C1)CC2CCCC2=O)C(=O)O
,4008,Manidipine,,,,,,,,,,,,,,1196,Manidipine,1,,4008,CID4008,right_only,CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC
,4020,Mazindol,,,,,,,,,,,,,,1197,Mazindol,1,,4020,CID4020,right_only,C1CN2C(=N1)C3=CC=CC=C3C2(C4=CC=C(C=C4)Cl)O
,5282367,Menatetrenone,,,,,,,,,,,,,,1198,Menatetrenone,1,,5282367,CID5282367,right_only,CC1=C(C(=O)C2=CC=CC=C2C1=O)C/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C
,4066,Mequitazine,,,,,,,,,,,,,,1199,Mequitazine,1,,4066,CID4066,right_only,C1CN2CCC1C(C2)CN3C4=CC=CC=C4SC5=CC=CC=C53
,26388,Metopimazine,,,,,,,,,,,,,,1200,Metopimazine,1,,26388,CID26388,right_only,CS(=O)(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCC(CC4)C(=O)N
,121891,Mitiglinide,,,,,,,,,,,,,,1201,Mitiglinide,1,,121891,CID121891,right_only,C1CC[C@H]2CN(C[C@H]2C1)C(=O)C[C@H](CC3=CC=CC=C3)C(=O)O
,104762,Mizoribine,,,,,,,,,,,,,,1202,Mizoribine,1,,104762,CID104762,right_only,C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)O)C(=O)N
,5353788,Molsidomine,,,,,,,,,,,,,,1203,Molsidomine,1,,5353788,CID5353788,right_only,CCO/C(=N/C1=C[N+](=NO1)N2CCOCC2)/[O-]
,119584,Mosapride,,,,,,,,,,,,,,1204,Mosapride,1,,119584,CID119584,right_only,CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N
,4810,Moxonidine,,,,,,,,,,,,,,1205,Moxonidine,1,,4810,CID4810,right_only,CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC
,4413,Nafamostat,,,,,,,,,,,,,,1206,Nafamostat,1,,4413,CID4413,right_only,C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N
,4417,Naftidrofuryl,,,,,,,,,,,,,,1207,Naftidrofuryl,1,,4417,CID4417,right_only,CCN(CC)CCOC(=O)C(CC1CCCO1)CC2=CC=CC3=CC=CC=C32
,4450,Nefopam,,,,,,,,,,,,,,1209,Nefopam,1,,4450,CID4450,right_only,CN1CCOC(C2=CC=CC=C2C1)C3=CC=CC=C3
,441306,Netilmicin,,,,,,,,,,,,,,1210,Netilmicin,1,,441306,CID441306,right_only,CCN[C@@H]1C[C@@H]([C@H]([C@@H]([C@H]1O[C@@H]2[C@@H]([C@H]([C@@](CO2)(C)O)NC)O)O)O[C@@H]3[C@@H](CC=C(O3)CN)N)N
,34040,Nicergoline,,,,,,,,,,,,,,1211,Nicergoline,1,,34040,CID34040,right_only,CN1C[C@@H](C[C@]2([C@H]1CC3=CN(C4=CC=CC2=C34)C)OC)COC(=O)C5=CC(=CN=C5)Br
,47528,Nicorandil,,,,,,,,,,,,,,1212,Nicorandil,1,,47528,CID47528,right_only,C1=CC(=CN=C1)C(=O)NCCO[N+](=O)[O-]
,4506,Nitrazepam,,,,,,,,,,,,,,1213,Nitrazepam,1,,4506,CID4506,right_only,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3
,4507,Nitrendipine,,,,,,,,,,,,,,1214,Nitrendipine,1,,4507,CID4507,right_only,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C
,2997,Nordazepam,,,,,,,,,,,,,,1215,Nordazepam,1,,2997,CID2997,right_only,C1C(=O)NC2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3
LT00211,6230,norethindrone,1973,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,HH,,Positive,,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac7391da-1789-493d-a025-dbc697f32e60,2,1216,Norethisterone,1,,6230,CID6230,both,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34
,5281071,Olopatadine,,,,,,,,,,,,,,1217,Olopatadine,1,,5281071,CID5281071,right_only,CN(C)CC/C=C\1/C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O
,4615,Oxatomide,,,,,,,,,,,,,,1218,Oxatomide,1,,4615,CID4615,right_only,C1CN(CCN1CCCN2C3=CC=CC=C3NC2=O)C(C4=CC=CC=C4)C5=CC=CC=C5
,4641,Oxyphenbutazone,,,,,,,,,,,,,,1219,Oxyphenbutazone,1,,4641,CID4641,right_only,CCCCC1C(=O)N(N(C1=O)C2=CC=C(C=C2)O)C3=CC=CC=C3
,5282440,Ozagrel,,,,,,,,,,,,,,1220,Ozagrel,1,,5282440,CID5282440,right_only,C1=CC(=CC=C1CN2C=CN=C2)/C=C/C(=O)O
,65957,Pazufloxacin,,,,,,,,,,,,,,1221,Pazufloxacin,1,,65957,CID65957,right_only,C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2C4(CC4)N)F)C(=O)O
,154234,Peramivir,,,,,,,,,,,,,,1222,Peramivir,1,,154234,CID154234,right_only,CCC(CC)[C@@H]([C@H]1[C@@H](C[C@@H]([C@H]1O)C(=O)O)N=C(N)N)NC(=O)C
,8249,Phenformin,,,,,,,,,,,,,,1223,Phenformin,1,,8249,CID8249,right_only,C1=CC=C(C=C1)CCN=C(N)N=C(N)N
,54680692,Phenprocoumon,,,,,,,,,,,,,,1224,Phenprocoumon,1,,54680692,CID54680692,right_only,CCC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O
,6041,Phenylephrine,,,,,,,,,,,,,,1225,Phenylephrine,1,,6041,CID6041,right_only,CNC[C@@H](C1=CC(=CC=C1)O)O
,359,Phloroglucinol,,,,,,,,,,,,,,1226,Phloroglucinol,1,,359,CID359,right_only,C1=C(C=C(C=C1O)O)O
,31018,Picolamine,,,,,,,,,,,,,,1227,Picolamine,1,,31018,CID31018,right_only,C1=CC(=CN=C1)CN
,4820,Pilsicainide,,,,,,,,,,,,,,1228,Pilsicainide,1,,4820,CID4820,right_only,CC1=C(C(=CC=C1)C)NC(=O)CC23CCCN2CCC3
,6509979,Pimecrolimus,,,,,,,,,,,,,,1229,Pimecrolimus,1,,6509979,CID6509979,right_only,CC[C@@H]1/C=C(/C[C@@H](C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC1=O)O)C)/C(=C/[C@@H]4CC[C@@H]([C@@H](C4)OC)Cl)/C)O)C)OC)OC)C)\C
,40704,Pinaverium,,,,,,,,,,,,,,1230,Pinaverium,1,,40704,CID40704,right_only,CC1(C2CCC(C1C2)CCOCC[N+]3(CCOCC3)CC4=CC(=C(C=C4Br)OC)OC)C
,19675,Piperacetazine,,,,,,,,,,,,,,1231,Piperacetazine,1,,19675,CID19675,right_only,CC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCC(CC4)CCO
,4842,Pipobroman,,,,,,,,,,,,,,1232,Pipobroman,1,,4842,CID4842,right_only,C1CN(CCN1C(=O)CCBr)C(=O)CCBr
,4843,Piracetam,,,,,,,,,,,,,,1233,Piracetam,1,,4843,CID4843,right_only,C1CC(=O)N(C1)CC(=O)N
,636397,Pirarubicin,,,,,,,,,,,,,,1234,Pirarubicin,1,,636397,CID636397,right_only,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O[C@H]6CCCCO6
,4887,Pranlukast,,,,,,,,,,,,,,1235,Pranlukast,1,,4887,CID4887,right_only,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5
,4888,Pranoprofen,,,,,,,,,,,,,,1236,Pranoprofen,1,,4888,CID4888,right_only,CC(C1=CC2=C(C=C1)OC3=C(C2)C=CC=N3)C(=O)O
,4890,Prazepam,,,,,,,,,,,,,,1237,Prazepam,1,,4890,CID4890,right_only,C1CC1CN2C(=O)CN=C(C3=C2C=CC(=C3)Cl)C4=CC=CC=C4
,68865,Propacetamol,,,,,,,,,,,,,,1238,Propacetamol,1,,68865,CID68865,right_only,CCN(CC)CC(=O)OC1=CC=C(C=C1)NC(=O)C
,4942,Propiverine,,,,,,,,,,,,,,1239,Propiverine,1,,4942,CID4942,right_only,CCCOC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OC3CCN(CC3)C
,135400182,Raltitrexed,,,,,,,,,,,,,,1240,Raltitrexed,1,,135400182,CID135400182,right_only,CC1=NC2=C(C=C(C=C2)CN(C)C3=CC=C(S3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)N1
,5042,Rebamipide,,,,,,,,,,,,,,1241,Rebamipide,1,,5042,CID5042,right_only,C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl
,68712,Rilmenidine,,,,,,,,,,,,,,1242,Rilmenidine,1,,68712,CID68712,right_only,C1CC1C(C2CC2)NC3=NCCO3
,9875401,Rivaroxaban,,,,,,,,,,,,,,1243,Rivaroxaban,1,,9875401,CID9875401,right_only,C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl
,91276,Roxatidine,,,,,,,,,,,,,,1244,Roxatidine,1,,91276,CID91276,right_only,C1CCN(CC1)CC2=CC(=CC=C2)OCCCNC(=O)CO
,338,Salicylic acid,,,,,,,,,,,,,,1245,Salicylic acid,1,,338,CID338,right_only,C1=CC=C(C(=C1)C(=O)O)O
,5160,Sarpogrelate,,,,,,,,,,,,,,1246,Sarpogrelate,1,,5160,CID5160,right_only,CN(C)CC(COC1=CC=CC=C1CCC2=CC(=CC=C2)OC)OC(=O)CCC(=O)O
,656822,Sennoside,,,,,,,,,,,,,,1247,Sennoside,1,,656822,CID656822,right_only,C1=CC2=C(C(=C1)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C(=O)C4=C(C2C5C6=C(C(=CC=C6)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)C(=O)C8=C5C=C(C=C8O)C(=O)O)C=C(C=C4O)C(=O)O
,5282219,Sofalcone,,,,,,,,,,,,,,1248,Sofalcone,1,,5282219,CID5282219,right_only,CC(=CCOC1=CC=C(C=C1)/C=C/C(=O)C2=C(C=C(C=C2)OCC=C(C)C)OCC(=O)O)C
,60464,Sparfloxacin,,,,,,,,,,,,,,1249,Sparfloxacin,1,,60464,CID60464,right_only,C[C@@H]1CN(C[C@@H](N1)C)C2=C(C(=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)N)F
,5329,Sulfamethoxazole,,,,,,,,,,,,,,1250,Sulfamethoxazole,1,,5329,CID5329,right_only,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N
,5355,Sulpiride,,,,,,,,,,,,,,1251,Sulpiride,1,,5355,CID5355,right_only,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC
,71774,Suplatast,,,,,,,,,,,,,,1252,Suplatast,1,,71774,CID71774,right_only,CCOCC(COC1=CC=C(C=C1)NC(=O)CC[S+](C)C)O
,91273,Tandospirone,,,,,,,,,,,,,,1253,Tandospirone,1,,91273,CID91273,right_only,C1C[C@H]2C[C@@H]1[C@H]3[C@@H]2C(=O)N(C3=O)CCCCN4CCN(CC4)C5=NC=CC=N5
,3010818,Telaprevir,,,,,,,,,,,,,,1254,Telaprevir,1,,3010818,CID3010818,right_only,CCC[C@@H](C(=O)C(=O)NC1CC1)NC(=O)[C@@H]2[C@H]3CCC[C@H]3CN2C(=O)[C@H](C(C)(C)C)NC(=O)[C@H](C4CCCCC4)NC(=O)C5=NC=CN=C5
,443874,Temocapril,,,,,,,,,,,,,,1255,Temocapril,1,,443874,CID443874,right_only,CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]2CS[C@@H](CN(C2=O)CC(=O)O)C3=CC=CS3
,5282199,Teprenone,,,,,,,,,,,,,,1256,Teprenone,1,,5282199,CID5282199,right_only,CC(=CCC/C(=C/CC/C(=C/CC/C(=C/CCC(=O)C)/C)/C)/C)C
,25215,Tetrazepam,,,,,,,,,,,,,,1257,Tetrazepam,1,,25215,CID25215,right_only,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CCCCC3
,5429,Theobromine,,,,,,,,,,,,,,1258,Theobromine,1,,5429,CID5429,right_only,CN1C=NC2=C1C(=O)NC(=O)N2C
,9915886,Thiocolchicoside,,,,,,,,,,,,,,1259,Thiocolchicoside,1,,9915886,CID9915886,right_only,CC(=O)N[C@H]1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)SC)OC)OC)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O
,5467,Tiapride,,,,,,,,,,,,,,1260,Tiapride,1,,5467,CID5467,right_only,CCN(CC)CCNC(=O)C1=C(C=CC(=C1)S(=O)(=O)C)OC
,5468,Tiaprofenic acid,,,,,,,,,,,,,,1261,Tiaprofenic acid,1,,5468,CID5468,right_only,CC(C1=CC=C(S1)C(=O)C2=CC=CC=C2)C(=O)O
,72160,Tiquizium,,,,,,,,,,,,,,1262,Tiquizium,1,,72160,CID72160,right_only,C[N@+]12CCCC[C@@H]1CCC(=C(C3=CC=CS3)C4=CC=CS4)C2
,38945,Tocainide,,,,,,,,,,,,,,1263,Tocainide,1,,38945,CID38945,right_only,CC1=C(C(=CC=C1)C)NC(=O)C(C)N
,108150,Trabectedin,,,,,,,,,,,,,,1264,Trabectedin,1,,108150,CID108150,right_only,CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)O)COC(=O)[C@@]8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O
,5282230,Tranilast,,,,,,,,,,,,,,1265,Tranilast,1,,5282230,CID5282230,right_only,COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC
,5531,Trapidil,,,,,,,,,,,,,,1266,Trapidil,1,,5531,CID5531,right_only,CCN(CC)C1=CC(=NC2=NC=NN12)C
,5560,Trichlormethiazide,,,,,,,,,,,,,,1267,Trichlormethiazide,1,,5560,CID5560,right_only,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl
,5573,Trimebutine,,,,,,,,,,,,,,1268,Trimebutine,1,,5573,CID5573,right_only,CCC(COC(=O)C1=CC(=C(C(=C1)OC)OC)OC)(C2=CC=CC=C2)N(C)C
,21109,Trimetazidine,,,,,,,,,,,,,,1269,Trimetazidine,1,,21109,CID21109,right_only,COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC
,198068,Tropatepine,,,,,,,,,,,,,,1270,Tropatepine,1,,198068,CID198068,right_only,CN1C2CCC1CC(=C3C4=CC=CC=C4CSC5=CC=CC=C53)C2
,5597,Troxipide,,,,,,,,,,,,,,1271,Troxipide,1,,5597,CID5597,right_only,COC1=CC(=CC(=C1OC)OC)C(=O)NC2CCCNC2
,5639,Urapidil,,,,,,,,,,,,,,1272,Urapidil,1,,5639,CID5639,right_only,CN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC
,71113,Valpromide,,,,,,,,,,,,,,1273,Valpromide,1,,71113,CID71113,right_only,CCCC(CCC)C(=O)N
,42611257,Vemurafenib,,,,,,,,,,,,,,1274,Vemurafenib,1,,42611257,CID42611257,right_only,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F
,40839,Vindesine,,,,,,,,,,,,,,1275,Vindesine,1,,40839,CID40839,right_only,CC[C@@]1(C[C@@H]2C[C@@](C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)[C@]78CCN9[C@H]7[C@@](C=CC9)([C@H]([C@@]([C@@H]8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O
,444020,Voglibose,,,,,,,,,,,,,,1276,Voglibose,1,,444020,CID444020,right_only,C1[C@@H]([C@@H]([C@H]([C@@H]([C@]1(CO)O)O)O)O)NC(CO)CO
,5709,Xylometazoline,,,,,,,,,,,,,,1277,Xylometazoline,1,,5709,CID5709,right_only,CC1=CC(=CC(=C1CC2=NCCN2)C)C(C)(C)C
,5720,Zaltoprofen,,,,,,,,,,,,,,1278,Zaltoprofen,1,,5720,CID5720,right_only,CC(C1=CC2=C(C=C1)SC3=CC=CC=C3C(=O)C2)C(=O)O
,5735,Zopiclone,,,,,,,,,,,,,,1279,Zopiclone,1,,5735,CID5735,right_only,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl
LT02031,6446,fluoxymesterone,1956,Most-DILI-Concern,8,Warnings and precautions,,Ambiguous DILI-concern,,,,,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5328c194-5650-4d1f-9e28-8cea038cce81,2,,fluoxymesterone,,,6446,,left_only,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O)F
LT00065,10133,chenodiol,1983,Most-DILI-Concern,8,Warnings and precautions,,Ambiguous DILI-concern,HH,,Positive,,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b8b4539b-31d1-40cb-b284-86cf8b16522a,2,,chenodiol,,,10133,,left_only,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C
LT00512,6335412,balsalazide,2000,Less-DILI-Concern,8,Adverse reactions,,Ambiguous DILI-concern,,,,,C1=CC(=CC=C1C(=O)NCCC(=O)O)N/N=C\2/C=CC(=O)C(=C2)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f12ffa32-d14b-e9d9-e957-2ef08b64e8b4,2,,balsalazide,,,54585,,left_only,C1=CC(=CC=C1C(=O)NCCC(=O)O)N=NC2=CC(=C(C=C2)O)C(=O)O
LT01206,119182,clofarabine,2004,Most-DILI-Concern,8,Warnings and precautions,,Ambiguous DILI-concern,,,,,C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)N=C(N=C2N)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c35903cd-e9eb-4841-93d1-fc14249d1e9f,2,,clofarabine,,,119182,,left_only,C1=NC2=C(N=C(N=C2N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)F)Cl)N
LT01600,4493,nilutamide,1996,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,Hepatotoxic,,,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d2e5c32-3221-4605-955f-37c6bb61aef7,2,,nilutamide,,,4493,,left_only,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C
LT00401,104741,fulvestrant,2002,Less-DILI-Concern,7,Adverse reactions,,Ambiguous DILI-concern,,,,,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=83d7a440-e904-4e36-afb5-cb02b1c919f7,2,,fulvestrant,,,104741,,left_only,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F
LT00381,5462501,enalaprilat,1988,Less-DILI-Concern,7,Adverse reactions,,Ambiguous DILI-concern,,,,,C[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N[C@@H](CCC2=CC=CC=C2)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b59da9a8-0fd0-42eb-8e95-1ce9a0fd6372,2,,enalaprilat,,,5462501,,left_only,C[C@@H](C(=O)N1CCC[C@H]1C(=O)O)N[C@@H](CCC2=CC=CC=C2)C(=O)O
LT02203,6445540,ixabepilone,2007,Less-DILI-Concern,7,Adverse reactions,,Ambiguous DILI-concern,,,,,C[C@H]1CCC[C@@]2([C@@H](O2)C[C@H](NC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C3=CSC(=N3)C)/C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e7992f6b-279b-46a7-b9c3-fea4e17718dc,2,,ixabepilone,,,6445540,,left_only,C[C@H]1CCC[C@@]2([C@@H](O2)C[C@H](NC(=O)C[C@@H](C(C(=O)[C@@H]([C@H]1O)C)(C)C)O)/C(=C/C3=CSC(=N3)C)/C)C
LT01406,3454,ganciclovir,1989,Less-DILI-Concern,7,Adverse reactions,,Ambiguous DILI-concern,,,,,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b47f5d1c-36b8-49b6-a410-3b3f4661dde7,1,,ganciclovir,,,135398740,,left_only,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N
LT01092,115355,nitisinone,2002,Less-DILI-Concern,7,Adverse reactions,,Ambiguous DILI-concern,,,,,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1eecf439-77ff-40c8-aef8-71e024ea8b7c,2,,nitisinone,,,115355,,left_only,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-]
LT00962,16130295,aprotinin,1993,Less-DILI-Concern,7,Adverse reactions,,Ambiguous DILI-concern,,,,,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N4CCC[C@H]4C(=O)N5CCC[C@H]5C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N6CCC[C@H]6C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3)CC(=O)O)CCC(=O)O)C)CO)CCCCN)CC7=CC=CC=C7)CC(=O)N)CC(=O)N)CCCNC(=N)N)CCCCN)C)CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CCC(=O)N)[C@@H](C)O)CC8=CC=CC=C8)C(C)C)CC9=CC=C(C=C9)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCNC(=N)N)C)CCCCN)[C@@H](C)O)CC1=CC=C(C=C1)O)CCC(=O)O)CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)CCCNC(=N)N)CCSC)CC(C)C)C)CCCCN)C)CC(=O)N)CC1=CC=C(C=C1)O)CC1=CC=CC=C1)CC1=CC=C(C=C1)O)CCCNC(=N)N)[C@@H](C)CC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8a5982c6-825f-4d05-90f5-1519a7291d15,2,,aprotinin,,,53487898,,left_only,CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N4CCC[C@H]4C(=O)N5CCC[C@H]5C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N6CCC[C@H]6C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N3)CC(=O)O)CCC(=O)O)C)CO)CCCCN)CC7=CC=CC=C7)CC(=O)N)CC(=O)N)CCCNC(=N)N)CCCCN)C)CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC2=O)CCC(=O)N)[C@@H](C)O)CC8=CC=CC=C8)C(C)C)CC9=CC=C(C=C9)O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCNC(=N)N)C)CCCCN)[C@@H](C)O)CC1=CC=C(C=C1)O)CCC(=O)O)CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(=N)N)N)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)CCCNC(=N)N)CCSC)CC(C)C)C)CCCCN)C)CC(=O)N)CC1=CC=C(C=C1)O)CC1=CC=CC=C1)CC1=CC=C(C=C1)O)CCCNC(=N)N)[C@@H](C)CC
LT00971,5280427,epoprostenol,1995,Less-DILI-Concern,7,Adverse reactions,,Ambiguous DILI-concern,,,,,CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1CC(=CCCCC(=O)O)O2)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=df502787-46ec-4dd1-a2c0-be90f6d95a5d,2,,epoprostenol,,,5282411,,left_only,CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1CC(=CCCCC(=O)O)O2)O)O
LT02929,146570,escitalopram,2002,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,,,,Postive,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2db02476-325f-ee47-a7e5-b5aed56c364c,2,,escitalopram,,,146570,,left_only,CN(C)CCC[C@@]1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F
LT00213,6503,tromethamine,1965,Less-DILI-Concern,6,Adverse reactions,,Ambiguous DILI-concern,NE,,Negative,,C(C(CO)(CO)N)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4af52118-c12b-4ad5-30bb-959848357e8a,2,,tromethamine,,,6503,,left_only,C(C(CO)(CO)N)O
LT01076,3698,amrinone,1984,Less-DILI-Concern,5,Adverse reactions,,Ambiguous DILI-concern,HH,,Positive,,C1=CN=CC=C1C2=CNC(=O)C(=C2)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42cd4847-b706-4d51-97e3-b736839c2d24,2,,amrinone,,,3698,,left_only,C1=CN=CC=C1C2=CNC(=O)C(=C2)N
LT01025,2754,cilostazol,1999,Less-DILI-Concern,5,Adverse reactions,,Ambiguous DILI-concern,,non-hepatotixic,,,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=66e0ed7b-e29a-45ee-82bb-3db6142c2697,2,,cilostazol,,,2754,,left_only,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4
LT01652,4740,pentoxifylline,1984,Less-DILI-Concern,5,Adverse reactions,,Ambiguous DILI-concern,,,,,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ff347283-b9ce-4570-8501-43cab7e2ecc8,2,,pentoxifylline,,,4740,,left_only,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C
LT01840,5576,trimethadione,1946,Most-DILI-Concern,5,Warnings and precautions,,Ambiguous DILI-concern,HH,,Positive,,CC1(C(=O)N(C(=O)O1)C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b9322f58-ffcc-4831-5381-93a535b49a09,2,,trimethadione,,,5576,,left_only,CC1(C(=O)N(C(=O)O1)C)C
LT01469,3759,isocarboxazid,1959,Most-DILI-Concern,5,Warnings and precautions,,Ambiguous DILI-concern,WE,,Negative,,CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac387aa0-3f04-4865-a913-db6ed6f4fdc5,1,,isocarboxazid,,,3759,,left_only,CC1=CC(=NO1)C(=O)NNCC2=CC=CC=C2
LT01520,4060,mephenytoin,1946,Less-DILI-Concern,5,Adverse reactions,,Ambiguous DILI-concern,,,,,CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9370d8e6-7db4-452d-9792-9093e7b4f4bd,2,,mephenytoin,,,4060,,left_only,CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2
LT01193,40976,etonogestrel,2006,Most-DILI-Concern,5,Warnings and precautions,,Ambiguous DILI-concern,,,,,CCC12CC(=C)C3C(C1CC[C@]2(C#C)O)CCC4=CC(=O)CCC34,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b03a3917-9a65-45c2-bbbb-871da858ef34,2,,etonogestrel,,,6917715,,left_only,CCC12CC(=C)C3C(C1CC[C@]2(C#C)O)CCC4=CC(=O)CCC34
LT01571,34633,moricizine,1990,Less-DILI-Concern,5,Adverse reactions,,Ambiguous DILI-concern,HH,,Positive,,CCOC(=O)NC1=CC2=C(C=C1)SC3=CC=CC=C3N2C(=O)CCN4CCOCC4,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8fe88f7-b72d-406b-a883-d3419a5e065a,2,,moricizine,,,34633,,left_only,CCOC(=O)NC1=CC2=C(C=C1)SC3=CC=CC=C3N2C(=O)CCN4CCOCC4
LT01527,4078,mesoridazine,1970,Less-DILI-Concern,5,Adverse reactions,,Ambiguous DILI-concern,HH,,Positive,,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)C,http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/16-774S073.pdf,2,,mesoridazine,,,4078,,left_only,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)C
LT01503,4011,maprotiline,1980,Less-DILI-Concern,5,Adverse reactions,,Ambiguous DILI-concern,WE,non-hepatotixic,Negative,,CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c3ca69e6-1ea0-4c2c-abcb-7264b2e79a87,1,,maprotiline,,,4011,,left_only,CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24
LT01273,71384,dexrazoxane,1995,Less-DILI-Concern,4,Adverse reactions,,Ambiguous DILI-concern,,,,,C[C@@H](CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=071340ec-9d21-484e-93d4-f49c98df8c5e,2,,dexrazoxane,,,71384,,left_only,C[C@@H](CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2
LT02343,4775,4-phenylbutyric acid,,Less-DILI-Concern,4,Adverse reactions,,Ambiguous DILI-concern,,,,,C1=CC=C(C=C1)CCCC(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa638c13-3048-42b2-8a8b-79dae040ea35,2,,4-phenylbutyric acid,,,4775,,left_only,C1=CC=C(C=C1)CCCC(=O)O
LT01063,68602,dexmedetomidine,1999,Less-DILI-Concern,4,Adverse reactions,,Ambiguous DILI-concern,,,,,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=548a88c0-afda-427e-75ac-5af0cfa2224c,2,,dexmedetomidine,,,5311068,,left_only,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C
LT00607,644241,nilotinib,2007,Most-DILI-Concern,4,Warnings and precautions,,Ambiguous DILI-concern,,,,,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6093952a-5248-45cb-ad17-33716a411146,2,,nilotinib,,,644241,,left_only,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
LT01589,9579578,esomeprazole Sodium,2001,Less-DILI-Concern,4,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC1=CN=C(C(=C1OC)C)C[S@@](=O)C2=NC3=C(N2)C=C(C=C3)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=61a5a84e-0194-4f11-91f8-83d7ac404932,2,,esomeprazole Sodium,,,46853837,,left_only,CC1=CN=C(C(=C1OC)C)C[S@@](=O)C2=NC3=C(N2)C=C(C=C3)OC
LT02064,61635,gallium nitrate,2003,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,NE,,Negative,,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Ga+3],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bc2ddf8-d695-46b3-bf76-9f85ce6027e3,2,,gallium nitrate,,,61635,,left_only,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Ga+3]
LT00933,5862,l-cysteine,1986,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,C([C@@H](C(=O)O)N)S,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=85669228-2bb1-4095-b90e-a467d357b9bb,2,,l-cysteine,,,5862,,left_only,C([C@@H](C(=O)O)N)S
LT00708,3520,guanidine,1939,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,Negative,C(=N)(N)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=903fbd33-e5d9-41fb-9414-7bd6f42a8593,2,,guanidine,,,3520,,left_only,C(=N)(N)N
LT00482,5961,l-glutamine,2004,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C(CC(=O)N)[C@@H](C(=O)O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cd3fb572-c5b1-43da-aea2-31208985f544,2,,l-glutamine,,,5961,,left_only,C(CC(=O)N)[C@@H](C(=O)O)N
LT00760,6049,edetic acid,1953,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=74435a8a-28a9-4080-93d0-d9d5f10b325e,2,,edetic acid,,,6049,,left_only,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O
LT01526,598,mesna,1988,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C(CS(=O)(=O)O)S,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4a51ffdb-f59f-4e02-b3c4-f3457ab7b514,2,,mesna,,,23662354,,left_only,C(CS(=O)(=O)O)S
LT01256,6058,cysteamine,1994,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C(CS)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f495b76d-96c6-48e5-8fa3-30a4336628eb,2,,cysteamine,,,6058,,left_only,C(CS)N
LT00985,3081884,glatiramer acetate,1996,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C[C@@H](C(=O)O)N.CC(=O)O.C1=CC(=CC=C1C[C@@H](C(=O)O)N)O.C(CCN)C[C@@H](C(=O)O)N.C(CC(=O)O)[C@@H](C(=O)O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aa88f583-4f5f-433b-80b4-1f4c9fb28357,2,,glatiramer acetate,,,3081884,,left_only,C[C@@H](C(=O)O)N.CC(=O)O.C1=CC(=CC=C1C[C@@H](C(=O)O)N)O.C(CCN)C[C@@H](C(=O)O)N.C(CC(=O)O)[C@@H](C(=O)O)N
LT00571,11597698,lisdexamfetamine,2007,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=704e4378-ca83-445c-8b45-3cfa51c1ecad,2,,lisdexamfetamine,,,11597698,,left_only,C[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCCCN)N
LT00623,73303,doripenem,2007,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ded65c55-db1c-4dab-a707-951e7cc87c79,2,,doripenem,,,73303,,left_only,C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1S[C@H]3C[C@H](NC3)CNS(=O)(=O)N)C(=O)O)[C@@H](C)O
LT00082,5743,dexamethasone,1958,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,non-hepatotixic,Negative,,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=95984c21-5734-4cba-a173-70eb88e3c8cf,1,,dexamethasone,,,5743,,left_only,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C
LT01757,15541,spectinomycin,1971,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,HH,,Positive,,C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=becf7b7a-508c-44ff-add0-558a60fd0067,2,,spectinomycin,,,15541,,left_only,C[C@@H]1CC(=O)[C@]2([C@@H](O1)O[C@@H]3[C@H]([C@@H]([C@@H]([C@@H]([C@H]3O2)NC)O)NC)O)O
LT01048,83898,cevimeline,2000,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C[C@@H]1O[C@]2(CN3CCC2CC3)CS1,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=773a19e8-4c3e-4414-99a6-aea98c9790ee,2,,cevimeline,,,83898,,left_only,C[C@@H]1O[C@]2(CN3CCC2CC3)CS1
LT01015,5281104,paricalcitol,1998,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C3C[C@H](C[C@@H](C3)O)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7c0687e0-de7e-4219-a711-ad75240ca69c,2,,paricalcitol,,,5281104,,left_only,C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C3C[C@H](C[C@@H](C3)O)O)C
LT00464,5281107,doxercalciferol,1999,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dc676bc5-f3f7-4755-92e1-1814498c1f4f,2,,doxercalciferol,,,5281107,,left_only,C[C@H](/C=C/[C@H](C)C(C)C)[C@H]1CC[C@@H]\2[C@@]1(CCC/C2=C\C=C/3\C[C@H](C[C@@H](C3=C)O)O)C
LT00484,25074887,cetrorelix,2000,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=aca7768e-28a7-4027-b1d8-e66247665f79,2,,cetrorelix,,,25074887,,left_only,C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C
LT00655,44151801,degarelix,2008,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C[C@H](C(=O)N)NC(=O)C1CCCN1C(=O)[C@H](CCCCNC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CC=C(C=C2)NC(=O)N)NC(=O)[C@H](CC3=CC=C(C=C3)NC(=O)[C@H]4CC(=O)NC(=O)N4)NC(=O)[C@H](CO)NC(=O)[C@@H](CC5=CN=CC=C5)NC(=O)[C@@H](CC6=CC=C(C=C6)Cl)NC(=O)[C@@H](CC7=CC8=CC=CC=C8C=C7)NC(=O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a89f93f-db62-846e-336e-ebbdb171056d,2,,degarelix,,,16136245,,left_only,C[C@H](C(=O)N)NC(=O)C1CCCN1C(=O)[C@H](CCCCNC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CC=C(C=C2)NC(=O)N)NC(=O)[C@H](CC3=CC=C(C=C3)NC(=O)[C@H]4CC(=O)NC(=O)N4)NC(=O)[C@H](CO)NC(=O)[C@@H](CC5=CN=CC=C5)NC(=O)[C@@H](CC6=CC=C(C=C6)Cl)NC(=O)[C@@H](CC7=CC8=CC=CC=C8C=C7)NC(=O)C
LT01195,151165,aprepitant,2003,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@H]2[C@H](N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ec44482e-6194-4829-a3f7-ebe8d48a41a5,2,,aprepitant,,,135413536,,left_only,C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F
LT00610,5353894,pralidoxime,1964,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CN\1C=CC=C/C1=C\[NH+]=O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2741d8fd-51c2-46be-880b-99f2b20a6137,2,,pralidoxime,,,135398747,,left_only,C[N+]1=CC=CC=C1/C=N/O
LT00673,148121,pralatrexate,2009,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5e4cf15b-bf7b-4b83-863e-e9ef27741a51,2,,pralatrexate,,,148121,,left_only,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
LT00340,27661,isosorbide mononitrate,,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C1[C@@H]([C@@H]2[C@H](O1)[C@@H](CO2)O[N+](=O)[O-])O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06faac0a-d719-4b54-85df-fdf3a5c6599f,1,,isosorbide mononitrate,,,27661,,left_only,C1[C@@H]([C@@H]2[C@H](O1)[C@@H](CO2)O[N+](=O)[O-])O
LT00956,37720,pentosan polysulfate,1996,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2CO[C@H]([C@@H]([C@H]2OS(=O)(=O)O)OS(=O)(=O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f0ba651e-3d8a-11df-8fbe-119855d89593,2,,pentosan polysulfate,,,37720,,left_only,C1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2CO[C@H]([C@@H]([C@H]2OS(=O)(=O)O)OS(=O)(=O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)O
LT01422,3519,guanfacine,1986,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9fc0bdc2-5ba2-48dd-aa87-7b0050a2d6ce,2,,guanfacine,,,3519,,left_only,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl
LT00564,129228,rufinamide,2008,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a3fa925-1abd-458a-bd57-4ae780a1ef2d,2,,rufinamide,,,129228,,left_only,C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F
LT01257,5270819,fosaprepitant,2008,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C1=CC(=CC=C1C2=NN=C(S2)NC3=CC=C(C=C3)Br)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=44f634f4-b794-4d55-8ab7-037fdef8ff0f,2,,fosaprepitant,,,135413538,,left_only,C1=CC(=CC=C1C2=NN=C(S2)NC3=CC=C(C=C3)Br)Cl
LT01157,60843,pemetrexed,2004,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)N[C@H](CCC(=O)O)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5a860f3-37ec-429c-ae04-9c88d7c55c08,2,,pemetrexed,,,135410875,,left_only,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O
LT01230,9690109,armodafinil,2007,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,C1=CC=C(C=C1)C(C2=CC=CC=C2)[S@](=O)CC(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0310a062-51fd-4e74-8a5f-7f21a16f52c9,2,,armodafinil,,,9690109,,left_only,C1=CC=C(C=C1)C(C2=CC=CC=C2)[S@](=O)CC(=O)N
LT01253,401,cycloserine,1964,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,C1C(C(=O)NO1)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=10727aa8-a03e-4b61-9a80-a024cb4a2d28,2,,cycloserine,,,6234,,left_only,C1C(C(=O)NO1)N
LT00668,5282451,pitavastatin,2009,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,C1C(C1)C2=NC3=CC=CC=C3C(=C2/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C4=CC=C(C=C4)F.C1C(C1)C2=NC3=CC=CC=C3C(=C2/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C4=CC=C(C=C4)F.[Ca+2],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b3c41a2f-da77-4465-8af6-038006a7ea58,2,,pitavastatin,,,5282452,,left_only,C1C(C1)C2=NC3=CC=CC=C3C(=C2/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C4=CC=C(C=C4)F.C1C(C1)C2=NC3=CC=CC=C3C(=C2/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C4=CC=C(C=C4)F.[Ca+2]
LT00964,2182,anagrelide,1997,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,C1C2=C(C=CC(=C2Cl)Cl)NC3=NC(=O)CN31,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6727d5d4-e8ec-4a85-bc82-ec70b641eecf,2,,anagrelide,,,135409400,,left_only,C1C2=C(C=CC(=C2Cl)Cl)N=C3N1CC(=O)N3
LT00896,27991,desmopressin,1978,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=043be50e-73b5-45bf-9316-776d4f675170,2,,desmopressin,,,5311065,,left_only,C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N
LT00294,3108,dipyridamole,1961,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,NE,,Negative,,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dcf785b2-e923-43bf-93bb-00a9501479f4,2,,dipyridamole,,,3108,,left_only,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO
LT00322,4101,methenamine hippurate ,1967,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,C1N2CN3CN1CN(C2)C3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ad741dc5-816c-4ab2-9273-9b1a586149bc,2,,methenamine hippurate,,,21945,,left_only,C1N2CN3CN1CN(C2)C3
LT00660,219078,lacosamide,2008,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,CC(=O)N[C@H](COC)C(=O)NCC1=CC=CC=C1,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9e79b42c-38a3-4b2c-a196-a5a1948250e2,2,,lacosamide,,,219078,,left_only,CC(=O)N[C@H](COC)C(=O)NCC1=CC=CC=C1
LT00913,1990,acetohydroxamic acid,1983,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,Negative,CC(=O)NO,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6660b616-a82d-9109-19ce-2bdf9747acea,2,,acetohydroxamic acid,,,1990,,left_only,CC(=O)NO
LT01818,5483,tiopronin,1988,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,CC(C(=O)NCC(=O)O)S,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=494a714e-923c-cd57-df6c-12886afb265a,2,,tiopronin,,,5483,,left_only,CC(C(=O)NCC(=O)O)S
LT01109,64147,valganciclovir,2001,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1NC(=NC2=O)N)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dc548ff9-e8ea-4d6e-b9b4-e31f53ac4078,2,,valganciclovir,,,135413535,,left_only,CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N
LT00939,47725,goserelin,1989,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6bd94a89-f18a-45e5-d0a4-b343a4f0f03d,2,,goserelin,,,5311128,,left_only,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6
LT01239,6018,tetrabenazine,2008,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac768bab-8afa-4446-bc7f-caeeffec0cda,2,,tetrabenazine,,,6018,,left_only,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC
LT01055,65016,amprenavir,1999,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a05ef847-96e1-4f95-b35f-92c907df1e1f,2,,amprenavir,,,65016,,left_only,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N
LT01194,131536,fosamprenavir,2003,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=24feb9be-32a6-45fd-a896-f3e202edd8a9,2,,fosamprenavir,,,131536,,left_only,CC(C)CN(C[C@H]([C@H](CC1=CC=CC=C1)NC(=O)O[C@H]2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N
LT00946,62937,metoprolol succinate,1978,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,O(c1ccc(cc1)CCOC)CC(O)CNC(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=71c1d33e-be6f-6d59-b715-45075445891a,2,,metoprolol succinate,,,62937,,left_only,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.C(CC(=O)O)C(=O)O
LT00298,3394,flurbiprofen,1986,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,HH,,Positive,,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=972b557c-1abb-4032-89f9-2d6cfde422e7,1,,flurbiprofen,,,3394,,left_only,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O
LT01013,16132441,lepirudin,1998,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CN=CN3)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N5CCC[C@H]5C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC6=CC=C(C=C6)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC7=CC=C(C=C7)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6d4819a3-b934-40a8-a967-947cc456c53c,2,,lepirudin,,,118856773,,left_only,CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC3=CN=CN3)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N5CCC[C@H]5C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC6=CC=C(C=C6)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC7=CC=C(C=C7)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)N
LT01671,5910,pilocarpine,1974,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,NE,,Negative,,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=16b10412-0031-4e7b-b510-99ae89b138e5,2,,pilocarpine,,,5910,,left_only,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2C
LT01511,4037,meclofenamic acid,1980,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,HH,,Positive,Negative,CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)O)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=96f19af4-de8f-4fd7-90d8-55fe6ebdd81d,2,,meclofenamic acid,,,4037,,left_only,CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)O)Cl
LT00338,444795,tretinoin,1971,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,HH,Hepatotoxic,,Negative,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0f81f505-a962-414e-8612-c3ef3b159e9a,2,,tretinoin,,,444795,,left_only,CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C
LT00931,4197,milrinone,1987,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac43ba6b-635d-4129-8eea-96f3f5a4785e,2,,milrinone,,,4197,,left_only,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2
LT01843,5583,trimetrexate,1993,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,CC1=C(C=CC2=C1C(=NC(=N2)N)N)CNC3=CC(=C(C(=C3)OC)OC)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ad0f8925-f817-4460-aa6b-172a043a440b,2,,trimetrexate,,,5583,,left_only,CC1=C(C=CC2=C1C(=NC(=N2)N)N)CNC3=CC(=C(C(=C3)OC)OC)OC
LT01075,5362420,verteporfin**,2000,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31512723-9ff0-4e18-aa3a-55ab833038c6,2,,verteporfin,,,5362420,,left_only,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5[C@@]6([C@@H](C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C
LT00310,446541,mycophenolic acid,2004,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CC1=C(C(=C(C2=C1COC2=O)O)C/C=C(\C)/CCC(=O)O)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eed26501-890d-4ff6-88e7-6dbea4726e53,2,,mycophenolic acid,,,446541,,left_only,CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)O)O
LT01258,11953898,hydroxocobalamin,1978,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@@H](C)CNC(=O)CC[C@@]\4([C@H](C5[C@]6([C@@]([C@@H](C(=N6)/C(=C\7/[C@@]([C@@H](C(=N7)/C=C\8/C([C@@H](C(=N8)/C(=C4\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=416c7978-5661-6e63-6546-6f7265766572,2,,hydroxocobalamin,,,70689311,,left_only,CC1=CC2=C(C=C1C)N(C=N2)[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)([O-])O[C@@H](C)CNC(=O)CC[C@@]\4([C@H](C5[C@]6([C@@]([C@@H](C(=N6)/C(=C\7/[C@@]([C@@H](C(=N7)/C=C\8/C([C@@H](C(=N8)/C(=C4\[N-]5)/C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)/C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co]
LT00494,3406,fomepizole,1997,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,CC1=CNN=C1,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f82eb104-ac36-4908-96fe-9d64318597e8,2,,fomepizole,,,3406,,left_only,CC1=CNN=C1
LT00865,3019,diazoxide,1973,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b16c7832-2fd9-49af-b923-1dc0d91fd6e2,2,,diazoxide,,,3019,,left_only,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl
LT00707,2479,butabarbital,1939,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CCC(C)C1(C(=O)NC(=O)NC1=O)CC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7883bbc0-0874-11dc-a818-0002a5d5c51b,2,,butabarbital,,,2479,,left_only,CCC(C)C1(C(=O)NC(=O)NC1=O)CC
LT01491,656509,lincomycin,1964,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,Negative,CCC[C@@H]1CC(N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c01906fa-2c73-4c13-9765-2fd06628d263,2,,lincomycin,,,3000540,,left_only,CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O
LT02346,443385,clindamycin-2-phosphate,,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)OP(=O)(O)O)O)O)[C@H](C)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7741156f-b98f-4975-a7e3-1c7d508a6a14,2,,clindamycin-2-phosphate,,,443385,,left_only,CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)OP(=O)(O)O)O)O)[C@H](C)Cl
LT00803,9034,methohexital,1960,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CCC#CC(C)C1(C(=O)NC(=O)N(C1=O)C)CC=C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=eccd8340-ead3-4363-8902-0c19d33aa2ac,2,,methohexital,,,9034,,left_only,CCC#CC(C)C1(C(=O)NC(=O)N(C1=O)C)CC=C
LT00130,4737,pentobarbital,1973,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5c380ab0-4386-48b6-80ab-ca594b23bc74,2,,pentobarbital,,,4737,,left_only,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC
LT00922,5282381,misoprostol,1988,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CCCCC(C)(C/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)OC)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4179736a-1cb2-4661-8c50-3d68ec7f4025,2,,misoprostol,,,5282381,,left_only,CCCCC(C)(C/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)OC)O)O
LT00909,16078,marinol,1985,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,Negative,CCCCCC1=CC2=C([C@@H]3C=C(CC[C@H]3C(O2)(C)C)C)C(=C1)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=68b4168b-5782-4e68-a25a-5b4e4408dbce,2,,marinol,,,16078,,left_only,CCCCCC1=CC(=C2[C@@H]3C=C(CC[C@H]3C(OC2=C1)(C)C)C)O
LT02427,52919,haloperidol decanoate,,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CCCCCCCCCC(=O)OC1(CCN(CC1)CCCC(=O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5632ada4-05bd-4638-a27a-81d37a66a084,2,,haloperidol decanoate,,,52919,,left_only,CCCCCCCCCC(=O)OC1(CCN(CC1)CCCC(=O)C2=CC=C(C=C2)F)C3=CC=C(C=C3)Cl
LT00795,3292,ethotoin,1957,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,CCN1C(=O)C(NC1=O)C2=CC=CC=C2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9ad9c6e-bce5-4d0d-a2dd-b8fd1ef0b565,2,,ethotoin,,,3292,,left_only,CCN1C(=O)C(NC1=O)C2=CC=CC=C2
LT01587,4421,nalidixic acid,1964,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,HH,,Positive,Negative,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d61be7a2-0f54-44c2-9ed0-2316f4cb6128,2,,nalidixic acid,,,4421,,left_only,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O
LT00426,25084151,histrelin acetate,1991,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CN(C=N2)CC3=CC=CC=C3)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8.CC(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=78b88748-8318-11dc-8314-0800200c9a66,2,,histrelin acetate,,,25084151,,left_only,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC2=CN(C=N2)CC3=CC=CC=C3)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC5=CNC6=CC=CC=C65)NC(=O)[C@H](CC7=CN=CN7)NC(=O)[C@@H]8CCC(=O)N8.CC(=O)O
LT00628,29327,streptozocin,1982,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,NE,,Negative,,CN(C(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1O)CO)O)O)N=O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=15d161ed-9e7b-4c92-ba45-0556d2423e67,1,,streptozocin,,,29327,,left_only,CN(C(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@@H]1O)CO)O)O)N=O
LT00158,3005573,toremifene,1997,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,CN(C)CCOC1=CC=C(C=C1)/C(=C(/CCCl)\C2=CC=CC=C2)/C3=CC=CC=C3,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2cab8dd1-3a10-48e6-86ce-0e5275ed49e5,1,,toremifene,,,3005573,,left_only,CN(C)CCOC1=CC=C(C=C1)/C(=C(/CCCl)\C2=CC=CC=C2)/C3=CC=CC=C3
LT01178,50614,cefotetan,1985,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,NE,,Negative,,CN1C(=NN=N1)SCC2=C(N3C([C@@](C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)O)S4)OC)SC2)C(=O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bd22c66b-8a1c-44c8-b5b6-3ab0ce5c800e,2,,cefotetan,,,53025,,left_only,CN1C(=NN=N1)SCC2=C(N3C([C@@](C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)O)S4)OC)SC2)C(=O)O
LT00951,60754,gadodiamide,1993,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d539c8b2-13fe-4ba2-994e-b4d0ee1ef490,2,,gadodiamide,,,153921,,left_only,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3]
LT01093,518740,arsenic trioxide,2000,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,HH,,Positive,,O1[As]2O[As]1O2,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dec51fab-3784-deb7-752f-2d4d5692a20f,2,,arsenic trioxide,,,518740,,left_only,O1[As]2O[As]1O2
LT02043,5870,estrone,1979,Less-DILI-Concern,2,Warnings and precautions,,Ambiguous DILI-concern,HH,,Positive,,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=09ff0633-2992-4aba-96ed-45a69f3ee589,2,,estrone,,,5870,,left_only,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)O
LT00677,5284555,estropipate,1977,Less-DILI-Concern,2,Adverse reactions,,Ambiguous DILI-concern,,,,,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O.C1CNCCN1,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5ee9f406-8fdb-467f-9019-f9c11423bd91,2,,estropipate,,,5284555,,left_only,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O.C1CNCCN1
LT01513,10631,medroxyprogesterone,1959,Less-DILI-Concern,2,Adverse reactions,,Ambiguous DILI-concern,WE,,Negative,,C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2627eb11-06bf-4a45-9172-094468e3ca07,2,,medroxyprogesterone,,,10631,,left_only,C[C@H]1C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C
LT00969,5665,vigabatrin,2009,Less-DILI-Concern,2,Adverse reactions,,Ambiguous DILI-concern,,,,,C=CC(CCC(=O)O)N,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a5d389d2-d0e1-4395-a2a2-b552808e7f98,2,,vigabatrin,,,5665,,left_only,C=CC(CCC(=O)O)N
LT00814,3647,hydroflumethiazide,1959,Less-DILI-Concern,2,Adverse reactions,,Ambiguous DILI-concern,,,,,C1NC2=C(C=C(C(=C2)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N1,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6153ef9e-77f0-4233-a5bc-3e3d1f732323,2,,hydroflumethiazide,,,3647,,left_only,C1NC2=C(C=C(C(=C2)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N1
LT00110,6238,hydroxyprogesterone caproate,1975,Less-DILI-Concern,2,Warnings and precautions,,Ambiguous DILI-concern,,,,,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a1998c1d-8337-4f00-8dcb-af3b54d39b77,2,,hydroxyprogesterone caproate,,,169870,,left_only,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O
LT00654,71360,iloperidone,2009,Less-DILI-Concern,2,Adverse reactions,,Ambiguous DILI-concern,,,,,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=43452bf8-76e7-47a9-a5d8-41fe84d061f0,2,,iloperidone,,,71360,,left_only,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC
LT00670,64928,fenofibric acid,2009,Less-DILI-Concern,2,Warnings and precautions,,Ambiguous DILI-concern,,,,,CC(C(=O)O)OC1=CC=C(C=C1)OC2=CC=C(C=C2)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3990db09-2395-4ec9-9426-d61d9aa7aefc,2,,fenofibric acid,,,64929,,left_only,CC(C(=O)O)OC1=CC=C(C=C1)OC2=CC=C(C=C2)Cl
LT01844,5584,trimipramine,1979,Less-DILI-Concern,2,Adverse reactions,,Ambiguous DILI-concern,,,,,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0177d783-773c-41bf-9db9-eb7e5c64474a,2,,trimipramine,,,5584,,left_only,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C
LT00639,41781,torasemide,1993,Less-DILI-Concern,2,Warnings and precautions,,Ambiguous DILI-concern,,non-hepatotixic,,,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8a95cbdb-0601-47a5-9b3a-0c3b0629ceb9,2,,torasemide,,,41781,,left_only,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C
LT00833,4121,methyclothiazide,1960,Less-DILI-Concern,2,Adverse reactions,,Ambiguous DILI-concern,,,,Negative,CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CCl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4910dad2-c533-4232-85bf-e6b0235379c2,2,,methyclothiazide,,,4121,,left_only,CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CCl
LT01805,941651,thiothixene,1967,Less-DILI-Concern,2,Warnings and precautions,,Ambiguous DILI-concern,WE,,Negative,,CN1CCN(CC1)CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=92a1f215-e063-4c3e-89f5-f56d78a4c64e,2,,thiothixene,,,941651,,left_only,CN1CCN(CC1)CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)S(=O)(=O)N(C)C
LT02424,23676225,"Estrogens, Conjugated",1942,Less-DILI-Concern,1,Adverse reactions,,Ambiguous DILI-concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=258e1602-a3cf-4ccc-ca80-73dbbfb812ff,2,,"Estrogens, Conjugated",,,23676225,,left_only,C[C@]12CC[C@H]3C(=CCC4=C3C=CC(=C4)OS(=O)(=O)[O-])[C@@H]1CCC2=O.[Na+]
LT00220,19090,megestrol,1971,Less-DILI-Concern,1,Adverse reactions,,Ambiguous DILI-concern,,,,,CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fd97ca46-3f69-440b-80f1-28fed4544f2a,2,,megestrol,,,19090,,left_only,CC1=C[C@@H]2[C@H](CC[C@]3([C@H]2CC[C@@]3(C(=O)C)O)C)[C@@]4(C1=CC(=O)CC4)C
LT01855,31401,ursodeoxycholic acid,1987,Less-DILI-Concern,0,Warnings and precautions,,Ambiguous DILI-concern,,,Negative,,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e8fc4fc2-fe5c-4cba-b6e0-5ceaf2157a61,2,,ursodeoxycholic acid,,,31401,,left_only,C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C
LT01437,3658,hydroxyzine,1956,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,non-hepatotixic,,,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8e5fce17-936e-46ea-a969-518c952c2091,1,,hydroxyzine,,,3658,,left_only,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
LT02086,4086,orciprenaline,1973,No-DILI-Concern,0,No match,,vNo-DILI-Concern,HH,,Positive,,CC(C)NCC(C1=CC(=CC(=C1)O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=43ff5156-e08b-4dc4-93a6-8c727676daa1,1,,orciprenaline,,,4086,,left_only,CC(C)NCC(C1=CC(=CC(=C1)O)O)O
LT02093,3202,edrophonium,1951,No-DILI-Concern,0,No match,,vNo-DILI-Concern,NE,,Negative,Negative,CC[N+](C)(C)C1=CC(=CC=C1)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=98a5a2f6-3194-4202-963f-0fcd28ecadbc,1,,edrophonium,,,3202,,left_only,CC[N+](C)(C)C1=CC(=CC=C1)O
LT00477,NOCID_054,gemtuzumab ozogamicin,2000,Most-DILI-Concern,8,Box warning,,vMost-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=32fd2bb2-1cfa-4250-feb8-d7956c794e05,1,227,gemtuzumab ozogamicin,1,Intravenous,NOCID_054,CIDNOCID_054,both,
LT00725,NOCID_022,hyaluronidase,1950,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8396ea96-7cb5-4e26-87a4-90bca9c3c6dd,2,344,hyaluronidase,0,Subcutaneous,NOCID_022,CIDNOCID_022,both,
LT00728,NOCID_042,protamine sulfate,1969,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e1964129-33f4-4e4e-86e3-8e6a4e65bd83,2,346,protamine sulfate,0,Intravenous,NOCID_042,CIDNOCID_042,both,
LT00751,NOCID_050,thyrotropin alfa,1953,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b52dfa36-f90b-4e19-9b5e-26db9d04df2b,2,354,thyrotropin alfa,0,Intramuscular,NOCID_050,CIDNOCID_050,both,
LT00888,NOCID_048,somatropin recombinant,1987,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=58d84ffa-4056-4e36-ad67-7bd4aef444a5,2,400,somatropin recombinant,0,Subcutaneous,NOCID_048,CIDNOCID_048,both,
LT00941,NOCID_040,pegademase bovine,1990,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9880b900-ea23-11dc-ad56-0002a5d5c51b,2,419,pegademase bovine,0,Intramuscular,NOCID_040,CIDNOCID_040,both,
LT00954,25244225,enoxaparin,1993,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C([C@@H]1C([C@@H](C(C(O1)O)NS(=O)(=O)[O-])O)O[C@H]2C([C@H](C(C(O2)C(=O)[O-])O)O)OS(=O)(=O)[O-])OS(=O)(=O)[O-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3e6bf2b3-9339-4104-bda3-ad86a1949703,2,424,enoxaparin,1,Subcutaneous,772,CID772,both,
LT00961,NOCID_016,dalteparin sodium,1994,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,C(C1C(C(C(C(O1)O)NS(=O)(=O)[O-])O)OC2C(C(C(C(O2)C(=O)[O-])O)O)OS(=O)(=O)[O-])OS(=O)(=O)[O-],http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c5cd4a8e-14c0-440b-b453-9f3d3250c951,2,427,dalteparin sodium,1,Subcutaneous,NOCID_016,CIDNOCID_016,both,
LT00966,NOCID_020,ferumoxsil,1996,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=67f778f2-8af3-4d4e-850a-e8f3a54743b7,2,428,ferumoxsil,0,Oral,NOCID_020,CIDNOCID_020,both,
LT00995,174,polyethylene glycol 3350**,1999,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6b95dddc-4265-416b-954a-683a592a6cfd,2,443,polyethylene glycol 3350,0,Oral,174,CID174,both,
LT01229,NOCID_052,urokinase,2007,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bfe5cfb9-591d-4df8-12a3-6555cde3185d,2,584,urokinase,0,Intravenous,NOCID_052,CIDNOCID_052,both,
LT01303,NOCID_008,asparaginase,1994,Most-DILI-Concern,7,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a03b1720-54cf-4779-9924-2fd617bf1eb9,2,619,asparaginase,1,Intravenous,NOCID_008,CIDNOCID_008,both,
LT01305,NOCID_011,botulinum toxin type a,1991,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=485d9b71-6881-42c5-a620-a4360c7192ab,2,620,botulinum toxin type a,0,Intramuscular,NOCID_011,CIDNOCID_011,both,
LT01311,NOCID_028,"interferon alfa-2a, recombinant",1986,Most-DILI-Concern,8,Warnings and precautions,Yes(literature),vMost-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4c918b02-f158-4f7c-8ecc-fd49574ec228,2,624,"interferon alfa-2a, recombinant",1,Subcutaneous,NOCID_028,CIDNOCID_028,both,
LT01315,NOCID_007,alteplase,1996,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=91ecdef2-95ff-42dd-a31c-c8a09cab3ad9,2,627,alteplase,0,Intravenous,NOCID_007,CIDNOCID_007,both,
LT01321,NOCID_047,sargramostim,1991,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c96afe62-f0cf-4d4b-b57d-194a8ec12389,2,631,sargramostim,0,Intravenous,NOCID_047,CIDNOCID_047,both,
LT01322,436058,pegaspargase**,1994,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC1=CC(=C(C=C1)C(=O)C(=C)CN(C)C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d933e1d1-06b7-4d70-981f-3e8984b0683f,2,632,pegaspargase,1,Intravenous,NOCID_084,CIDNOCID_084,both,
LT01326,NOCID_032,muromonab-cd3,1992,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2a1f1c18-fa95-45e6-bd00-ac53c73f4747,2,634,muromonab-cd3,0,Intravenous,NOCID_032,CIDNOCID_032,both,
LT01328,NOCID_031,interferon beta-1b,1993,Most-DILI-Concern,7,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=261fde67-efb2-4bd7-947e-4f68a56e76ff,2,635,interferon beta-1b,1,Subcutaneous,NOCID_031,CIDNOCID_031,both,
LT01330,NOCID_002,abciximab,1993,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=033d4c3b-4630-4256-b8f7-9ed5f15de9a3,2,636,abciximab,0,Intravenous,NOCID_002,CIDNOCID_002,both,
LT01332,NOCID_030,interferon beta-1a,1996,Most-DILI-Concern,7,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d4fa325-4e86-4ef2-9861-5420653e34f6,2,637,interferon beta-1a,1,Intramuscular,NOCID_030,CIDNOCID_030,both,
LT01336,NOCID_029,interferon alfacon-1,1997,Most-DILI-Concern,7,Warnings and precautions,Yes(literature),vMost-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a7248eca-45d6-472d-8c2a-d8887c2594d5,2,640,interferon alfacon-1,1,Subcutaneous,NOCID_029,CIDNOCID_029,both,
LT01339,NOCID_036,oprelvekin,1997,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6408f6b7-8794-4dd5-2db6-0b44660c586d,2,641,oprelvekin,0,Subcutaneous,NOCID_036,CIDNOCID_036,both,
LT01346,NOCID_009,basiliximab,1998,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1af01887-b69d-444b-91ed-ebfe12784440,2,644,basiliximab,0,Intravenous,NOCID_009,CIDNOCID_009,both,
LT01349,NOCID_038,palivizumab,1998,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8e35c4c8-bf56-458f-a73c-8f5733829788,2,646,palivizumab,0,Intramuscular,NOCID_038,CIDNOCID_038,both,
LT01350,NOCID_027,infliximab,1998,Most-DILI-Concern,8,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a0a046c1-056d-45a9-bfd9-13b47c24f257,2,647,infliximab,1,Intravenous,NOCID_027,CIDNOCID_027,both,
LT01351,NOCID_044,reteplase,1996,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e9ae6656-977c-4105-8528-bee664aab27a,2,648,reteplase,0,Intravenous,NOCID_044,CIDNOCID_044,both,
LT01352,NOCID_051,trastuzumab,1998,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=492dbdb2-077e-4064-bff3-372d6af0a7a2,2,649,trastuzumab,1,Intravenous,NOCID_051,CIDNOCID_051,both,
LT01353,NOCID_019,etanercept,1998,Less-DILI-Concern,3,Warnings and precautions,Yes,vLess-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a002b40c-097d-47a5-957f-7a7b1807af7f,2,650,etanercept,1,Subcutaneous,NOCID_019,CIDNOCID_019,both,
LT01356,NOCID_012,botulinum toxin type b,2000,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=675cb354-9d13-482e-8ac2-22f709c58b4f,2,652,botulinum toxin type b,0,Intramuscular,NOCID_012,CIDNOCID_012,both,
LT01360,NOCID_049,tenecteplase,2000,No-DILI-concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=69e391bf-1250-4083-aa60-6aa41c33657f ,2,655,tenecteplase,0,Intravenous,NOCID_049,CIDNOCID_049,both,
LT01363,NOCID_043,rasburicase,2002,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0ae10bc4-6b65-402f-9db5-2d7753054922,2,656,rasburicase,0,Intravenous,NOCID_043,CIDNOCID_043,both,
LT01364,NOCID_005,alemtuzumab,2001,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4f5f7255-7abc-4328-bd1a-ceaf139ef3e0,2,657,alemtuzumab,0,Intravenous,NOCID_005,CIDNOCID_005,both,
LT01367,NOCID_041,peginterferon alfa-2b,2001,Most-DILI-Concern,4,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a8f3137-0e3a-4a60-a872-cb7d761b30e1,2,658,peginterferon alfa-2b,1,Subcutaneous,NOCID_041,CIDNOCID_041,both,
LT01374,NOCID_017,darbepoetin alfa,2001,No-DILI-Concern,0,No match,Yes,vLess-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0fd36cb9-c4f6-4167-93c9-8530865db3f9,2,663,darbepoetin alfa,1,Intravenous,NOCID_017,CIDNOCID_017,both,
LT01377,NOCID_035,omalizumab,2003,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7f6a2191-adfb-48b9-9bfa-0d9920479f0d,2,665,omalizumab,0,Subcutaneous,NOCID_035,CIDNOCID_035,both,
LT01378,NOCID_024,ibritumomab tiuxetan,2002,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ccf29429-bf8e-4cce-bd12-1de56853fc5b,2,666,ibritumomab tiuxetan,0,Intravenous,NOCID_024,CIDNOCID_024,both,
LT01387,NOCID_003,adalimumab,2002,Less-DILI-Concern,7,Adverse reactions,Yes,vLess-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=608d4f0d-b19f-46d3-749a-7159aa5f933d ,2,671,adalimumab,1,Subcutaneous,NOCID_003,CIDNOCID_003,both,
LT01389,NOCID_015,cetuximab,2004,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bc6397e-4bd8-4d37-a007-a327e4da34d9,2,672,cetuximab,0,Intravenous,NOCID_015,CIDNOCID_015,both,
LT01390,NOCID_010,bevacizumab,2004,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=939b5d1f-9fb2-4499-80ef-0607aa6b114e,2,673,bevacizumab,0,Intravenous,NOCID_010,CIDNOCID_010,both,
LT01392,NOCID_037,palifermin,2004,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=426f6e64-2c20-4a61-6d65-7320426f6e64,2,674,palifermin,0,Intravenous,NOCID_037,CIDNOCID_037,both,
LT01393,NOCID_033,natalizumab,2004,Most-DILI-Concern,5,Warnings and precautions,Yes,vMost-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6fa00cb8-4229-4770-9d2a-d4a8542b3180,2,675,natalizumab,1,Intravenous,NOCID_033,CIDNOCID_033,both,
LT01401,NOCID_021,galsulfase,2005,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=59341250-deac-ed71-3823-a4f5d64dbd77,2,682,galsulfase,0,Intravenous,NOCID_021,CIDNOCID_021,both,
LT01402,NOCID_001,abatacept,2005,No-DILI-Concern,0,No match,Yes(literature),vLess-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0836c6ac-ee37-5640-2fed-a3185a0b16eb,2,683,abatacept,1,Intravenous,NOCID_001,CIDNOCID_001,both,
LT01404,NOCID_006,alglucosidase alfa,2006,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d6bfbc45-2d34-439e-8aad-59ee2d53d4df,2,684,alglucosidase alfa,0,Intravenous,NOCID_006,CIDNOCID_006,both,
LT01408,NOCID_039,panitumumab,2006,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e0fa4bca-f245-4d92-ae29-b0c630a315c2,2,686,panitumumab,0,Intravenous,NOCID_039,CIDNOCID_039,both,
LT01409,NOCID_025,idursulfase,2006,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=60cba843-5aab-4dd7-96dc-66648d413be3,2,687,idursulfase,0,Intravenous,NOCID_025,CIDNOCID_025,both,
LT01412,NOCID_014,certolizumab pegol,2008,Less-DILI-Concern,4,Adverse reactions,,Ambiguous DILI-concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b4c2c9dc-a0bb-4d64-a667-a67ebe88392d,2,688,certolizumab pegol,0,Subcutaneous,NOCID_014,CIDNOCID_014,both,
LT01414,NOCID_018,eculizumab,2007,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ebcd67fa-b4d1-4a22-b33d-ee8bf6b9c722,2,689,eculizumab,0,Intravenous,NOCID_018,CIDNOCID_018,both,
LT01415,NOCID_045,rilonacept,2008,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=282f4099-e848-432a-bac1-e041c192a5ba,2,690,rilonacept,0,Subcutaneous,NOCID_045,CIDNOCID_045,both,
LT01416,NOCID_053,ustekinumab,2009,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c77a9664-e3bb-4023-b400-127aa53bca2b,2,691,ustekinumab,0,Subcutaneous,NOCID_053,CIDNOCID_053,both,
LT01417,NOCID_046,romiplostim,2008,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c45f9a58-37c1-4f76-8e36-97d38c577037,2,692,romiplostim,0,Subcutaneous,NOCID_046,CIDNOCID_046,both,
LT01421,NOCID_034,ofatumumab,2009,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e6e738dc-9026-4cd3-8f85-7b10ac730e7d,2,693,ofatumumab,0,Intravenous,NOCID_034,CIDNOCID_034,both,
LT02330,NOCID85,erythropoietin,,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9bbe9a5b-ad1d-41a4-9699-ff6dc776bce1,2,886,erythropoietin,0,Intravenous,NOCID85,CIDNOCID85,both,
LT02384,NOCID_026,imiglucerase,1994,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=df60f030-866b-4374-a31f-8ae3f6b45c38,2,892,imiglucerase,0,Intravenous,NOCID_026,CIDNOCID_026,both,
LT02385,NOCID_004,agalsidase beta,2003,No-DILI-Concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=988513ab-b06f-4dd0-93f7-d2d4531dcce4,2,893,agalsidase beta,0,Intravenous,NOCID_004,CIDNOCID_004,both,
LT02432,NOCID_013,canakinumab,2009,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7d271f3b-e4f9-4d80-8dcf-28d49123f80e,2,895,canakinumab,1,Subcutaneous,NOCID_013,CIDNOCID_013,both,
LT02913,NOCID_023,hyaluronidase recombinant human,2005,No-DILI-concern,0,No match,,vNo-DILI-Concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=95db9785-298f-49bd-a914-a00a306a8bc2 ,2,900,hyaluronidase recombinant human,0,Subcutaneous,NOCID_023,CIDNOCID_023,both,
,NOCID_067,Androgenic steroids*,,,,,,,,,,,,,,901,Androgenic steroids*,1,,NOCID_067,CIDNOCID_067,right_only,
,NOCID_068,Peginterferon,,,,,,,,,,,,,,905,Peginterferon,1,,NOCID_068,CIDNOCID_068,right_only,
,NOCID_069,Sulfonamides*,,,,,,,,,,,,,,906,Sulfonamides*,1,oral,NOCID_069,CIDNOCID_069,right_only,
,3086677,Alatrofloxacin,,,,,,,,,,,,,,955,Alatrofloxacin,1,,3086677,CID3086677,right_only,
,NOCID_070,Antithymocyte Immunoglobulin,,,,,,,,,,,,,,958,Antithymocyte Immunoglobulin,1,,NOCID_070,CIDNOCID_070,right_only,
,2313,bendazolic acid,,,,,,,,,,,,,,961,bendazolic acid,1,,2313,CID2313,right_only,
,NOCID_071,Clomacron,,,,,,,,,,,,,,968,Clomacron,1,,NOCID_071,CIDNOCID_071,right_only,
,NOCID_072,Diacetoxydiphenolisatin,,,,,,,,,,,,,,976,Diacetoxydiphenolisatin,1,,NOCID_072,CIDNOCID_072,right_only,
,NOCID_073,Gemtuzumab,,,,,,,,,,,,,,985,Gemtuzumab,1,,NOCID_073,CIDNOCID_073,right_only,
,NOCID_074,Growth Hormone,,,,,,,,,,,,,,987,Growth Hormone,1,Intravenous,NOCID_074,CIDNOCID_074,right_only,
,NOCID_075,Interferon Unspecified,,,,,,,,,,,,,,988,Interferon Unspecified,1,,NOCID_075,CIDNOCID_075,right_only,
,NOCID_076,Interferon-Beta-1a,,,,,,,,,,,,,,989,Interferon-Beta-1a,1,,NOCID_076,CIDNOCID_076,right_only,
,NOCID_077,interferon-Beta-1b,,,,,,,,,,,,,,990,interferon-Beta-1b,1,,NOCID_077,CIDNOCID_077,right_only,
,NOCID_078,Ioxaglate And Meglumine,,,,,,,,,,,,,,991,Ioxaglate And Meglumine,1,Intravascular,NOCID_078,CIDNOCID_078,right_only,
,NOCID_079,Methylene Dioxymethamphetamine,,,,,,,,,,,,,,998,Methylene Dioxymethamphetamine,1,,NOCID_079,CIDNOCID_079,right_only,
,NOCID_080,Oxyiminoalkanoic acid derivative,,,,,,,,,,,,,,1000,Oxyiminoalkanoic acid derivative,1,,NOCID_080,CIDNOCID_080,right_only,
,NOCID_081,Peginterferon-Alfa-2a,,,,,,,,,,,,,,1001,Peginterferon-Alfa-2a,1,,NOCID_081,CIDNOCID_081,right_only,
,29321,Phenisatin,,,,,,,,,,,,,,1003,Phenisatin,1,,29321,CID29321,right_only,
,NOCID_082,STREPTOKINASE,,,,,,,,,,,,,,1009,STREPTOKINASE,1,Intracoronary; Intravenous,NOCID_082,CIDNOCID_082,right_only,
,5354,Suloctidil,,,,,,,,,,,,,,1010,Suloctidil,1,,5354,CID5354,right_only,
,13109,norgestrel,,,,,,,,,,,,,,1056,norgestrel,1,Oral,13109,CID13109,right_only,
,NOCID_083,octylmethoxycinnamate,,,,,,,,,,,,,,1065,octylmethoxycinnamate,1,,NOCID_083,CIDNOCID_083,right_only,
,1549000,Levocetirizine,,,,,,,,,,,,,,1191,Levocetirizine,1,,1549000,CID1549000,right_only,
,9904,Nandrolone,,,,,,,,,,,,,,1208,Nandrolone,1,,9904,CID9904,right_only,
LT01419,NOCID_063,golimumab,2009,Less-DILI-Concern,8,Adverse reactions,,Ambiguous DILI-concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f86cb4a7-c358-4136-ae57-b32bda9bba00,2,,golimumab,,,NOCID_063,,left_only,
LT01376,NOCID_062,peginterferon alfa-2a,2002,Most-DILI-Concern,7,Warnings and precautions,,Ambiguous DILI-concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=de61685e-2b8c-4e22-84bb-869e13600440,2,,peginterferon alfa-2a,,,NOCID_062,,left_only,
LT02907,NOCID_066,laronidase,2003,Less-DILI-Concern,4,Adverse reactions,,Ambiguous DILI-concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a80ac249-cae4-41f3-88bb-344088b20e60 ,2,,laronidase,,,NOCID_066,,left_only,
LT01426,772,heparin sodium,1939,Less-DILI-Concern,3,Adverse reactions,Yes,vLess-DILI-Concern,,,,,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0d929726-76c3-48fc-b4e7-fd06409f9fb3,2,,heparin sodium,,,22833565,,left_only,
LT00973,772,tinzaparin,2000,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,C(C1OC(C(N[S](=O)(=O)O)C(C1OC2OC(C(C(C2O[S](=O)(=O)O)O)O)C(=O)O)O[S](=O)(=O)O)OC3C(OC(C(C3O)O[S](=O)(=O)O)OC4C(OC(C(C4O)NC(=O)C)O)CO[S](=O)(=O)O)C(=O)O)O,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1513b960-d9d1-11de-8a1e-0002a5d5c51b,2,,tinzaparin,,,772,,left_only,
LT01069,NOCID_055,pegvisomant,2003,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=222a28ca-70c3-474c-850e-fae39eaaf40f,2,,pegvisomant,,,NOCID_055,,left_only,
LT01082,NOCID_056,choriogonadotropin alfa,2000,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a683e58a-63ea-44b8-a326-1a99a537bcf2,2,,choriogonadotropin alfa,,,NOCID_056,,left_only,
LT01227,NOCID_057,mecasermin,2005,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a8b27a1b-a611-4f91-ad22-76d4b390c3ae,2,,mecasermin,,,NOCID_057,,left_only,
LT01319,NOCID_058,aldesleukin,1992,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e2b687e-47f2-4f3c-80ab-e3224befffca,2,,aldesleukin,,,NOCID_058,,left_only,
LT01347,NOCID_060,denileukin diftitox,1999,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=42dfffb1-d0f3-42d5-944c-64f092fc436e,2,,denileukin diftitox,,,NOCID_060,,left_only,
LT01354,NOCID_061,interferon gamma-1b,1999,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1145af19-824f-4701-9620-ee1c76a892b5,2,,interferon gamma-1b,,,NOCID_061,,left_only,
LT01442,NOCID_064,antithymocyte globulin,,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bd545ba1-2366-4df1-bd67-10dfd7632b54,2,,antithymocyte globulin,,,NOCID_064,,left_only,
LT01953,NOCID_065,follitropin alfa/beta,1997,Less-DILI-Concern,3,Warnings and precautions,,Ambiguous DILI-concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=56bac591-9f78-4958-8a3b-878d36d3ceca,2,,follitropin alfa/beta,,,NOCID_065,,left_only,
LT00463,135113,sacrosidase**,1998,Less-DILI-Concern,3,Adverse reactions,,Ambiguous DILI-concern,,,,,CC1OC2=C(O1)C=C(C=C2)C(C)(C)C,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d613bb7f-c3f4-462e-81a2-da2347cc4b6b,2,,sacrosidase,,,,,left_only,
LT01320,NOCID_059,filgrastim,1991,Less-DILI-Concern,1,Adverse reactions,,Ambiguous DILI-concern,,,,,,http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=97cc73cc-b5b7-458a-a933-77b00523e193,2,,filgrastim,,,NOCID_059,,left_only,